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The cat only grinned when it saw Alice. It looked good-natured, she thought: 
still it had VERY long claws and a great many teeth, so she felt that it ought to 
be treated with respect.
‘Cheshire Puss,’ she began, rather timidly, as she did not at all know whether it 
would like the name: however, it only grinned a little wider. ‘Come, its pleased 
so far,’ thought Alice, and she went on. ‘Would you tell me, please, which way I 
ought to go from here?’
‘That depends a good deal on where you want to get to,’ said the Cat.
‘I don’t much care where -- ’ said Alice.
‘Then it doesn’t matter which way you go,’ said the Cat.
‘-- so long as I get SOMEWHERE,’ Alice added as an explanation.
‘Oh, you’re sure to do that,’ said the Cat, ‘if you only walk long enough.’
Alice’s adventures in Wonderland
Lewis Carroll (1832-1898)
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Understanding heart development is important for identifying the origin of congenital heart 
malformations, the most common birth defects. The heart is the first functional organ in the 
developing embryo. The early heart tube elongates by addition of cells from a pool of progenitors, 
called the second heart field (SHF), from which most regions of the heart are derived. After 
heart looping is completed, the formation of the chambers starts, as well as valvulogenesis in the 
atrioventricular canal (AVC) and in the outflow tract (OFT). A complex network of signalling 
molecules and transcription factors regulates heart morphogenesis and although different aspects of 
heart formation have been extensively studied, some of the processes are still not fully understood. 
For instance, the cellular mechanism of cell deployment from the SHF to the heart tube is unknown; 
also, later events in valve formation remain poorly understood. 
Arid3b, a member of the conserved ARID family, was identified in the course of a candidate 
gene screen for factors important in vertebrate organogenesis. Based on its initial expression 
pattern, we decided to study its possible role in heart development. Arid3b expression can be 
detected in the early heart tube and in the SHF cells. When looping starts, the expression in the 
chambers diminishes but is maintained strong in the poles. Later, expression can be detected in the 
endocardium and in the epicardium. We used a gene-trap loss of function mouse line to analyse 
Arid3b function in heart development. Three main defects were observed: shortening of the poles 
of the heart, loss of normal patterning of the AVC and lack of epithelial-to-mesenchimal transition 
(EMT) in the AVC. The patterning defect in the myocardium seems to be responsible for EMT 
disruption, since in AVC explants in vitro, the invasion capacity of mesenchymal cells can be 
rescued by addition of Bmp2, a factor reduced in the mutant myocardium by the stage EMT starts. 
An RNA microarray analysis of wild type versus mutant embryos revealed a set of differentially 
expressed genes related to cell morphology and cell movement, suggesting that Arid3b might be 
involved in the regulation of these processes. The motility defect observed in mouse embryonic 
fibroblast derived from Arid3b-null embryos further supports this hypothesis. Moreover, while 
the balance of cell proliferation and cell death was normal in the SHF of mutant embryos, normal 
architecture was disrupted. DiI labelling of precursors from the SHF showed that in Arid3b-null 
embryos cells fail to properly ingress into the heart tube, pointing again to a role of this gene in 
cell motility. Precursors entering the heart tube also failed to differentiate properly and one of the 
candidate genes from the microarray, Bhlhb2 (upregulated in the mutant heart), might be involved 
in this process. On the other hand, conditional deletion of Arid3b in the Nkx2.5 positive population 
using a floxed line, leads to defective valve remodelling, pointing to a later role of the gene in 
valve maturation. 
This work uncovers an unsuspected role for Arid3b in heart formation, provides new mechanistic 
insight to heart development and reveals Arid3b as a candidate gene of human cardiac congenital 
malformations.
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Embryonic development is the sum of biological processes that lead to the formation of a mature 
complex organism from an unicellular zygote. Although important variations in development exist 
between different species, common mechanisms are present in all of them. Multicellular organisms 
arise by progressive changes driven by an increase in cell number, differentiation and specification 
into different cell types and their organization in tissues and organs. Disruption of any of the 
tightly regulated steps of development leads to malformations, a major issue in human health, 
as about 3% of live births occur with some kind of congenital defects, according to the Centres 
for Disease Control and Prevention (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a2.
htm) (Parker S.E. et al., 2010).     
The heart is the first organ to function during embryonic development. Even at very early 
developmental stages, as soon as the heart tube is formed, a peristaltic contraction pattern can 
be detected. In mammals, the mature heart is a four-chambered muscular organ with separated 
pulmonary and systemic circulatory pathways, which pumps blood through blood vessels (Figure 
1). Before the definitive structure is achieved, the heartbeat has to be maintained and modified 
through development, while the organ grows and suffers morphogenetic changes. The primitive 
heart tube, which is first formed only by two layers, the myocardium and the endocardium, 
undergoes a stage of elongation by addition of cells from the pharingeal mesoderm and looping, 
followed by chamber specification, valvulogenesis, trabeculation, formation of the third layer, the 
epicardium, and septation. A large set of structural and functional defects that arise during cardiac 
embryogenesis lead to congenital heart disease (CHD), the most common congenital anomaly in 
new-borns (Fahed A.C. et al., 2013). 
Figure 1. Anterior view of a mature 
mammalian heart. It is formed by 
four chambers: the left ventricle 
(LV) connected to the aorta; the 
right ventricle (RV), from which 
the pulmonary artery emerges; the 
right atrium (RA) connected to the 
caval veins; the left atrium (LA), in 
contact with the pulmonary artery. 
The heart also contains four valves: 
the aortic valve, the pulmonary valve, 
the tricuspid valve and the mitral 
or bicuspid valve. The wall of the 
heart is formed by three layers: the 
myocardium, the endocardium and 
the epicardium.
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The use of mice as a model organism has proven to be very useful to address normal heart 
development, as well as the aetiology of human cardiac diseases. Mice are closely related to 
humans and show great similarities in anatomy, physiology and genetics; moreover, our ability to 
manipulate the mouse genome provides a powerful tool to study gene function and model human 
disease.
HEART DEVELOPMENT
Early steps in heart formation
The heart derives from the lateral plate mesoderm. During gastrulation epiblast cells ingress 
through the primitive streak and form the mesodermal layer. The trunk mesoderm of a neurula-
stage embryo can be subdivided in four regions: the chordamesoderm, the paraxial or somatic 
mesoderm, the intermediate mesoderm and the lateral plate mesoderm. The lateral plate mesoderm 
is located farthest away from the notochord and gives rise to the heart, blood vessels and blood 
cells and the lining of the body cavities, including the pericardial cavity which envelops the heart. 
In the early gastrula heart progenitor cells ingress at the rostral and middle segments of the 
primitive streak along with other cells destined for rostral structures, such as head mesoderm. Heart 
precursors get established in the lateral plate mesoderm where they form two bilateral cardiogenic 
fields. In the chick myocardial specification is induced by the hypoblast through transforming 
growth factor family b (TGF-b) factors, while in the mouse this function might be taken by 
the anterior visceral endoderm (Nijmeijer R.M. et al., 2009). Mesp1 (mesoderm posterior1) is 
expressed in the early mesodermal cells that ingress into the primitive streak and, as shown by 
genetic lineage tracing, almost all cardiac cells derive form Mesp1 positive population (Saga Y. 
et al., 1999) (Saga Y. et al., 2000). Together with Mesp2 it controls the exit of the mesoderm 
precursors of the primitive streak by regulating epithelial to mesenchymal transition (EMT) and 
cell migration (Kitajima S. et al., 2000) (Lindsley R.C. et al., 2008). It also acts as a key regulator 
of cardiovascular lineage commitment promoting the expression of the majority of cardiovascular 
transcription factors, such as Gata4, Nkx2.5, Hand2, Mef2c, Tbx20, myocardin (Bondue A. et al., 
2008) (Bondue A. and Blanpain, 2010). 
Once located in the lateral plate mesoderm the heart progenitors form a region called the cardiac 
crescent where promyocardial and endothelial cells are intermingled. The future myocardial cells 
express Nkx2.5, a master gene essential for integration of patterning information (Prall O.W.J. et 
al., 2007). At the same time, the neural plate starts to fold to become the neural tube, a process 
coupled with the invagination of the endoderm to produce the foregut. The heart forming regions 
move to the midline of the embryo in close proximity to the endoderm and fuse to form the initial 
heart tube (Moorman A. et al., 2003) (Wagner M. and Siddiqui, 2007). Together with Nkx2.5, 
Gata4 is one of the earliest genes expressed in the cardiac crescent and it regulates the expression 
of a number of myocardium-specific factors. Other genes, such as Tbx5, Mef2c (MADS-box) and 
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basic helix-loop-helix Hand1/2 are also implicated in the differentiation of myocardial cells in the 
crescent. Recently, important cardiogenic induction properties have been discovered for chromatin 
remodelling component Baf60c/Smarcd3. Non-cardiogenic mesoderm can be differentiated into 
contracting cardiomyocytes in the presence of Gata4, Tbx5 and Baf60c; Baf60c seems to recruit 
BAF chromatin remodelling complexes to heart-specific enhancers (Takeuchi J.K. and Bruneau, 
2009). 
The heart fields
Classically, it was considered that cardiac precursor cells were pre-patterned in terms of their 
contribution to the heart tube along the anterior-posterior axis, a pre-patterning which was present 
in the cardiac crescent and retained in the heart tube. This led to the proposal of the segmental 
model of heart formation where each region of the heart was composed of a separate unit and 
derived from a pre-patterned pool of progenitor cells, as well as supported the idea that all the 
heart forming cells were contained in the early heart tube (reviewed in (Buckingham M. et al., 
2005)). However, for many years, studies from both chick and mouse appreciated that the heart 
tube continues to elongate through addition of cells to the poles. In their work in chick embryos, 
de la Cruz and colleagues observed that iron oxide particles placed in the cephalic end of the 
cardiac tube were observed at later stages inside the heart. In other series of experiments, the heart 
tube was separated from its anterior attachment and, as a consequence, failed to form the cephalic 
region. Their work led them to propose that not all parts of the heart are present in the pre-looped 
stage, but are added at different developmental moments (Argüello C. et al., 1975) (de la Cruz 
M.V. et al., 1977). However, it was not until 2001 when three independent studies, two in chick 
and one in mouse, confirmed the existence of a source of arterial progenitors through molecular 
and labelling techniques (Waldo K.L. et al., 2001) (Mjaatvedt C.H. et al., 2001) (Kelly R.G. et al., 
2001) (reviewed in (Kelly, 2012)). The elongation and looping of the heart is driven by the addition 
to the poles of a highly proliferative population of cardiac precursor cells. They are located in the 
pharyngeal mesoderm beneath the heart tube and were termed the second heart field (SHF), as 
opposite to the first heart field which forms the tube (Buckingham M. et al., 2005) (Figure 2). The 
SHF cells express LIM homeodomain transcription factor Islet1 and lineage tracing experiments 
showed that the right ventricle, outflow tract (OFT) and the inflow region of the heart are derived 
from these Islet1 positive progenitors located in the pharyngeal mesoderm. Mutation of this gene 
leads to the formation of a linear heart tube unable to loop and elongate (Cai C.L. et al., 2003). 
Islet1+ progenitors are multipotent, as they are able to differentiate to cardiomyocytes, endothelial 
and smooth muscle cells (Moretti A. et al., 2006). 
Subdomains within the SHF: the AHF and the pSHF
Inside the SHF, different subdomains can be distinguished, depending on the expression profile 
and the regions they form (Figure 2) (Vincent S.D. and Buckingham, 2010). The anterior region of 
the SHF (anterior heart field, AHF) provides cells to the arterial pole of the heart and gives rise to 
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the right ventricle and OFT (Kelly R.G. et al., 2001) (Zaffran S. et al., 2004). The AHF is marked 
by expression of several factors, such as Fgf8, Fgf10, Tbx1, Mef2c SHF enhancer. On the other 
hand, cells that contribute to the inflow region of the heart express Islet1 but not AHF markers 
and can be defined as the posterior SHF (pSHF). It has been shown that the atrioventricular canal 
(AVC), large proportion of the atria and the systemic venous inflow are derived from pSHF. 
The anterior-posterior patterning of the SHF is regulated by retinoic acid (RA). The mutation 
of retinaldehyde dehydrogenase 2 (RALDH2), which catalyzes the second oxidative step in RA 
Figure 2. Overview of early heart development. (A) Schematic representation of mouse embryo at E7.5 
when cardiac precursors migrate anteriorly from the primitive streak (PS). (B) Frontal view of an E8.0 
embryo, the cardiac crescent is formed with cells from the first heart field (FHF, green). Precursor cells from 
the second heart field (SHF, red) lie medially to the cardiac crescent. (C) By E8.5, the cardiac tube is formed 
by fusion of the heart forming regions in the midline of the embryo; at this stage the heart starts to loop. (D) 
Frontal view of an E9.5 embryo where already a common ventricle (V) and atria (A) can be distinguished, as 
well as the atrioventricular canal (AVC) and the outflow tract (OFT). Contribution of SHF to the OFT, right 
ventricle, inflow region (IFT) and AVC can be observed depicted in pink. Also at this stage the neural crest 
cells (yellow) migrate from the pharyngeal arches to the arterial pole of the heart. Adapted from (Vincent 
S.D. and Buckingham, 2010). (E) Lateral view of an E8.5 and E9.5 embryos showing the elongation of the 
poles of the heart. Some of the molecules important for the development of both anterior heart field (AHF) 
and posterior SHF (pSHF) are d picted. Already the right and left vent icles can be distinguished (RV nd 
LV), as well as two regions in the OFT, the proximal (pOFT) and distal (dOFT).
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biosynthesis, causes a severe embryonic RA deficiency. Mutants for this enzyme present a posterior 
expansion of AHF markers, such as Tbx1 and Fgf8, fail to undergo heart looping and to form 
normal atria and sinus venosus (Ryckebusch L. et al., 2008). Islet1 expression is also expanded 
caudally when RA signalling is disrupted, suggesting that RA controls the posterior limits of the 
SHF (Sirbu I.O. et al., 2008). Hox genes are some of the important targets of RA. Their expression 
characterize distinct subdomains along the antero-posterior axis in the SHF and expressing cells 
contribute both to the atria and future myocardium at the base of the aorta (Bertrand N. et al., 
2011).
Different studies have described a set of transcriptional and growth factors expressed in the 
AHF and involved in proper OFT and right ventricle formation, as their deletion gives rise to 
defects in the formation of these structures. For instance, ablation of Fgf8 from the pharyngeal 
mesoderm leads to truncation of OFT and right ventricle, as a result of decreased cell proliferation 
and increased cell death of the AHF population (Ilagan R. et al., 2006) (Park E.J. et al., 2006). 
Tbx1, a T-box-containing transcription factor responsible for many defects observed in 22q11 
deletion syndrome, is also expressed in the AHF and its ablation leads to OFT defects related to 
decrease in cell proliferation (Zhang Z. et al., 2006). Canonical Wnt/b-catenin signalling is also 
active in the pharyngeal mesoderm. b-catenin ablation leads to decrease in proliferation of Islet1+ 
progenitors and loss of FGF signalling, and, as a consequence, the OFT appears shortened and the 
right ventricle is reduced. On the other hand, stabilization of b-catenin in the nucleus produces 
the opposite effect: expansion of Islet1+ cells, enlarged OFT, abnormal right ventricle and defects 
in differentiation of Islet1+ cells in the OFT (Cohen E.D et al., 2007) (Qyang Y. et al., 2007) (Ai 
D. et al., 2007). Bmp2 and 4 are expressed in the OFT and promote myocardial differentiation of 
SHF cells: deletion of both of these genes leads to an expanded progenitor gene expression (Islet1 
and Tbx1) and reduction of myocardial markers, such as sarcomeric myosin, in the proximal OFT 
(Wang J. et al., 2010). 
Development of the posterior pole of the heart is poorly understood in comparison with the 
AHF region. It has been shown that more cranial cells in the pSHF contribute to the AVC and atria, 
while more caudal regions give rise to the sinus venosus. The contribution is symmetric from the 
distal portion, but the fate of cranial pSHF is asymmetrical, with the right region contributing 
to the ventral left atrium (Domínguez J.N. et al., 2012). The Wnt/b-catenin pathway plays an 
important role in the regulation of the posterior cardiac mesoderm; Wnt2, an activator of the 
pathway, is expressed in the posterior pole of the heart and in the inflow region from E8.5. In 
Wnt2 mutant embryos formation of the atria and AVC is compromised. Signalling by Wnt2 proved 
to be necessary for the expansion of SHF progenitors and the later myocardial proliferation and 
differentiation, partially through activation of Gata6 (Tian Y. et al., 2010). The sinus horns of the 
systemic venous return are derived from a population of cells positioned ventral-caudal-lateral to 
the SHF. These cells fail to express Nkx2.5 and Islet1, but are marked by Tbx18 expression and 
form a myocardium distinguished from the atria myocardium by its Nkx2.5- Cx40- expression 
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profile (Christoffels V.M. et al., 2006). This lateral rim of cardiogenic mesoderm also contains 
the precursors of the proepicardium, which will give rise to the epicardium, coronary vessels and 
fibroblasts. 
SHF proliferation and deployment
One of the obvious changes occurring in the early heart tube is its growth and increase in the 
number of cardiomyocytes. Strikingly, proliferation of the heart precursors decreases dramatically 
when they differentiate and incorporate into the heart tube. Consequently, cardiomyocytes within 
the early heart tube proliferate at a very slow rate. Both in chick and in mouse early cardiac 
growth occurs through the recruitment of cells to the poles of the heart from the SHF pool of 
progenitors (Soufan A.T. et al., 2006) (de Boer B.A. et al., 2012). As has been shown above, a 
number of signalling pathways that impact SHF promote proliferation. Recent results in the chick 
indicate that the heart elongates gradually at both poles from a single bilateral caudal growth 
centre located in the caudomedial pericardial wall and positive for Islet1. Moreover, cells from 
this region can be traced as they move cranially to differentiate into myocardium in the arterial 
pole (van den Berg G. et al., 2009) (van den Berg G. and Moorman, 2009). However, although it 
is clear that SHF precursors contribute to the poles, the cellular mechanism by which progenitors 
move from the SHF into the growing heart tube is unknown. In the chick, the SHF is described 
as a pseudostratified columnar layer of epithelial cells (Waldo K.L. et al., 2005). Non-canonical 
Wnt signalling seems to be important for OFT development. Wnt11 mutants show early OFT 
defects and cytoskeletal rearrangements and polarized cell movement required for proper OFT 
morphogenesis are affected (Zhou W. et al., 2007). Disheveled (Dvl) is a regulator of both the 
canonical Wnt/b-catenin and the planar cell polarity (PCP) pathways. Dvl1/2 mutants display OFT 
shortening, similarly to those observed in Vangl2 (the core PCP gene) mutants and in the absence 
of non-canonical Wnt gene Wnt5a. Both in Dvl1/2 and Wnt5a mutants the caudal splachnic 
mesoderm presents aberrant cell packing and reduced filopodia formation. It was proposed that 
PCP signalling induces a mesenchymal to epithelial conversion, promoting SHF contribution to 
the OFT by a cell intercalation process (Sinha T. et al., 2012). Deletion of both Wnt5a and Wnt11 
showed their requirement to inhibit the canonical Wnt/b-catenin pathway, but no analysis were 
done of other possible SHF defects in these double mutants (Cohen E.D. et al., 2012).
Interaction of SHF with the pharyngeal endoderm and neural crest cells
SHF development, proliferation and deployment are also dependent on the interaction with 
other cell types. For instance, the ventral pharyngeal endoderm remains in close contact with the 
SHF precursors and generates some molecular cues important for the maintenance of this pool 
of progenitors. Fgf8, apart of being expressed in the SHF, is also expressed in the pharyngeal 
endoderm and its function in this tissue is required for proper OFT septation (Park E.J. et al., 
2006). Shh is also expressed in the pharyngeal endoderm and its disruption gives rise to defects 
in both the arterial and venous poles. The AHF requires Shh signalling for proper septation of the 
OFT (Goddeeris M.M. et al., 2007). Shh signalling is also necessary for atrial septation (Hoffmann 
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A.D. et al., 2009). 
The cardiac neural crest (CNC) is a subpopulation of neural crest cells that contribute to the 
smooth muscle of the pharyngeal arch arteries and also migrate through the AHF into the OFT 
to contribute to the endocardial cushions. However, CNC ablation leads not only to septation 
defects, but also to reduction in OFT myocardium and arterial pole defects. In chick it has been 
shown that cells destined to form the OFT myocardium fail to migrate and are retained at the 
base of the arterial pole after elimination of CNC (Waldo K.L. et al., 2005). Ablation of the CNC 
leads to increased levels of Fgf8 (otherwise, buffered by these cells) in the caudal pharynx, which 
disrupts SHF cells deployment (Hutson M.R. et al., 2006). In the mouse, mutation of Tbx3, which 
is expressed in the CNC, leads to OFT shortening; in this case, impaired CNC cells function seems 
to affect proliferation and deployment of the SHF cells (Mesbah K. et al., 2008). BMP pathway 
also plays an important role in the crosstalk between CNC and SHF, as deletion of Smad4 from 
the CNC leads to increased apoptosis in these cells, but also to alteration in the expression of some 
factors in the SHF and in OFT elongation defect (Jia Q. et al., 2007).
Multiple heart fields?
The identification of a second mesodermal region as a source of cardiac cells changed the 
view on the formation of the heart. However, controversy exists on whether the so-called FHF 
and SHF represent two separate lineages or reflect a gradual contribution and differentiation of the 
precursors. Islet1 was considered a marker for the SHF, but later studies showed that expression 
of Islet1 is broader and it can be detected in the cardiac crescent, in the FHF and partially in the 
left ventricle (Prall O.W.J. et al., 2007) (Ma Q. et al., 2008) (Sun Y. et al., 2007). So, rather than 
marking a distinct lineage, expression of Islet1 seems to be related to the differentiation state of the 
precursors. However, it is interesting to notice that deletion of Islet1 does not affect the formation 
of the primary heart tube and the phenotype mainly reflects a problem of SHF contribution to the 
heart tube (Cai C.L. et al., 2003). To address the question of lineage relationship between different 
regions of the heart in a gene expression-independent manner, a retrospective clonal analysis, where 
low frequency recombination events produce random clones in the myocardium, was carried out. 
The authors observed some clones in two or more adjacent cardiac compartments, other clones 
present exclusively in the left ventricle or in the poles of the heart and clones extending through 
all the cardiac compartments. The authors concluded that the results point to the existence of two 
lineages that segregate early from a common progenitor and, while most regions of the heart are 
colonized by both, there is an exclusive contribution of the first lineage to the left ventricle and of 
the second to the OFT (Meilhac S.M. et al., 2004). However, another interpretation can be given 
to these results. The distribution of clones over the heart reflects the gradual formation of this 
organ. In this case, early recombination events will give rise to clones in the left ventricle and in 
contiguous compartments, which are the first to be formed, while later recombination will take 
place in the precursors of the poles of the heart, which are formed later (Moorman A.F.M. et al., 
2007). Recently, a distinct, tertiary field was proposed to exist in the chick embryo. Pacemaker cells 
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arise from a discrete region of mesoderm outside the classical FHF and SHF and are recruited by 
canonical Wnt signalling (Bressan M. et al., 2013). The proposal of distinct fields existing inside 
the heart-forming region (HFR) would imply a specific fate commitment to each of these fields. 
Classical experiments performed in early chick embryos that transplanted tissue within the HFR 
showed that relocated cells are able to adapt to their new location, arguing against an irreversible 
commitment of these cells (Satin J. et al., 1988). It would be interesting to repeat these studies 
with the current knowledge of heart formation to add new evidence about the nature of the HFR. 
Differentiation of the heart tube
Shortly after its emergence, the heart tube starts to loop, while cells are added to its poles and 
Islet1+ cells differentiate into cardiomyocytes and start expressing muscular markers. The newly 
formed myocardium displays characteristics of a primary or embryonic myocardium with slow 
proliferation, slow conduction, slow contraction and the ability to depolarize spontaneously. But 
shortly after looping, ventricular and atrial chambers are formed and the myocardial phenotype of 
these regions changes: now, it is characterized by formation of gap junctions consistent of Cx40/
Cx43 for fast conduction and an increase in the proliferation rate. The remaining regions – the 
inflow tract (IFT), the AVC and the OFT - retain the characteristics of the embryonic myocardium 
(Christoffels V.M. et al., 2000). The primary myocardium plays important roles in the developing 
heart. The myocardium of the AVC and the OFT signals to the endocardium to form the cushion 
mesenchyme which would later give rise to the valves (Eisenberg L.M. and Markwald, 1995). 
Also, the primary myocardium protects against the backflow of blood before the valves are formed 
and provides progenitors for the nodes of the conduction system. 
The regionalization of the myocardium is driven by differential gene expression. The nascent 
chamber myocardium is characterized by expression of Anf, Cited1, Cx40, Cx43 and Chisel, while 
Tbx2 and Tbx3 are present exclusively in regions of primary myocardium. Deletion of Tbx5 in 
the developing heart leads to decreased levels of Anf and Cx40 in the chambers (Bruneau B.G. et 
al., 2001). Tbx5 associates synergistically with Nkx2.5 to promote cardiomyocyte differentiation; 
they both bind to the Anf promoter and activate its expression (Hiroi Y. et al., 2001). At the same 
time, Tbx2 is expressed in regions of primary myocardium (IFT, AVC and OFT) where it forms 
a complex with Nkx2.5 and represses the expression of Anf (Habets P.E.M.H. et al., 2002). 
Overexpression of Tbx2 through the whole myocardium inhibits chamber formation and represses 
Cx40 and Cx43 promoter activity and Anf expression, confirming the role of Tbx2 as a determinant 
factor in the repression of chamber specific genes (Christoffels V.M. et al., 2004). Interestingly, 
genetic lineage tracing showed that Tbx2+ primary myocardium contributes to both ventricles; 
in the AVC, Tbx2 represses differentiation and proliferation of the myocardium, but switching 
off Tbx2 expression allows these cells to initiate differentiation into chamber myocardium and to 
proliferate (Aanhaanen W.T.J. et al., 2009). Tbx20, another T-box factor, is expressed through the 
whole myocardium and is necessary to ensure the progression from the linear heart tube to multi-
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chambered heart by repressing Tbx2. In Tbx20 mutant embryos chamber myocardium is not formed 
and Tbx2 is ectopically expressed in the linear heart tube (Singh M.K. et al., 2005). Another factor 
controlling multiple aspects of AVC morphogenesis is Bmp2. Apart from its role in early cardiac 
formation, Bmp2 is also expressed at high levels in the AVC and at lower in the OFT. Deletion of 
Bmp2 from the AVC leads to downregulation of Tbx2 and expansion of chamber-specific genes to 
the AVC (Ma L. et al., 2005). Bmp2 has been shown to regulate directly the expression of Tbx2 
through pSmad1/5/8 binding to a Tbx2 enhancer that confers AVC specific expression to Tbx2. 
Tbx20 competes with Smad4 for binding Smad1 and 5 and thus supresses Tbx2 expression in the 
chambers (Singh R. et al., 2009). Tbx20 has been also proposed to regulate positively Hey1 and 
Hey2. Hey1 and Hey2, expressed in atrium and ventricle, respectively, regulate the AVC boundary 
and repress Tbx2 expression in the chambers (Kokubo H. et al., 2007). 
Tbx3 is yet another member of the T-box family implicated in the regulation of heart 
development. At early stages of embryonic development, Tbx3 is expressed in a continuous way in 
a myocardial domain that extends from the sinoatrial node to the atrioventricular region. Similarly 
to Tbx2, Tbx3 represses Anf and Cx40 expression and disrupts their activation by the Nkx2.5-Tbx5 
complex (Hoogaars W.M. et al., 2004). Tbx3 expression also delineates the sinoatrial node region, 
which controls the rate and rhythm of contraction and serves as the pacemaker of the heart. Ectopic 
expression of Tbx3 represses the atrial phenotype and imposes a pacemaker phenotype on atrial 
cells. Tbx3 is also required for molecular specification of the atrioventricular bundle and proximal 
bundle branches through repression of differentiation and proliferation, imposing the conduction 
system phenotype (Hoogaars W.M.H. et al., 2007) (Bakker M.L. et al., 2008). Although a direct 
regulation as in the case of Tbx2 has not been shown, Bmp2 is upstream of Tbx3 expression, as 
Bmp2 inactivation in myocardium leads to loss of Tbx3 in the AVC (Singh R. et al., 2012). 
Valve formation.
The first step in heart septation is the formation of endocardial cushions, which later will be 
remodelled into atrioventricular cardiac valves (the ones formed in the AVC) and conoventricular 
cardiac valves (formed in the OFT). The myocardial and endocardial layers of the early heart 
tube are separated by an extracellular matrix, known as cardiac jelly, which expands focally to 
form endocardial cushions in the AVC and in the OFT. Later, endocardial cells that line these 
cushions undergo epithelial-to-mesenchymal transition (EMT) and the formed mesenchymal cells, 
precursors of the future valves, populate the cushions. Next steps involve their proliferation and 
expansion and elongation and remodelling of the valves to form mature leaflets (von Gise A. and 
Pu, 2012). Endocardial EMT occurs in both AVC and OFT, but in the last case valve formation 
starts later in gestation and involves important contribution from the cardiac neural crest, so the 
two processes will be discussed separately. 
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AVC cushions 
Endocardial EMT depends on both the specialized AVC myocardium and cushion endocardium 
and the signal exchange between them (Figure 3). Bmp2, although expressed only in the 
myocardium and not in the endocardium, is required to enhance the formation of the cardiac 
jelly and to induce endocardial EMT (Ma L. et al., 2005). A feedback loop exists between Bmp2-
Tbx2/3; while Bmp2 induces the expression of these two transcription factors, their expression 
is needed to maintain Bmp2 levels in the myocardium, as in double Tbx2/3 mutants Bmp2 
expression is reduced. Moreover, misexpression of either Tbx2 or Tbx3 in the heart leads to ectopic 
expression of Bmp2 in the chamber myocardium and of EMT markers, such as Snail1 and Has2, 
in the underlying endocardium, with consequent cardiac jelly expansion and cushion formation. 
This induction is dependent on Bmp2, as inhibition of the BMP receptor down-regulates EMT 
markers and cushion formation (Singh R. et al., 2012) (Shirai M. et al., 2009). Indeed, Bmp2 can 
substitute for AVC myocardium in AVC explant cultures, supporting its role as a key myocardial 
EMT-inducing factor (Sugi Y. et al., 2004) (Rivera-Feliciano J. et al., 2006). Bmp2 activates the 
expression of some EMT genes in the endocardium, like Twist1, which acts upstream of Tbx20 
in the endocardium and promotes mesenchymal cell proliferation and migration, while inhibiting 
valve cell differentiating (Shelton E.L. and Yutzey, 2007) (Shelton E.L. and Yutzey, 2008). Tgf-b2 
is another important factor for EMT that acts downstream of Bmp2. Tgf-b2 mutants show reduced 
number of mesenchymal cells, and it is also required to conclude the later stages of EMT (Sugi Y. 
et al., 2004) (Azhar M. et al., 2009). Tgf-b2 also has a role in valve remodelling and differentiation 
by inducing matrix organization and repressing the differentiation of the cushion mesenchyme into 
the cartilage cell lineage (Azhar M. et al., 2011). 
The Notch pathway is also required for several steps in valve development. The Notch receptor 
is a single-pass transmembrane protein with an extracellular domain through which it binds to 
its ligands (Delta or Jagged), and a Notch intracellular domain (NICD), which is released after 
activation by the ligand and translocates into the nucleus to activate gene expression (Andersson 
E.R. et al., 2011). N1ICD (the active form of Notch1) is expressed in the endocardium lining 
the AVC and the OFT (del Monte G. et al., 2007), indicating that, contrary to Bmp2, it promotes 
endocardial EMT directly from the endocardium. Deletion of Notch activity in the endocardium 
leads to downregulation of Tgf-b2 and Snail1, a key promoter of EMT, and absence of EMT 
both in vivo and in vitro (Timmerman L.A. et al., 2004). Contrarily, overexpression of N1ICD 
through out the endocardium leads to ectopical activation of the mesenchymal gene program. 
Notch confines Bmp2 expression to the AVC myocardium, as Hey1 and Hey2, targets of Notch, 
repress Bmp2 expression in the endocardium. Bmp2 and Notch1 signalling pathways converge in 
Snail1 activation and promote a valve-forming field in the developing heart (Luna-Zurita L. et al., 
2010) (de la Pompa J.L. and Epstein, 2012).  
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OFT cushions and neural crest cells (NCCs)
 OFT cushion development implies interaction between endocardium, endocardial-derived 
mesenchyme and cardiac neural crest. At the same time as the OFT is remodelled and separates 
into two vessels, the aorta and the pulmonary trunk, it rotates and aligns with the ventricles, so 
that the aorta emerges from the left ventricle and the pulmonary trunk from the right ventricle. The 
OFT contains two pairs of cushions: the conal cushions that form the conal septum when they fuse 
and separate the proximal OFT into right and left ventricular outlets; the truncal cushions which 
form the aortopulmonary septum, dividing the distal OFT into the aorta and pulmonary trunk. 
Adjacent to the conotruncal cushions, the intercalated cushions are formed and together they form 
the aortic and pulmonar valves (Lin C.J. et al., 2012). Deletion of both BMP6 and BMP7 from the 
myocardium disrupts the invasion of the cushions by endocardial cells (Kim R.Y. et al., 2001). At 
the same time, the SHF provides a source of Bmp4, which is necessary for cushion expansion and 
remodelling (Liu W. et al., 2004) (McCulley D.J. et al., 2008). On the other hand, Tbx2, which is 
expressed in the OFT myocardium, has been shown to activate directly the expression of Tgf-b2 
in the myocardium, ultimately responsible for the induction of EMT in OFT cushions (Sakabe M. 
et al., 2012). 
  The NCCs migrate from their original location in the rhombomeres 6-8 and invade the OFT to 
form the aortopulmonary septum. The OFT myocardium secretes Sema3c to attract the NCCs and 
promote the invasion of the truncal cushions where they turn into mesenchymal cells (Toyofuku 
Figure 3. Schematic presentation of early steps of valve formation. AVC myocardium expresses 
Bmp2 that acts both on the myocardium (red) and on the endocardium (green). In the myocardium, Bmp2 
induces the expression of Tbx2 and Tbx3 through pSmad1/5/8 signalling. Tbx2/3 repress the expression of 
chamber markers, such as Anf. In the AVC endocardium, part of the endothelial cells undergo epithelial-to-
mesenchymal transition (EMT) and invade the underlying cardiac jelly (yellow). Notch1 and its ligands are 
expressed in the endocardium and activated Notch intracellular domain (NICD) together with pSmad1/5/8 
activated by myocardial Bmp2 promote the expression of genes involved in EMT, such as Snail1/2, Tgfb2 
and Twist1.
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T. et al., 2008). The truncal mesenchyme later differentiates into smooth muscle septum. Fgf8 
signalling is important for the surviving of migrating NCCs, as reduction of Fgf8 levels leads to 
massive cell death when NCCs delaminate from the neural tube or when they reach the pharynx 
(Abu-Issa R. et al., 2002). FGF has been also shown to upregulate Bmp4, which enhances smooth 
muscle differentiation of NCCs (Zhang J. et al., 2010). Also, Notch in the NCCs is necessary for 
their differentiation into smooth muscle cells (High F.A et al., 2009). 
Maturation of the cardiac valves
Post-EMT valve remodelling, where mesenchymal cells differentiate into interstitial fibroblasts 
and remodel their environment into a mature valve, is poorly understood. The expansion of the 
cushions is driven by proliferation of mesenchymal cells controlled by multiple signals such as 
Wnt/b-catenin pathway, BMPs and Fgf4 (Combs M.D. and Yutzey, 2009). It has been proposed that 
two distinct zones exist within the developing cushion tissue: a zone of proliferation close to the 
endocardium and a zone of differentiation adjacent to the myocardium, although the mechanisms 
for this regionalization are unknown (de Vlaming A. et al., 2012). During fetal stages the valve 
elongates to form a thin valve leaflets. This is accomplished by an increase of cellular density and 
reorganization of extracellular matrix (Kruithof B.P. et al., 2007). Differentiation of mesenchymal 
cells and appropriate deposition and ordering of the extracellular matrix are two processes essential 
for the formation of a functional valve. Periostin, a protein of the extracellular matrix, plays an 
important role in stimulating a valvulogenic signalling pathway. Periostin is secreted by cushion 
cells into the extracellular matrix and via b-integrin/FAK/ERK pathway promotes cell adhesion, 
migration and survival, as well as regulates the expression of hyaluronan and collagen I and 
activates collagen compaction (Norris R.A. et al., 2009) (Ghatak S. et al., 2014).  
ARID FAMILY
The ARID family is a family of transcriptional factors characterized by a highly conserved 
DNA binding domain called ARID domain. The name stands for AT rich interaction domain, and 
derives from the first study where the founding member of the family, Bright (B cell regulator of 
IgH transcription) was described. In this work, the authors observed a previously unknown DNA 
binding domain with affinity for AT-rich DNA (Herrscher R.F. et al., 1995). Briefly after that, the 
dead ringer (dri) gene was described in Drosophila, identified in a screen as a gene with similar 
DNA-binding characteristics of homeodomain proteins. The newly described gene lacked any 
homology to the homeobox, but its ARID domain was closely related to other genes, including 
Bright. A novel, highly conserved family of DNA-binding proteins was established (Gregory S.L. 
et al., 1996). Later, members of the ARID family were found in a wide range of species, from yeasts 
to nematodes, insects and mammals, as well as in plants and fungi (Zhu H. et al., 2008) (Hansen 
F.T. et al., 2008). There are 15 proteins described in humans and 6 in Drosophila and members of 
the family have been shown to be involved in chromatin remodelling, cell differentiation, control 
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of cell cycle and embryonic development (Kortschak R.D. et al., 2000) (Wilsker D. et al., 2002). 
Since the number of members of the ARID family grew, a tighter consensus sequence for the 
ARID domain emerged. This consensus sequence extends across around 100 residues; outside 
the ARID domain, the proteins of the family show diversity of sequence, structure and functions 
(Wilsker D. et al., 2002). The ARID domain codifies for six a-helices that form a non-canonical 
helix-turn-helix motif. The 3D structure of the minimal ARID domain-DNA complex, together with 
the poor conservation of aminoacids which dictate binding specificity to the DNA, suggests that 
most ARIDs bind DNA less tightly and with no AT-specificity, as was supposed earlier (Iwahara 
J. et al., 2002) (Cai S. et al., 2007). Indeed, recombinant GST-fusion proteins that included the 
ARID domain of each protein of the family showed that most of the ARID subfamilies bind DNA 
without any sequence preference (Patsialou A. et al., 2005). Some members of the family, which 
include Bright and Dri, present an “extended ARID (eARID)” domain with a 40 extra aminoacids, 
which forms one extra N-terminal and one extra C-terminal helix. This extra C-terminal helix 
might increase DNA affinity.
The ARID family can be subdivided in seven subfamilies based on the degree of sequence 
identity between individual proteins (Figure 4). Some of the main characteristics of these 
subfamilies are discussed below. 
Figure 4. The human ARID family of proteins grouped in subfamilies according to their similarities within 
the ARID domain and the presence of other conserved domains; adapted from (Patsialou A. et al., 2005).
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ARID1: includes Arid1a and Arid1b, the two largest and mutually exclusive subunits of SWI/
SNF complexes, which are ATP-dependent chromatin remodelling complexes. The presence of 
one or the other protein in a SWI/SNF complex determines whether complexes would be further 
formed with activators or repressors (Nagl N.G.Jr. et al., 2007). Arid1a is expressed through 
embryonic development at higher levels than Arid1b and the levels of both proteins are regulated 
during different cell cycle phases (Flores-Alcantar A. et al., 2011). 
ARID2: Arid2 has been shown to form part of the PBAF SWI/SNF complexes; inside this 
complex, Arid2 is required to mediate the expression of an interferon-responsive gene (Yan Z. et 
al., 2005).
ARID4: includes Arid4a (RBP1) and Arid4b (RBP1L1). Arid4a was cloned in search for pRb 
binding partners. The authors showed that pRb represses transcription by binding Arid4a, which 
serves as a bridging molecule to recruit histone deacetylases (HDACs), as well as functions at 
an additional HDAC-independent level as a repressor (Lai A. et al., 1999) (Lai A. et al., 2001). 
Moreover, the class III deacetylase SIRT1 associates with HDAC1 complexes through Arid4a/b 
and regulates the HDAC1-mediated transcriptional silencing (Binda O. et al., 2008).
ARID5: includes Arid5a (MRF-1) and Arid5b (MRF2). Arid5b is implicated in different 
processes. It has been shown to regulate smooth muscle cell differentiation and proliferation in 
cell culture (Watanabe M. et al., 2002). Targeted mutation in this gene in mice leads to reduced 
viability, delayed growth, abnormalities in the reproductive organs, as well as alterations in the T 
and B cell compartments of primary lymphoid organs (Lahoud M.H. et al., 2001). At the molecular 
level, Arid5b together with Phf2, a jmjC demethylase, forms a histone lysine demethylase complex, 
which is a signal-sensing modulator of histone methylation and gene transcription (Baba A. et al., 
2011). By facilitating Phf2-mediated histone demethylation of Sox9-regulated chondrogenic gene 
promoters, Arid5b facilitates chondrogenesis (Hata K. et al., 2013). Recent genome-wide screens 
have identified genetic variations in ARID5B associated with susceptibility to childhood acute 
lymphoblastic leukemia (ALL) and these polymorphisms are determinant of ALL susceptibility 
and treatment outcome (Healy J. et al., 2010) (Xu H. et al., 2012).
JARID1: this subfamily includes four members: Jarid1a (RBP2), Jarid1b (PLU-1), Jarid1c 
(SMCX), Jarid1d (SMCY). Apart from the ARID domain, these proteins present two conserved 
jumonji (jmj) domains – jmjC (domain with histone demethylse activity) and jmjN, and a PHD 
finger domain (Takeuchi T. et al., 2006). Jarid1a-c proteins regulate histone demethylation in vivo 
and contribute to transcriptional silencing by keeping the levels of H3K4me3 low (Christensen 
J. et al., 2007). Jarid1a repression promotes differentiation; on the other hand, in the presence of 
pRb, it can also act as a coactivator and drive differentiation (Benevolenskaya E.V. et al., 2005). 
Jarid1b is expressed in some restricted tissues during embryonic development, including brain, 
mammary bud, thymus, limb, olfactory epithelium, teeth, eye and stomach (Madsen B. et al., 
2002). Deletion of Jarid1b leads to early embryonic lethality, while Jarid1a knock-outs are viable 
and fertile (Catchpole S. et al., 2011). Jarid1c plays important roles in brain development and its 
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mutations in humans cause X-linked mental retardation. In accordance with the human pathology, 
in zebrafish and primary mammalian neurons it is involved in neuronal survival and dendritic 
development (Jensen L.R. et al., 2005) (Iwase S. et al., 2007). 
JARID2: also known as Jumonji (Jmj). It presents the jmjC and jmjN domains, but lacks the 
PHD domain. It is involved in heart development, as its deletion leads to neonatal birth due to heart 
defects, such as ventricular septal defect, non-compaction of the ventricular wall, double-outlet 
right ventricle and dilated atria (Lee Y. et al., 2000). Jmj represses Anf expression by directly 
binding to Nkx2.5 and Gata4 (Kim T.G. et al., 2004), and its own expression is repressed by 
Nkx2.5 in the SHF (Barth J.L. et al., 2010). Several studies point to a major role for Jarid2 in 
mediating the recruitment of histone methylase-containing PRC2 repressor complexes to target 
genes. Jmj deletion leads to impaired differentiation in Xenopus laevis and in mouse embryonic 
stem cells, consistent with the essential role of PRC2 proteins in early development (Peng J.C. et 
al., 2009) (Li G. et al., 2010) (Pasini D. et al., 2010) (Landeira D. et al., 2010).
ARID3 subfamily
The Arid3 subfamily, as mentioned above, presents an extended ARID domain with two extra 
a-helices, possibly implicated in the specificity of DNA recognition (Iwahara J. and Clubb, 1999) 
(Iwahara J. et al., 2002). Members of the subfamily include the Drosophila Dead ringer and its three 
mammalian homologous - Arid3a/Bright, Arid3b/BDP and Arid3c – and are present specifically 
in metazoans (Kortschak R.D. et al., 2000). Apart from the ARID domain, the subfamily presents 
two domains in the C-terminal region called REKLES-a and REKLES-b, which have not been 
found in any non-Arid protein. These two domains contain nuclear import and export signals (Kim 
D. and Tucker, 2006). It has been proposed that REKLES-b is required for self-association of 
Arid3 proteins or association with other proteins, as well as for nuclear matrix interaction (Kim D. 
et al., 2007). However, controversy exists regarding this function, since a previous report claimed 
that REKLES-b is not required for self-association (Shandala T. et al., 2002). 
Dead ringer/Retained in Drosophila development 
The Dead ringer/Retained (Dri/Retn) protein can be detected from the first hours of development 
of Drosophila expressed nuclearly and ubiquitously until after gastrulation. After germ band 
extension it localizes predominantly in the mesoderm and during embryogenesis it can be detected 
in the pharyngeal muscles, in different regions of the brain and the digestive tube, as well as in 
the extraembryonic amnioserosa (Gregory S.L. et al., 1996). Dri mutants die during embryonic 
development. It is essential for early embryonic patterning and expression of some terminal genes, 
such as argos and buttonhead, as well as even-skipped, a gene required for segment formation, is 
disrupted in Dri mutants. Also, somatic musculature development is impaired. Interestingly, the 
more dramatic phenotypes, involving patterning defects, arise when the dri maternal component 
is removed, while dri deletion in the embryo yields only muscular and digestive defects (Shandala 
T. et al., 1999). The use of hypomorphic mutants enables the study of the role of Dri in late 
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development of longitudinal glia where it is involved in differentiation and migration to their 
final destination (Shandala T. et al., 2003). Dri is also involved in dorso-ventral patterning. Dri-
depended recruitment of Groucho to Dorsal (Dl) binding sites switches Dl into a repressor and 
enables the restriction of Zernüllt (Zen) to the dorsal region of the embryo and supresses Huckbein 
(Hkb) expression in the ventral region (Häder T. et al., 2000). Together, these data suggest that Dri 
can act as a co-activator or co-repressor depending on the cellular context.
Arid3a and Arid3c
Arid3a/Bright is the most studied gene of the three mammalian Dri homologs. During adulthood 
it is expressed specifically in the B-lymphocytes in both mice and humans and its most known 
function is the regulation of the immunoglobulin heavy chain expression (Herrscher R.F. et al., 
1995) (Nixon J.C. et al., 2004). Arid3a-DNA binding complexes are observed in the nucleus of 
activated murine B cells (Webb C.F. et al., 2000). It has been also suggested that Bright contributes 
to increased gene expression by remodelling the immunoglobulin locus (Kaplan M.H. et al., 
2001). During embryonic development, deletion of Arid3a leads to midgestational death from 
failed hematopoiesis, as hematopoietic stem cells fail to differentiate into mature erythrocytes 
(Webb C.F. et al., 2011). Recently, a role for Arid3a in pluripotency and differentiation was 
proposed. Arid3a-deficient cells from adult tissues express a number of pluripotency-associated 
gene products, expand indefinitely and spontaneously differentiate into cells of multiple lineages, 
suggesting its role in pluripotency suppression (An G. et al., 2010). It appears as an Oct4 binding 
partner in mouse embryonic stem cells, although further studies are needed to confirm the in vivo 
importance of this interaction (Pardo M. et al., 2010) (van den Berg D.L.C. et al., 2010). It also 
appears, together with Arid3b, as one of the most upregulated genes upon ES cells differentiation 
(Wang J. et al., 2006). 
 Arid3c is the less known member of the Arid3 subfamily. Only recently it has been reported 
that this gene encodes for two alternatively spliced forms, one of which lacks the REKLES domain. 
The largest isoform co-activates Arid3a-dependent immunoglobulin transcription (Tidwell J.A. et 
al., 2011). 
Arid3b 
Arid3b was discovered in a screen of a human testis library and found as being expressed in 
some other adult tissues, like placenta and leukocytes. It was named Bdp (Bright-derived protein) 
and was confirmed its homology to Bright and Dri. The same report addressed its capacity to 
bind pRb in vitro (Numata S. et al., 1999). In the field of cancer research, some studies point 
to the important role of this protein in different cancer types. Arid3b is expressed in different 
neuroblastoma-derived lines and their growth ceases after suppression of Arid3b by siRNA. 
Moreover, it is also expressed in some human neuroblastoma stage IV tumours. Overexpression 
of Arid3b in mouse embryonic fibroblasts (MEFs) leads to the immortalization of these cells. 
Co-transfection with MYCN enhances MYCN oncogenic activity by supressing MYCN-induced 
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apoptosis in both MEFs and neural stem cells (Kobayashi K. et al., 2006) (Kobayashi K. et al., 
2013). On the other hand, Arid3b is also overexpressed in malignant ovarian cancers and involved 
in the mesenchymal transformation of the ovarian epithelium (Cowden Dahl K.D. et al., 2009). 
Similarly, in breast cancer cells Arid3b has been described as a miR-125b target with roles in cell 
motility, as its transient silencing leads to decreased cell migration (Akhavantabasi S. et al., 2012). 
More recently, an alternative splicing form of Arid3b has been described in different cancer cell 
lines, including ovarian cancer. The full-length form and short form of Arid3b show different 
intracellular distribution and different capacity to induce apoptosis (Joseph S. et al., 2012). 
Additionally, Chip-seq experiments suggest that Arid3b might be a direct target of p53; consistent 
with it, the gene is deregulated in different cancers where p53 appears mutated (Garritano S. et al., 
2013). 
Less is known about Arid3b function during embryonic development. A first report described 
a dynamic pattern of expression of the gene in different structures, mostly the branchial arches, 
neural crest, rombomeres, OFT of the heart, otic vesicle, caudal neural tube and mesoderm and 
nascent somites. It also described a loss-of-function mutant, which dies at midgestation (E11.5-
12.5) with growth delay and cardiovascular and craneofascial defects. The most striking phenotype 
observed was the massive death of cranial mesenchyme, which the authors pointed as the cause 
of embryonic death, as well as the cause of the cardiovascular phenotype (Takebe A. et al., 2006). 
Arid3b is also involved in limb development. Its expression can be detected in the apical 
ectodermal ridge (AER). While signalling pathways involved in AER formation remain unaltered 
in both mutant mouse and loss-of-function assays in chick, AER maturation and structuring are 
affected. AER compaction is not achieved and in vivo DiI labelling of pre-AER cells in chick 
embryos shows reduced movement of these cells and defective contribution to the AER in the 
absence of Arid3b. The results point to a role of Arid3b in the regulation of cell motility and 
rearrangements that lead to AER maturation (Casanova J.C. et al., 2011).
Some recent studies have identified Arid3b as a protein involved in stem cells maintenance 
and differentiation. Indeed, similarly to what happens in tumours, Arid3b protects ES mouse cells 
from MYCN-induced apoptosis and both genes are upregulated in induced pluripotent cells (iPC) 
from neural stem cells (Kobayashi K. et al., 2013). Interestingly, in other study Arid3b appears as 
one of the most upregulated genes in differentiating ES mouse cells (Wang J. et al., 2006). Also, 
Arid3b was identified in several screens as a possible Oct4-binding partner in mouse ES cells and, 
additionally, as a possible target of Oct4, but no biological confirmation was obtained so far (Wang 
J. et al., 2006) (Wang J. and Orkin, 2008) (Sharov A.A. et al., 2008). Still, the specific roles of 
Arid3b remain elusive. 
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El desarrollo embrionario es la suma de los procesos biológicos que llevan a la formación de un 
organismo maduro y complejo a partir de un cigoto unicelular. A pesar de que existen variaciones 
sustanciales entre diferentes especies, algunos mecanismos comunes están presentes en todas. 
Los organismos pluricelulares se desarrollan a través de cambios progresivos que comprenden un 
aumento en el número de células, la  diferenciación y especificación hacia diferentes tipos celulares 
y su organización en tejidos y órganos. La alteración de cualquiera de los pasos del desarrollo 
embrionario produce malformaciones, un tema importante en el campo de la salud humana, ya que 
hasta el 3% de los recién nacidos presentan algún defecto congénito, según el Centro de Control y 
Prevención de  Enfermedades de Estados Unidos (Parker S.E. et al., 2010).
El corazón es el primer órgano en funcionar durante el desarrollo embrionario. En mamíferos, 
el corazón maduro es un órgano muscular de cuatro cámaras que permite una circulación de 
sangre cerrada y separada en circulación sistémica y pulmonar. Antes de se adquiera la estructura 
definitiva, el latido cardiaco se tiene que mantener y modificar mientras el órgano crece y sufre 
cambios morfogenéticos. El tubo cardiaco temprano pasa por una fase de elongación a través de la 
adición de células desde el mesodermo faríngeo y por una fase de giro, seguidas de la especificación 
de cámaras, valvulogénesis, trabeculación, formación de la tercera capa –epicardio– y septación. 
Defectos estructurales y funcionales pueden dar lugar a patologías congénitas cardiacas, las 
anomalías más comunes en los recién nacidos (Fahed A.C. et al., 2013). 
El uso del ratón como organismo modelo ha demostrado ser muy útil para el estudio del 
desarrollo embrionario del corazón, así como de la etiología de patologías cardiacas humanas. El 
ratón guarda grandes similitudes con los humanos en cuanto a anatomía, fisiología y genética se 
refiere; además, la posibilidad de manipular el genoma murino proporciona una potente herramienta 
para el estudio de la función de genes y para modelar enfermedades humanas.  
DESARROLLO CARDIACO
Procesos tempranos en la formación del corazón
El corazón deriva del mesodermo lateral. Durante la gastrulación, las células del epiblasto 
ingresan a través de la línea primitiva y forman la capa mesodérmica. El mesodermo del embrión 
en el estado de neurula se puede subdividir en cuatro regiones: el cordamesodermo, el mesodermo 
paraxial o somático, el mesodermo intermedio y el mesodermo lateral. El mesodermo lateral es 
el que se encuentra más alejado de la notocorda y origina el corazón, los vasos y las células 
sanguíneas, así como los recubrimientos de las cavidades del cuerpo, incluida la cavidad pericárdica 
que envuelve el corazón.
Durante la gastrulación, los progenitores cardiacos ingresan en los segmentos rostrales y 
medios de la línea primitiva junto con las células destinadas a dar lugar a estructuras rostrales, 
como el mesodermo cefálico. Los precursores del corazón se establecen en el mesodermo lateral, 
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donde forman campos cardiogénicos. En el embrión de pollo la especificación del miocardio se 
produce a través del factor TGFb secretado por el hipoblasto, mientras que en el ratón esta función 
posiblemente le corresponde al endodermo visceral anterior (Nijmeijer R.M. et al., 2009). Mesp1 
se expresa en las células mesodérmicas tempranas que ingresan a través de la línea primitiva y, 
según trazados de linaje genéticos, prácticamente todas las células cardiacas derivan de la población 
Mesp1+ (Saga Y. et al., 1999) (Saga Y. et al., 2000). Junto con Mesp2, controla la salida de los 
precursores mesodérmicos de la línea primitiva a través de la regulación de la transición epitelio-
mesénquima (EMT) y la migración celular (Kitajima S. et al., 2000) (Lindsley R.C. et al., 2008). 
Además, es un factor clave en el compromiso hacia linajes cardiovasculares, ya que promueve la 
expresión de la mayoría de los factores de transcripción cardiacos, como Gata4, Nkx2.5, Hand2, 
Mef2c, Tbx20, myocardin (Bondue A. et al., 2008) (Bondue A. and Blanpain, 2010).
Una vez localizados en el mesodermo lateral, los precursores cardiacos forman una región 
denominada cresta cardiaca, donde las células pre-miocárdicas y endoteliales están entremezcladas. 
Las futuras células del miocardio expresan Nkx2.5, un gen esencial para la integración de la 
información del establecimiento de patrón (Prall O.W.J. et al., 2007). Al mismo tiempo, la placa 
neuronal empieza a plegarse para formar el tubo neural, proceso que va acoplado con la invaginación 
del endodermo para formar el intestino embrionario anterior. Las regiones cardiogénicas se mueven 
hacia la línea media del embrión en íntimo contacto con el endodermo y se fusionan para dar lugar 
al tubo cardiaco primitivo (Moorman A. et al., 2003) (Wagner M. and Siddiqui, 2007). Junto con 
Nkx2.5, Gata4 es uno de los genes más tempranos de la cresta cardiaca, responsable de la expresión 
de una serie de factores miocardio-específicos. Otros genes, como Tbx5, Mef2c y Hand1/2 también 
están implicados en la diferenciación de células miocárdicas en la cresta. Recientemente, se han 
demostrado importantes propiedades de inducción cardiogénica del componente de complejos 
de remodelación cromatínica Baf60c/Smarcd3. Mesodermo no cardiogénico se puede diferenciar 
a cardiomiocitos contráctiles en presencia de Gata4, Tbx5 y Baf60c; el último parece reclutar 
complejos de remodelación de cromatina BAF a enhancers cardio-específicos (Takeuchi J.K. and 
Bruneau, 2009). 
Los campos cardiacos
Tradicionalmente se ha considerado que los precursores cardiacos estaban predestinados a 
contribuir a las diferentes regiones del tubo cardiaco en función de su posición a lo largo del eje 
antero-posterior, un pre-establecimiento de patrón presente tanto en la cresta cardiaca como en el 
tubo. Ello llevó a proponer el modelo segmental de la formación del corazón, según el cual cada 
región de este órgano era una unidad separada y derivada de un grupo  de progenitores predestinados, 
además de apoyar la idea de que todas las células formadoras de corazón estaban contenidas en el 
tubo cardiaco temprano (revisado en (Buckingham M. et al., 2005)). Sin embargo, durante muchos 
años, varios estudios realizados tanto en pollo como en ratón apuntaban a que el tubo cardiaco 
seguía alargándose por los polos. En su trabajo en embriones de pollo, de la Cruz y colaboradores 
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pudieron apreciar que partículas de óxido de hierro depositadas en el extremo cefálico del tubo 
cardiaco acababan desplazándose al interior del mismo en estadios más tardíos. En otra serie de 
experimentos, la separación del tubo cardiaco de su anclaje anterior conllevaba la formación de un 
corazón carente de la región cefálica. Sus resultados les llevaron a proponer que no todas las partes 
del corazón están presentes en el tubo del estadio previo al giro, sino que se añadían en diferentes 
momentos del desarrollo (Argüello C. et al., 1975) (de la Cruz M.V. et al., 1977). Aun así, no fue 
hasta el año 2001 cuando tres grupos independientes, uno con el modelo de ratón y los otros dos 
con el modelo de pollo, confirmaron la existencia de una fuente adicional de progenitores a través 
de técnicas genéticas y de marcaje (Waldo K.L. et al., 2001) (Mjaatvedt C.H. et al., 2001) (Kelly 
R.G. et al., 2001) (revisado en (Kelly, 2012)). La elongación y el giro del corazón son promovidos 
por la incorporación de una población de progenitores altamente proliferativa. Se localizan en el 
mesodermo faríngeo detrás del tubo cardiaco y se denominan campo secundario cardiaco (SHF), 
como contraposición al campo cardiaco primario (FHF) que forma el tubo (Buckingham M. et al., 
2005). El SHF expresa el factor de transcripción con homeodominio LIM Islet1, y experimentos 
de trazado de linaje han mostrado que el ventrículo derecho, el tracto de salida (OFT) y la región 
de entrada (IFT) derivan de estos progenitores Islet1+ localizados en el mesodermo faríngeo. 
La mutación de este gen conlleva a la formación de un tubo cardiaco lineal que no puede girar y 
alargarse (Cai C.L. et al., 2003). Los progenitores Islet1+ son multipotentes, dada su capacidad 
para diferenciarse a cardiomiocitos, células endoteliales y células de músculo liso (Moretti A. et 
al., 2006).
Subdominios dentro del SHF: el AHF y el pSHF
Dentro del SHF se pueden distinguir subdominios, dependiendo de la expresión génica y de 
las regiones a las que contribuyen (Vincent S.D. and Buckingham, 2010). La región anterior del 
SHF (AHF) proporciona células al polo arterial del corazón y forma el ventrículo derecho y el 
OFT (Kelly R.G. et al., 2001) (Zaffran S. et al., 2004). El AHF se caracteriza por la expresión 
de algunos factores, como Fgf8, Fgf10, Tbx1, Mef2c SHF enhancer. Por otro lado, células que 
contribuyen a la región de entrada expresan Islet1, pero no los demás marcadores de AHF y se 
conforman el SHF posterior (pSHF). Se pudo comprobar que el canal atrioventricular (AVC), gran 
parte de los atrios y la afluencia sistémica venosa derivan del pSHF. 
El establecimiento de patrón antero-posterior se regula por el ácido retinoico (RA). La mutación 
de retinaldehido dehidrogensa 2 (RALDH2), que cataliza el segundo paso de oxidación de la 
biosíntesis de RA, causa una severa deficiencia embrionaria en RA. Mutantes para esta enzima 
presentan una expansión posterior de marcadores de AHF, como Tbx1 y Fgf8, el tubo cardiaco no 
es capaz de girar y la formación de las atrios y el IFT es deficiente (Ryckebusch L. et al., 2008). 
La expresión de Islet1 también se expande caudalmente, sugiriendo que el RA controla los límites 
posteriores del SHF (Sirbu I.O. et al., 2008). Los genes Hox son una de las importantes dianas 
del RA. Su expresión define distintos subdominios a lo largo del eje antero-posterior del SHF que 
contribuyen tanto al atrio como al futuro miocardio de la base de la aorta (Bertrand N. et al., 2011). 
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Diferentes estudios han descrito una serie de factores de transcripción y de crecimiento que se 
expresan en el AHF y que están involucrados en la formación correcta del OFT y del ventrículo 
derecho, ya que su deleción genera defectos en la formación de estas estructuras. Así, la ablación 
de Fgf8 del mesodermo faríngeo produce OFT y ventrículo derecho truncados, como consecuencia 
de la disminución de la proliferación celular y un aumento de la apoptosis en el AHF (Ilagan R. et 
al., 2006) (Park E.J. et al., 2006). Tbx1, un factor de transcripción T-box, responsable de muchos 
de los defectos del síndrome de delección de 22q11, también se expresa en el AHF y su ablación 
produce defectos de formación de OFT relacionados con una disminución de la proliferación celular 
(Zhang Z. et al., 2006). La vía canónica de Wnt/b-catenina también está activa en el mesodermo 
faríngeo. La deleción de b-catenina tiene como consecuencia la disminución de la proliferación 
de células Islet1+ y pérdida de señalización por Fgf8, lo cual produce un acortamiento de OFT 
y reducción del ventrículo derecho. Por otro lado, la estabilización de b-catenina en el núcleo 
produce un efecto opuesto: expansión de las células Islet1+, excesivo alargamiento del OFT, 
ventrículo derecho anormal y defecto en la diferenciación de células Islet1+ en el OFT (Cohen 
E.D et al., 2007) (Qyang Y. et al., 2007) (Ai D. et al., 2007). Bmp2 y 4 se expresan en el OFT y 
promueven la diferenciación a miocardio de las células del SHF: la deleción de ambos produce un 
aumento en la expresión de genes de progenitores (Islet1 y Tbx1) y la reducción de los niveles de 
marcadores de miocardio, como la miosina sarcmérica, en el OFT proximal (Wang J. et al., 2010). 
El desarrollo del polo posterior del corazón es menos conocido que el de la región AHF. Se 
ha visto que las células más craneales del pSHF contribuyen al AVC y a los atrios, mientras que 
regiones más caudales dan lugar al seno venoso. La contribución es simétrica desde la porción distal, 
pero el destino de la región craneal del pSHF es asimétrico, pues la región derecha contribuye a la 
parte ventral del atrio izquierdo (Domínguez J.N. et al., 2012). La vía Wnt/b-catenina desempeña 
un papel importante en la regulación del mesodermo cardiaco posterior; Wnt2, un activador de la 
vía, se expresa en el polo posterior del corazón y en la región de entrada desde el estadio E8.5. 
En embriones mutantes de Wnt2 la formación de los atrios y el AVC está comprometida, ya que 
su señalización es necesaria para la expansión de los progenitores del SHF y, más tarde, para la 
proliferación y diferenciación del miocardio, parcialmente a través de la activación de Gata6 (Tian 
Y. et al., 2010). Los cuernos del seno venoso derivan de una población de células posicionada 
ventro-caudo-lateral con respecto al SHF. Estas células no expresan Nkx2.5 o Islet1, pero están 
marcadas por la expresión de Tbx18 y dan lugar a un miocardio distinguible del miocardio de los 
atrios por su perfil de expresión Nkx2.5- Cx40- (Christoffels V.M. et al., 2006). Este borde lateral 
de mesodermo cardiogénico también contiene a los precursores del proepicardio que va a dar lugar 
al epicardio, vasos coronarios y fibroblastos. 
Proliferación e incorporación del SHF
Uno de los cambios obvios que tiene lugar en el tubo cardiaco temprano es su crecimiento y el 
aumento del número de cardiomiocitos. Curiosamente, la proliferación de los precursores cardiacos 
decae drásticamente cuando se diferencian e incorporan al tubo cardiaco. De esta manera, los 
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cardiomiocitos del corazón temprano presentan un índice de proliferación muy bajo. Tanto en el 
pollo como en el ratón, el crecimiento temprano del corazón tiene lugar a través del reclutamiento 
de células a los polos del conjunto de progenitores de SHF (Soufan A.T. et al., 2006) (de Boer B.A. 
et al., 2012). Como se menciona arriba, varias vías de señalización importantes para el desarrollo 
del SHF promueven la proliferación. Recientes resultados en el pollo indican que el corazón 
se alarga gradualmente por los dos polos desde un único centro de crecimiento Islet1+  caudal 
bilateral, localizado en la pared pericárdica. Además, células de esta región se pueden rastrear 
conforme se desplazan cranealmente para diferenciarse en miocardio en el polo arterial (van den 
Berg G. et al., 2009) (van den Berg G. and Moorman, 2009). Sin embargo, aunque está claro que 
los precursores del SHF contribuyen a los polos, el mecanismo celular, por el cual los progenitores 
ingresan en el tubo cardiaco desde el SHF, se desconoce. En embriones de pollo, el SHF se ha 
descrito como una capa de epitelio columnar pseudoestratificado (Waldo K.L. et al., 2005). La vía 
no canónica de Wnt parece importante para el desarrollo del OFT. Mutantes de Wnt11 muestran 
defectos tempranos en el OFT, donde aparecen afectados la reorganización del citoesqueleto y 
el movimiento celular polarizado, necesario para una morfogénesis normal del OFT. (Zhou W. 
et al., 2007). Disheveled (Dvl) actúa como regulador, tanto de la vía canónica Wnt/b-catenina, 
como de la vía PCP. Mutantes dobles de Dvl1/2 presentan un acortamiento del OFT, similar al que 
se observa en mutantes de Vangl2 y en los mutantes del activador de la vía no canónica, Wnt5a. 
Tanto en mutantes de Dvl1/2, como en los de Wnt5a el mesodermo visceral caudal presenta una 
aberrante compactación celular y una disminución en el número de filopodios. Se ha propuesto 
que las señalización por PCP induce una conversión mesénquimo-epitelial, promoviendo de esta 
manera la contribución del SHF al OFT por un proceso de intercalación (Sinha T. et al., 2012). Una 
doble delección de Wnt5a y Wnt11 ha mostrado el requerimiento de estos factores para inhibir la 
vía canónica de Wnt/b-catenina, pero no se han analizado otros posibles defectos de SHF en estos 
dobles mutantes (Cohen E.D. et al., 2012).
Interacción del SHF con el endodermo faríngeo y las células de la cresta neuronal
El desarrollo, proliferación y reclutamiento del SHF dependen también de la interacción con 
otros tejidos. Así, el endodermo faríngeo ventral permanece en íntimo contacto con los precursores 
del SHF y genera algunas moléculas importantes para el mantenimiento del grupo de progenitores. 
Fgf8, aparte de expresarse en el SHF, también se expresa en el endodermo faríngeo, y su función 
en este tejido se requiere para una correcta septación del OFT (Park E.J. et al., 2006). Shh se 
expresa igualmente en el endodermo faríngeo y su deleción produce defectos en los dos polos. El 
AHF necesita Shh para la septación del OFT (Goddeeris M.M. et al., 2007) y la señalización por 
Shh es también requerida para la septación de los atrios (Hoffmann A.D. et al., 2009).
La cresta neural cardiaca (CNC) es una subpoblación de las células de la cresta neural que 
contribuye al músculo liso del arco aórtico faríngeo y que también migra a través del AHF hacia 
el OFT para contribuir a los cojinetes endocárdicos. Sin embargo, la ablación de la CNC produce 
no sólo defectos de septación, sino que conlleva una reducción del miocardio de OFT y defectos 
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en el polo arterial. En embriones de pollo se ha visto que células destinadas a formar el miocardio 
del OFT no son capaces de migrar correctamente y se quedan retenidas en la base del polo arterial 
(Waldo K.L. et al., 2005). La ablación de CNC produce un aumento de los niveles de Fgf8 en la 
faringe caudal, lo que interrumpe el ingreso de SHF en el corazón (Hutson M.R. et al., 2006). En 
el ratón, la mutación en Tbx3, que se expresa en la CNC, produce un acortamiento del OFT; en 
este caso, la incorrecta función de la CNC parece afectar la proliferación y el reclutamiento de las 
células del SHF (Mesbah K. et al., 2008). La señalización por BMPs parece también tener un papel 
importante en la comunicación entre CNC y SHF, ya que la deleción de Smad4 de la CNC produce 
un aumento de apoptosis en estas células, pero además altera la expresión de algunos factores en 
el SHF y da lugar a defectos en elongación del OFT (Jia Q. et al., 2007).
¿Múltiples campos cardiacos?
La identificación de una segunda región mesodérmica como fuente de células cardiacas cambió 
la visión sobre la formación del corazón. Sin embargo, existe cierta controversia sobre si los 
llamados FHF y SHF representan dos linajes separados o reflejan una contribución y diferenciación 
graduales de los precursores. Islet1 fue considerado un marcador del SHF, pero estudios posteriores 
mostraron que la expresión de Islet1 es más amplia y que se puede detectar en la cresta cardiaca, en 
el FHF y, parcialmente, en el ventrículo izquierdo (Prall O.W.J. et al., 2007) (Ma Q. et al., 2008) 
(Sun Y. et al., 2007). De esta manera, más que marcar un linaje, la expresión de Islet1 parece 
estar relacionada con el estado de diferenciación de los precursores. Es interesante destacar que 
la deleción de Islet1 no afecta la formación del tubo cardiaco primario y el fenotipo del mutante 
refleja principalmente un problema en la contribución del SHF al corazón (Cai C.L. et al., 2003). 
Para resolver la cuestión de la relación de linajes entre diferentes regiones cardiacas de manera 
independiente de la expresión génica, se llevó a cabo un trazado de linajes retrospectivo, donde 
recombinaciones de baja frecuencia producían clones aleatorios en el miocardio. Los autores han 
podido observar algunos clones en dos o más regiones contiguas del corazón, otros clones presentes 
exclusivamente en el ventrículo izquierdo o en los polos, y clones que se extendían a través de 
todo el tubo cardiaco. Los autores concluyen que el resultado apunta a la existencia de dos linajes 
que segregan temprano en desarrollo de un progenitor común y, mientras que la mayoría de las 
partes del corazón son colonizadas por los dos, existe una contribución exclusiva del primer linaje 
al ventrículo izquierdo y del segundo al OFT (Meilhac S.M. et al., 2004). Sin embargo, se puede 
dar una interpretación alternativa a estos resultados, según la cual la distribución de los clones en 
el corazón refleja la formación gradual de este órgano. En este caso, la recombinación en estadios 
más tempranos va a dar lugar a clones posicionados en el ventrículo izquierdo y en compartimentos 
cercanos, mientras la recombinación más tardía se da en precursores de los polos cardiacos, que se 
añaden más tarde (Moorman A.F.M. et al., 2007). Recientemente, se ha propuesto la existencia de 
un campo cardiaco terciario en el embrión de pollo. Según este estudio, las células generadoras del 
impulso eléctrico derivan de una región discreta del mesodermo localizada fuera de los clásicos 
FHF y SHF y reclutadas por señalización canónica de Wnt/b-catenina (Bressan M. et al., 2013). La 
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proposición de la existencia de distintos campos dentro de la región formadora de corazón (HFR) 
implica un específico compromiso de las células a cada uno de los diferentes campos. Experimentos 
clásicos llevados a cabo en embriones de pollo tempranos en los que se trasplantaban tejidos dentro 
del HFR, mostraron que las células recolocadas eran capaces de adaptarse a su nueva localización, 
contradiciendo, por lo tanto, una irreversible determinación de estas células (Satin J. et al., 1988). 
Sería interesante repetir estos experimentos con los conocimientos actuales sobre la formación 
cardiaca para obtener más evidencias sobre la naturaleza del HFR.  
Diferenciación del tubo cardiaco
Una vez formado, el primitivo tubo cardiaco empieza a girar, mientras células  Islet1+ se van 
añadiendo a sus polos y diferenciando a cardiomiocitos. El miocardio recién formado presenta 
características de un miocardio primario o embrionario, como son la baja tasa de proliferación, 
la baja conductividad, la baja contracción y la capacidad de despolarizarse espontáneamente. 
Pero, inmediatamente después del giro, se forman las cámaras (ventrículo y atrio) y el fenotipo 
del miocardio cambia: ahora, sus uniones gap están formadas por Cx40/Cx43 para una rápida 
conductividad y el índice de proliferación aumenta. Las otras regiones – el IFT, el AVC y el OFT – 
retienen las características de miocardio embrionario, hecho que desempeña un papel importante en 
el desarrollo del corazón (Christoffels V.M. et al., 2000). El miocardio del OFT y del AVC señaliza 
hacia el endocardio para formar los cojinetes endocárdicos, que en estadios más avanzados se 
remodelan para dar lugar a las válvulas cardiacas (Eisenberg L.M. and Markwald, 1995). Además, 
protege frente al reflujo de sangre antes de que se formen las válvulas y proporciona progenitores 
para el nodo del sistema conductor.  
La regionalización del miocardio se consigue gracias a la expresión diferencial de genes. El 
miocardio naciente de las cámaras se caracteriza por la expresión de Anf, Cited1, Cx40, Cx43 
y Chisel, mientras que Tbx2 y Tbx3 están presentes exclusivamente en regiones de miocardio 
primario. La deleción de Tbx5 del corazón embrionario produce una bajada en los niveles de Anf 
y Cx40 en las cámaras (Bruneau B.G. et al., 2001). Se ha visto que Tbx5 se asocia sinérgicamente 
con Nkx2.5 para promover la diferenciación de los cardiomiocitos; juntos se unen al promotor de 
Anf y activan su expresión (Hiroi Y. et al., 2001). Al mismo tiempo, Tbx2 se expresa en regiones 
de miocardio embrionario (IFT, AVC y OFT), donde también forma un complejo con Nkx2.5 y 
reprime la expresión de Anf (Habets P.E.M.H. et al., 2002). De esta manera, si se sobreexpresa 
Tbx2 en todo el miocardio, se inhibe la formación de cámaras y la expresión de Cx40/43 y de Anf; 
ello confirma la función de Tbx2 como un factor determinante en la represión de genes específicos 
de cámaras (Christoffels V.M. et al., 2004). Por otro lado, trazados de linaje genéticos mostraron 
que miocardio primario marcado por Tbx2 contribuye a los dos ventrículos: mientras está en el 
AVC y expresa Tbx2, la proliferación y diferenciación del miocardio están inhibidas, pero, una vez 
apagada la expresión de Tbx2, las células pueden iniciar la diferenciación a miocardio de cámara y 
empezar a proliferar (Aanhaanen W.T.J. et al., 2009). Tbx20, también un factor T-box, se expresa 
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a través de todo el miocardio y es esencial para asegurar la transición desde el tubo cardiaco a un 
corazón multicameral, ya que reprime la expresión de Tbx2. En mutantes de Tbx20, el miocardio 
de cámaras no se forma y se detecta expresión ectópica de Tbx2 en el corazón lineal (Singh M.K. 
et al., 2005). Otro gen que controla múltiples aspectos de morfogénesis de AVC es Bmp2. Además 
de tener un papel en la formación temprana del corazón, Bmp2 también se expresa a altos niveles 
en el AVC y más débilmente en el OFT. La deleción de Bmp2 del miocardio produce una reducción 
de los niveles de Tbx2 y la expansión de marcadores de cámaras al AVC (Ma L. et al., 2005). Se ha 
visto que Bmp2 regula directamente la expresión de Tbx2 a través de las pSmad1/5/8, que se unen 
a un enhancer de Tbx2 capaz de conferir una expresión específica de canal a Tbx2. Tbx20 compite 
con Smad4 por la unión a Smad1 y Smad5 y, de esta manera, suprime la expresión de Tbx2 en las 
cámaras (Singh R. et al., 2009). Tbx20 también podría regular positivamente a Hey1 y Hey2. Estos 
dos genes, expresados en el atrio y en el ventrículo, respectivamente, regulan la frontera del AVC 
y reprimen la expresión de Tbx2 en las cámaras (Kokubo H. et al., 2007).
Tbx3 también pertenece a la familia T-box de factores de transcripción y, como los anteriores, 
está implicado en la regulación del desarrollo cardiaco. A estadios tempranos, Tbx3 se expresa 
de manera continua en un dominio del miocardio que se extiende del nodo sinoatrial a la región 
atrioventricular. De manera similar a Tbx2, Tbx3 reprime la expresión de Anf y Cx40 e impide 
su activación por el complejo Nkx2.5-Tbx5 (Hoogaars W.M. et al., 2004). La expresión de Tbx3 
también delinea la región del nodo sinoatrial, responsable del control de la frecuencia y del ritmo 
de las contracciones cardiacas, y que funciona como el marcapasos del corazón. La sobreexpresión 
ectópica de Tbx3 produce una inhibición del fenotipo atrial en las células de dicha cámara e impone 
un fenotipo de células de marcapaso. Además, Tbx3 también es necesario para la especificación 
del fascículo atrioventricular y de las ramas próximas del fascículo, ya que reprime la proliferación 
y diferenciación y promueve el fenotipo de sistema conductor (Hoogaars W.M.H. et al., 2007) 
(Bakker M.L. et al., 2008). Aunque no se ha demostrado una regulación directa como en el caso de 
Tbx2, Bmp2 parece estar controlando la expresión de Tbx3, ya que su inactivación en el miocardio 
conlleva la pérdida de Tbx3 en el AVC (Singh R. et al., 2012).
Formación de válvulas
El primer paso en la septación del corazón es la formación de cojinetes endocárdicos, que más 
tarde son remodelados para dar lugar a válvulas atrioventriculares (las que se forman en el AVC) 
y válvulas conoventriculares (formadas en el OFT). Las capas de miocardio y endocardio del 
corazón temprano están separadas por una matriz extracelular, denominada gelatina cardiaca, que 
se expande focalmente para formar los cojinetes endocárdicos en el AVC y en el OFT. Más tarde, 
las células del endocardio que envuelven estos cojinetes sufren una transición epitelio-mesénquima 
(EMT) y las células mesenquimales formadas, precursoras de las futuras válvulas, invaden los 
cojinetes. Los siguientes pasos implican su proliferación y expansión, así como la elongación y 
remodelación de la válvula para formar las valvas maduras (von Gise A. and Pu, 2012). La EMT 
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endocárdica ocurre tanto en el AVC, como en el OFT, pero en el último caso empieza más tarde en 
el desarrollo embrionario e implica una importante contribución de las células de la cresta neural 
cardiaca; por ello, los dos procesos se discuten por separado.
Cojinetes del AVC
La EMT endocárdica depende tanto del miocardio especializado del AVC como del endocardio 
de los cojinetes y del intercambio de señales entre ellos. Bmp2, secretado desde el miocardio, se 
requiere para potenciar la formación de la gelatina cardiaca e inducir la EMT del endocardio (Ma 
L. et al., 2005). Existe un bucle de retroalimentación positiva entre Bmp2 y Tbx2/3; mientras que 
Bmp2 es necesario para inducir la expresión de estos factores de transcripción, lo cuales, a su 
vez, son necesarios para mantener los niveles de expresión de Bmp2, ya que en mutantes dobles 
de Tbx2/3 Bmp2 está reducido. Más aún, la incorrecta expresión de Tbx2 o Tbx3 en el corazón 
produce una expresión ectópica de Bmp2 en el miocardio de las cámaras, así como de marcadores 
de EMT, como Snail1 y Has2, en el endocardio que lo recubre, con la consecuente expansión de 
la gelatina cardiaca y la formación de cojinetes. Esta inducción es dependiente de Bmp2, ya que 
la inhibición del receptor de BMPs regula a la baja los marcadores de EMT y la formación de 
cojinetes (Singh R. et al., 2012) (Shirai M. et al., 2009). Ciertamente, Bmp2 puede sustituir el 
miocardio del AVC en cultivos de explantes de AVC, apoyando de esta manera su función como 
factor clave en la inducción de EMT (Sugi Y. et al., 2004) (Rivera-Feliciano J. et al., 2006). Algunos 
genes de EMT son activados por Bmp2, como, por ejemplo, Twist1, un activador de Tbx20 en el 
endocardio y promotor de la proliferación y migración de células mesenquimales, a la vez que 
inhibe la diferenciación de células de la válvula (Shelton E.L. and Yutzey, 2007) (Shelton E.L. and 
Yutzey, 2008). Tgf-b2 es otro factor importante para la EMT que actúa por debajo de la cascada de 
Bmp2. Los mutantes de Tgf-b2 presentan un número reducido de células mesenquimales; además, 
se requiere para completar estadios más tardíos de la EMT (Sugi Y. et al., 2004) (Azhar M. et al., 
2009). Una función adicional de Tgf-b2 tiene que ver con la remodelación y diferenciación de la 
válvula, ya que induce la organización de la matriz extracelular y reprime la diferenciación del 
mesénquima de los cojinetes hacia el linaje de células de cartílago (Azhar M. et al., 2011).
La vía de señalización de Notch también está implicada en varios pasos de la formación de 
la válvulas. El receptor de Notch es una proteína transmembranal con un dominio extracelular, 
con el cual se une a sus ligandos (Delta o Jagged), y un dominio intracelular (NICD), que se 
libera después de la activación por los ligandos y se transloca al núcleo, donde activa la expresión 
de genes (Andersson E.R. et al., 2011). N1ICD (la forma activa de Notch1) se expresa en el 
endocardio que recubre el AVC y el OFT (del Monte G. et al., 2007), indicando que, a diferencia 
de Bmp2, promueve la EMT directamente desde el endocardio. La deleción de la actividad de 
Notch en el endocardio produce una reducción de los niveles de Tgf-b2 y de Snail1, factor clave 
para la EMT, y la ausencia de este proceso tanto in vivo como in vitro (Timmerman L.A. et al., 
2004). Al contrario, si se sobreexpresa N1ICD a través de todo el endocardio, se produce una 
activación ectópica de genes mesenquimales. Notch, además, confina la expresión de Bmp2 al 
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miocardio del AVC, ya que Hey1 y Hey2, dianas de Notch, reprimen la expresión de Bmp2 en el 
endocardio. Las rutas de Bmp2 y de Notch1 convergen en la activación de Snail1 y promueven la 
formación de un campo valvulogénico en el corazón embrionario (de la Pompa J.L. and Epstein, 
2012; Luna-Zurita L. et al., 2010).
Los cojinetes del OFT y las células de la cresta neural (NCCs)
El desarrollo de los cojinetes del OFT implica la interacción entre el endocardio, el mesénquima 
derivado del endocardio y las células de la cresta neural. Al mismo tiempo que el OFT se remodela 
y se separa en dos grandes vasos (la aorta y la arteria pulmonar), gira y se alinea con los ventrículos, 
de tal manera que la aorta salga del ventrículo izquierdo y la arteria pulmonar del derecho. El 
OFT contiene dos pares de cojinetes: los proximales, que forman el septo conal y separan el 
OFT proximal en las salidas derecha e izquierda del ventrículo; los distales, que forman el septo 
aortopulmonar necesario para dividir el OFT distal en aorta y arteria pulmonar. Al lado a estos 
cojinetes se forman los cojinetes intercalados y, juntos, forman las válvulas aórtica y pulmonar 
(Lin C.J. et al., 2012). La deleción de Bmp6 y Bmp7 del miocardio impide la invasión de los 
cojinetes por parte de las células del endocardio (Kim R.Y. et al., 2001). Al mismo tiempo, el SHF 
proporciona una fuente de Bmp4, necesario para la expansión de los cojinetes y su remodelación 
(Liu W. et al., 2004) (McCulley D.J. et al., 2008). Por otro lado, se ha demostrado que Tbx2, 
expresado en el miocardio del OFT, activa directamente la expresión de Tgf-b2 en el miocardio, el 
efector real de la inducción de EMT en los cojinetes del OFT (Sakabe M. et al., 2012).
Las células de la CNC migran de su posición original en los rombómeros 6-8 e invaden el 
OFT para formar el septo aortopulmonar. El miocardio del OFT secreta Sema3c para atraer a 
las células de la CNC y promueve la invasión de los cojinetes distales, donde se transforman en 
células mesenquimales (Toyofuku T. et al., 2008). Este mesénquima más tarde se diferencia en 
septo de músculo liso. Fgf8 juega un papel importante en la supervivencia de las NCCs durante 
su migración, ya que la reducción de sus niveles produce una muerte masiva de estas células, 
bien cuando se delaminan del tubo nervioso o bien cuando alcanzan la faringe (Abu-Issa R. et 
al., 2002). Se ha demostrado que, además, FGF estimula la expresión de Bmp4, el cual, a su vez, 
potencia la diferenciación de las NCCs a músculo liso (Zhang J. et al., 2010). Notch expresado en 
las NCCs también es necesario para su diferenciación (High F.A et al., 2009).  
Maduración de las válvulas cardiacas
La remodelación posterior a la EMT, donde las células mesenquimales se diferencian a 
fibroblastos intersticiales y remodelan su entorno para formar una válvula madura, es un proceso 
poco conocido. La expansión de los cojinetes es promovida por la proliferación de células 
mesenquimales, controlada por múltiples señales, como la vía de Wnt/b-catenina, BMPs y Fgf4 
(Combs M.D. and Yutzey, 2009). Se ha propuesto que existen dos zonas distintas en el cojinete 
en desarrollo: una zona de proliferación cercana al endocardio y una zona de diferenciación 
adyacente al miocardio, aunque los mecanismos para esta regionalización se desconocen (de 
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Vlaming A. et al., 2012). Durante los estadios fetales, la válvula se alarga para formar las finas 
valvas. Ello se consiguen gracias a un aumento en la densidad celular y a la reorganización de la 
matriz extracellular (Kruithof B.P. et al., 2007). La diferenciación de las células mesenquimales y 
la correcta distribución y ordenamiento de la matriz extracelular son dos procesos fundamentales 
para la formación de una válvula funcional. Periostina, una de las proteínas de la matriz extracelular, 
desempeña un papel importante en la estimulación de la ruta valvulogénica. Es secretada por las 
células de los cojinetes hacia la matriz extracelular y desde ahí, a través de la ruta b-integrina/FAK/
ERK, promueve la adhesión, migración y supervivencia celulares, además de regular la expresión 
de hialuronano y del colágeno I, y de activar la compactación del colágeno (Norris R.A. et al., 
2009) (Ghatak S. et al., 2014).
FAMILIA ARID
La familia ARID es una familia de factores de transcripción caracterizados por un dominio de 
unión a ADN muy conservado, denominado ARID. El nombre proviene de AT rich interaction 
domain, y se debe al primer estudio donde se describió el miembro fundador de la familia, Bright. 
En este trabajo, los autores localizaron un dominio de unión a ADN previamente desconocido, 
con afinidad a regiones ricas en AT (Herrscher R.F. et al., 1995). No mucho tiempo después, se 
describió el gen dead ringer (dri) en Drosophila, en un screening donde se intentaban localizar 
genes con propiedades de unión a ADN similares a las proteínas con homeodominio. El gen descrito 
carecía de cualquier homología al homeobox, pero su dominio ARID estaba relacionado con otros 
genes, como Bright. De esta manera, se estableció una nueva familia de proteínas de unión a 
ADN altamente conservada (Gregory S.L. et al., 1996). Más tarde, miembros de la familia ARID 
se encontraron en un amplio rango de especies, desde las levaduras hasta nematodos, insectos y 
mamíferos, así como en plantas y hongos (Zhu H. et al., 2008) (Hansen F.T. et al., 2008). Hay 15 
proteínas descritas en humanos y 6 en Drosophila; miembros de esta familia participan en multitud 
de procesos, como la remodelación de cromatina, diferenciación celular, control del ciclo celular y 
desarrollo embrionario (Kortschak R.D. et al., 2000) (Wilsker D. et al., 2002). 
Como el número de miembros de la familia ARID crecía, surgió la necesidad de definir con 
mayor precisión la secuencia consenso del dominio ARID. Esta secuencia comprende alrededor 
de 100 aminoácidos; fuera del dominio ARID, las proteínas de la familia muestran diversidad de 
secuencias, estructuras y funciones (Wilsker D. et al., 2002). El dominio ARID codifica para seis 
hélices a que forman un motivo no canónico de hélice-giro-hélice. La estructura 3D del complejo 
ADN con el dominio ARID mínimo, junto a la poca conservación de los aminoácidos responsables 
de la especificidad de unión al ADN, sugieren que la mayoría de los ARIDs se unen al ADN sin 
mucha fuerza y sin especificidad de secuencia, al contrario de lo que se pensaba antes (Iwahara J. 
et al., 2002) (Cai S. et al., 2007). De hecho, proteínas GST de fusión que incluían el dominio ARID 
de cada miembro de la familia han mostrado que la mayoría de las subfamilias ARID se unen al 
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ADN sin preferencia por ninguna secuencia (Patsialou A. et al., 2005). Algunos miembros de la 
familia, incluyendo a Bright y a Dri, presentan un dominio “ARID extendido (eARID)” con 40 
aminoácidos más, que forman dos hélices extra, una en el N-terminal y otra en el C-terminal. Esta 
hélice C-terminal extra podría aumentar la afinidad de unión al ADN.
La familia ARID se puede subdividir en 7 subfamilias basándose en el grado de conservación 
de secuencia entre proteínas individuales. Algunas de las principales características de estas 
subfamilias se discuten a continuación:
ARID1: incluye a Arid1a y Arid1b, las dos mayores y mutuamente excluyentes subunidades 
de los complejos SWI/SNF, que son complejos remodeladores de cromatina dependientes de ATP. 
La presencia de uno u otro Arid1 en estos complejos determina la consiguiente asociación con 
activadores o supresores (Nagl N.G.Jr. et al., 2007). Arid1a se expresa más significativamente 
durante el desarrollo embrionario que Arid1b; los niveles de las dos proteínas se regulan durante 
las diferentes fases del ciclo celular (Flores-Alcantar A. et al., 2011). 
ARID2: Arid2 forma parte de los complejos PBAF SWI/SNF; dentro del complejo, se requiere 
para mediar la expresión de genes en respuesta a interferón (Yan Z. et al., 2005).  
ARID4: incluye a Arid4a (RBP1) y Arid4b (RBP1L1). Arid4a se clonó en un estudio donde 
se buscaban proteínas de unión a pRb. Se ha visto que pRb reprime la transcripción a través de 
la unión a Arid4a, que actúa como molécula puente para reclutar histona deacetilasas (HDACs), 
además de funcionar a otro nivel independiente de HDACs como represor (Lai A. et al., 1999) (Lai 
A. et al., 2001). Más aún, la deacetilasa de clase III SIRT1 se asocia con los complejos HDACs a 
través de Arid4a/b y de esta manera regula el silenciamiento de transcripción mediado por HDACs 
(Binda O. et al., 2008).
ARID5: incluye a Arid5a (MRF-1) y a Arid5b (MRF2). Arid5b está implicado en diferentes 
procesos. En cultivos celulares se ha visto que regula diferenciación y proliferación de células 
de músculo liso (Watanabe M. et al., 2002). Mutaciones de este gen en el ratón producen una 
reducción de la viabilidad, retraso en el crecimiento, anormalidades en los órganos reproductivos, 
así como defectos en los compartimentos de células T y B en los órganos limfáticos primarios 
(Lahoud M.H. et al., 2001). A nivel celular, Arid5b junto con Phf2, una jmjC demetilasa, forma 
un complejo de histona lisina demetilasa que actúa como modulador del estado de metilación 
de las histonas y de la transcripción génica en respuesta a señales (Baba A. et al., 2011). Este 
complejo actúa sobre los promotores de genes condrogénicos regulados por Sox9, consiguiendo 
así facilitar la condrogénesis (Hata K. et al., 2013). Recientes screens del genoma identificaron 
que las variaciones en ARID5B están asociadas con la susceptibilidad a la leucemia limfoblástica 
aguda infantil (ALL); estos polimorfismos son determinantes tanto para susceptibilidad a la ALL, 
así como para predecir el efecto del tratamiento (Healy J. et al., 2010) (Xu H. et al., 2012).
JARID1: esta subfamilia contiene cuatro miembros: Jarid1a (RBP2), Jarid1b (PLU-1), Jarid1c 
(SMCX) y Jarid1d (SMCY). Además del dominio ARID, estas proteínas poseen dos dominios 
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conservados jumonji (jmj) –jmjC (dominio con actividad histona demetilasa) y jmjN, además de un 
dominio PHD (Takeuchi T. et al., 2006). Las proteínas Jarid1a-c regulan la demetilación de histonas 
en vivo y contribuyen al silenciamiento transcripcional manteniendo los niveles de H3K4me3 
bajos (Christensen J. et al., 2007). El silenciamiento de Jarid1a promueve la diferenciación; por 
otro lado, en presencia de pRb puede actuar como un co-activador y favorecer la diferenciación 
(Benevolenskaya E.V. et al., 2005). Jarid1b se expresa en algunos tejidos durante el desarrollo 
embrionario, como cerebro, primordio mamario, timo, pata, epitelio olfativo, dientes, ojos y 
estómago (Madsen B. et al., 2002). La delección de Jarid1b produce mortalidad embrionaria, 
mientras que mutantes de Jarid1a son viables y fértiles (Catchpole S. et al., 2011). Jarid1c juega un 
papel importante en el desarrollo del cerebro y su mutación en humanos produce en retraso mental 
asociado al cromosoma X. En sintonía con la patología humana, en el pez cebra y en neuronas 
primarias de mamíferos Jarid1c está involucrado en supervivencia neuronal y desarrollo de las 
dendritas (Jensen L.R. et al., 2005) (Iwase S. et al., 2007).
JARID2: también conocido como Jumonji. También contiene los dominios jmjC y jmjN, pero 
carece del dominio PHD. Está involucrado en el desarrollo cardiaco, ya que su deleción produce 
muerte neonatal debida a anomalías en el corazón, como defectos en el septo interventricular, no-
compactación de la pared ventricular, ventrículo derecho con doble salida y atrio dilatado (Lee 
Y. et al., 2000). Jumonji reprime la expresión de Anf a través de la unión directa a Nkx2.5 y 
Gata4 (Kim T.G. et al., 2004); su propia expresión se inhibe por Nkx2.5 en el SHF (Barth J.L. 
et al., 2010). Varios estudios apuntan a una función importante de Jarid2 en el reclutamiento de 
complejos represores PRC2, que presentan acción histona metilasa, a sus genes diana. La delección 
de Jmj impide una correcta diferenciación en embriones de Xenopus laevis y en células de ratón 
embrionarias, consistente con el papel esencial de proteínas PRC2 en desarrollo temprano (Peng 
J.C. et al., 2009) (Li G. et al., 2010) (Pasini D. et al., 2010) (Landeira D. et al., 2010).
Subfamilia ARID3
La subfamilia Arid3, como ya se mencionó arriba, presenta un dominio ARID extendido con 
dos hélices extra, y que podría estar implicado en la especificidad de reconocimiento del ADN 
(Iwahara J. and Clubb, 1999) (Iwahara J. et al., 2002). La subfamilia incluye a Dead ringer de 
Drosophila y a sus tres homólogos mamíferos –Arid3a/Bright, Arid3b/BDP y Arid3c– y están 
presentes específicamente en los metazoos (Kortschak R.D. et al., 2000). Aparte del dominio 
ARID, esta subfamilia se caracteriza por dos dominios en la región C-terminal denominados 
REKLES-a y REKLES-b, no presentes en ninguna proteína no-Arid. Estos dominios contienen 
una señal de localización nuclear (Kim D. and Tucker, 2006). Se ha propuesto que REKLES-b se 
requiere para la homedimerización de las proteínas Arid3 y su unión a otras proteínas, así como 
la interacción con la matriz nuclear (Kim D. et al., 2007). Sin embargo, existe cierta controversia 
sobre esta función, ya que un estudio anterior indica que REKLES-b no es necesario para la 
homodimerización (Shandala T. et al., 2002).
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Dead ringer/Retained en el desarrollo de Drosophila 
Dead ringer/Retained (Dri/Retn) se puede detectar desde las primera horas del desarrollo de 
Drosophila, expresado en el núcleo ubicuamente hasta después de la gastrulación. Después de 
la extensión de la banda germinal, se localiza predominantemente en el mesodermo, y durante 
la embriogénesis se puede detectar en los músculos de la faringe, en diferentes regiones del 
cerebro y del tubo digestivo, y en la amnioserosa extraembrionaria (Gregory S.L. et al., 1996). 
Los mutantes de Dri mueren durante el desarrollo embrionario. Es esencial para el establecimiento 
de patrón temprano, y la expresión de algunos genes de clase Terminal, como argos y buttonhead, 
así como even-skipped, un gen requerido para la segmentación, está alterada en los mutantes de 
Dri. Además, está afectado el desarrollo de la musculatura somática. Curiosamente, el fenotipo 
más drástico, incluyendo defectos en el establecimiento de patrón, se da cuando el Dri de origen 
materno es eliminado, mientras que la deleción exclusiva del Dri embrionario produce sólo 
defectos musculares y digestivos (Shandala T. et al., 1999). El uso de mutantes hipomorfos para 
Dri permite el estudio de la función del gen en el desarrollo más tardío de la glía longitudinal, 
donde está involucrado en su diferenciación y migración a su lugar de destino (Shandala T. et al., 
2003). Dri también está implicado en el establecimiento de patrón dorso-ventral. El reclutamiento 
de Groucho, dependiente de Dri, a los sitios de unión de Dorsal (Dl), produce un cambio en la 
función de Dl a represor, lo cual permite la restricción de la expresión de Zernült (Zen) a la región 
dorsal, además de suprimir la expresión de Huckbein (Hkb) en la región ventral (Häder T. et al., 
2000). Los datos obtenidos hasta el momento sobre Dri sugieren que este gen puede actuar tanto 
como co-activador como co-represor, dependiendo del contexto celular.
Arid3a y Arid3c
Arid3a/Bright es el gen más estudiado de los tres homólogos mamíferos de Dri. En adultos 
se expresa específicamente en los linfocitos B, tanto en humanos como en ratón, y su función 
más conocida es la regulación de la expresión de la cadena pesada de la inmunoglobulina 
(Herrscher R.F. et al., 1995) (Nixon J.C. et al., 2004). Se pueden observar complejos Arid3a-
ADN en los núcleos de células B activadas (Webb C.F. et al., 2000). También se ha sugerido que 
Bright contribuye a un aumento de la expresión génica a través de la remodelación del locus de 
la inmunoglobulina (Kaplan M.H. et al., 2001). Durante el desarrollo embrionario, la deleción 
de Arid3a produce una muerte a mitad de la gestación por un fallo en la hematopoyesis, ya que 
las células madre hematopoyéticas no consiguen diferenciarse a eritrocitos maduros (Webb 
C.F. et al., 2011). Recientemente, se ha propuesto la implicación de Arid3a en pluripotencia y 
diferenciación. Células deficientes en Arid3a de tejidos adultos expresan algunos genes asociados 
a la pluripotencia, se expanden indefinidamente y se diferencian espontáneamente a células de 
múltiples linajes, sugiriendo así su función en la supresión de la pluripotencia (An G. et al., 2010). 
Además, aparece como proteína de unión a Oct4 en células madre de ratón, aunque son necesarios 
estudios más específicos para confirmar la importancia de esta unión en vivo (Pardo M. et al., 
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2010) (van den Berg D.L.C. et al., 2010). También aparece, junto a Arid3b, como uno de los genes 
más expresados después de la diferenciación de la células madre (Wang J. et al., 2006). 
Arid3c es el miembro menos conocido de la subfamilia Arid3. Sólo recientemente se ha descrito 
que su gen codifica para dos formas de splicing alternativas, una de las cuales carece del dominio 
REKLES. La isoforma más larga co-activa la transcripción de inmunoglobulinas dependiente de 
Arid3a (Tidwell J.A. et al., 2011).
Arid3b
Arid3b había sido descubierto a través de un screen de una biblioteca de testículo humano y 
se vio que también se expresa en otros tejidos adultos, como placenta y leucocitos. Se denominó 
Bdp (Bright-derived protein) y se confirmó su homología a Bright y a Dri. Además, se detectó 
su capacidad de unirse a pRb in vitro (Numata S. et al., 1999). En el campo del cáncer, algunos 
estudios apuntan a una importante función de esta proteína en diferentes tipos de tumores. Arid3b 
se expresa en varias líneas celulares derivadas de neuroblastomas y su crecimiento se detiene 
si la expresión de Arid3b se inhibe por siRNA. Además, también se ha detectado en algunos 
neuroblastomas humanos en la fase IV del tumor. La sobreexpresión de Arid3b en fibroblastos 
embrionarios de ratón (MEFs) produce la inmortalización de estas células. La co-transfección 
con MYCN amplifica su actividad oncogénica al inhibir la apoptosis que induce MYCN, tanto 
en MEFs, como en células madre neuronales (Kobayashi K. et al., 2006) (Kobayashi K. et al., 
2013). Por otro lado, Arid3b se encuentra sobreexpresado en cánceres de ovario malignos donde 
está involucrado en la transformación mesenquimal del epitelio ovárico (Cowden Dahl K.D. et al., 
2009). De manera similar, en células de cáncer de pecho, Arid3b se ha descrito como una diana de 
miR-125b con una función en motilidad celular, ya que su silenciamiento transitorio disminuye la 
migración celular (Akhavantabasi S. et al., 2012). Más recientemente, se ha detectado una forma 
de splicing alternativa de Arid3b en diferentes líneas tumorales, incluyendo cáncer ovárico. Las 
formas larga y corta muestran distintas distribuciones intracelulares y distinta capacidad de inducir 
apoptosis (Joseph S. et al., 2012). Adicionalmente, experimentos de Chip-seq sugieren que Arid3b 
podría ser una diana directa de p53; precisamente, su expresión está desregulada en diferentes 
cánceres donde p53 está mutado (Garritano S. et al., 2013). 
Menos se sabe sobre la función de Arid3b durante el desarrollo embrionario. El primer trabajo 
publicado describe un patrón dinámico de expresión del gen en diferentes estructuras, sobre todo 
arcos branquiales, cresta neural, rombómeros, OFT del corazón, vesícula ótica y somitos nacientes. 
También describe un mutante de pérdida de función que muere a mitad de gestación (E11.5-12.5) 
con retraso de crecimiento y defectos craneofaciales y cardiovasculares. El fenotipo más destacado 
es una muerte masiva del mesénquima craneal que los autores señalan como la causa de la muerte 
embrionaria, así como la causa del fenotipo cardiovascular (Takebe A. et al., 2006).
Arid3b también está involucrado en el desarrollo de la extremidad. Su expresión se puede 
detectar en la cresta ectodérmica apical (AER). Mientras que rutas de señalización importantes 
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para la formación del AER están inalteradas, tanto en ratón como en ensayos de pérdida de función 
en el pollo, la maduración y estructura del AER están afectadas. No se produce la compactación 
del AER y marcajes con DiI en vivo de células de pre-AER en embriones de pollo muestran 
una reducción en la motilidad de estas células y una aberrante contribución al AER en ausencia 
de Arid3b. Los resultados apuntan a un papel de Arid3b en la regulación de movimientos y 
reorganizaciones celulares que permiten la maduración del AER (Casanova J.C. et al., 2011).
Algunos estudios recientes identifican a Arid3b como una proteína con funciones en el 
mantenimiento y diferenciación de células madre. Ciertamente, de manera similar a lo que ocurre en 
los tumores, Arid3b protege células ES de ratón de la apoptosis inducida por MYCN; los dos genes 
aumentan su expresión cuando células madre neuronales se desdiferencian a células pluripotentes 
inducidas (iPC) (Kobayashi K. et al., 2013). Curiosamente, en otro estudio Arid3b aparece como 
uno de los genes más abundantes después de la diferenciación de las células ES (Wang J. et al., 
2006). Además, Arid3b se identificó en varios screens como una posible proteína de unión a Oct4 
en células ES de ratón y como una posible diana de Oct4, aunque no se ha obtenido ninguna 
confirmación biológica al respecto (Wang J. et al., 2006) (Wang J. and Orkin, 2008) (Sharov A.A. 
et al., 2008). Aún ahora las funciones específicas de Arid3b siguen sin estar claras.
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In the course of a candidate gene screen looking for new genes potentially involved in vertebrate 
limb development, the pattern of expression of Arid3b was analysed in mouse embryos. Although a 
previous study dismissed a direct role of Arid3b in heart development, we could detect expression 
in different regions of the heart and wondered whether it might be directly involved in its embryonic 
development. To address this question we decided to propose the following objectives.  
1. To describe in detail the expression pattern of Arid3b in the heart
2.  To analyse the role of Arid3b in early heart development using a mouse genetic model of 
loss-of-function of Arid3b
3. To search for Arid3b molecular targets and to understand the mechanisms of its function
4. To generate a conditional Arid3b floxed mouse line to determine tissue-specific functions 
of the gene during development
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Embryo staging
Mouse embryos were collected at the indicated gestational stages, with E0.5 defined as noon 
on the day on which a vaginal plug was detected. For a more precise staging, pairs of somites (ps) 
were counted and groups were assigned as follows: E8.5 (8-12 ps), E9.0 (13-16 ps), E9.25 (17-23 
ps), E9.5 (24-26 ps). Embryos were dissected in cold PBS and fixed overnight in 4% PFA at 4°C.
Mouse lines 
Mouse Arid3b gene-trap line
A mouse line (CD1;129P2-Arid3bGt(RRJ028) Byg) was generated as previously described 
from a Baygenomics gene trap ES cell line: (http://www.genetrap.org/cgi-bin/annotation.
py?cellline=RRJ028), which has an insertion of vector pGT0lxf in the intron after the first 
coding exon of Arid3b. This produces a fusion protein between the N-terminal of Arid3b and 
b-galactosidase enzyme, which lacks all the functional domains of Arid3b (Figure 5). Adult mice 
were genotyped by PCR from tail DNA, based on amplification of the first coding Arid3b exon (wt 
and heterozygous) and the presence of the b-Geo cassette in the gene-trap vector (heterozygous). 
Mutant (Arid3bgt/gt) embryos were obtained by mating heterozygous animals. Embryos were 
genotyped by b-Gal activity, measured as the clear different intensity of staining due to different lacZ 
dose (Figure 6). Heterozygous mice were viable and fertile and both wild type and heterozygous 
embryos were used as controls; for simplicity, we always use the term wild type for the control.
For genotyping adult mice the following set of primers were used:
Forward primer wild type: 5’-CAGCAGAAGCAGCCACAGCAG-3’
Reverse primer wild type: 5’-AGTTCGCACCCATCCTACACC-3’
Fragment size: 589 pb 
Figure 5. Scheme representing 
the Arid3b locus in the gene-trap 
mouse line. The b-geo cassette 
is located somewhere in the 
intron2-3 and has a splice acceptor 
site (SA) and stop codon after the 
b-galactosidase sequence. The 
resulting product of translation 
is a fusion protein between the 
N-terminal region of Arid3b (which 
lacks functional domains) and the 
b-geo.
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Forward primer heterozygous: 5’-ACTATCCCGACCGCCTTACT-3’
Reverse primer heterozygous: 5’-ATACTTTCTCGGCAGGAGCA-3’
Fragment size: 720 pb
PCR programme for genotyping: 
Arid3b floxed mice line
The Arid3b floxed line was generated by Gene Bridges Inc. The target floxed sequence was 
Arid3b second exon, which contains the ATG (Figure 7). Briefly, the PKG-gb2-neo/km cassette 
was inserted into the subcloned Arid3b sequence, containing the homology arms, and the whole 
construction was cloned into pMV vector (Figure 8) and electroporated into ES cells. Neomicin 
94ºC                   3’30’’
94ºC                    30’’
60ºC                    30’’          
	  
    x30 cycles
72ºC                   2’30’’
72ºC                     5’
4ºC                       …
Figure 6. b-Gal activity in wild type, Arid3bgt/+ and Arid3bgt/gt embryos 
enables to distinguish between different genotypes. Whole embryos (A) and 
tails (B-D) stained with Lac-Z in parallel; the difference in intensity between 
embryos allowed us to use this technique to genotype the embryos.
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(G-418) treatment was used to select electroporated clones, DNA was extracted and homologous 
recombination checked by Southern blot. Positive clones were injected into wild type blastocysts 
and implanted into foster mother to generate chimaeric mice. The ES cells used were from R1 
(129sv x129/sv-CP) background, while the blastocysts used were from C57BL/6 background. This 
enabled the selection of chimaeric mice by the colour of their fur. One chimaeric male form the 
first injections was able to transmit the colour to its progeny, suggesting germ line transmission 
of the floxed allele and, indeed, we confirmed by genotyping that his offsprings were genetically 
modified. To eliminate the neo cassette, Arid3bflox/flox;Neo cassette mice were crossed with mice carrying 
a Flp transgene which acts on FRT sites and liberates the cassette (Schaft J. et al., 2001) (Figure 
7). 
Figure 7. Schematic representation of the Arid3b floxed allele. The construction contains a resistance 
cassette flanked by FRT sites and the whole construction is flanked by loxP sites. The targeting sequence 
is the second exon where the ATG is located. Addition of Flp liberates the resistance cassette and now the 
second exon appears flanked by the loxP sites.
Figure 8. Targeting construct 
used for generation of Arid3b 
floxed line. 
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For genotyping adult mice and embryos, two pair of primers were used. The first surrounds 
the 3’ loxP site and produces a 323 pb PCR product by wild-type allele and 365 pb band when the 
loxP site is present (Figure 9): 
Forward primer 5’-TCTGCAGCCACTGAGATTTG-3’
Reverse primer 5’-GCTGCAGAGGCTCCATTACT-3’
The second pair of primers amplifies the region flanked by loxP sites. It produces a 1320 bp 
fragment by wild-type allele, 1446 bp in the presence of the loxP sites and a 383 pb fragment after 
Cre deletion (Figure 9).
Forward primer 5’-TCTGCAGCCACTGAGATTTG-3’
Reverse primer 5’-CTTGCTATCATCTTCAGCTTTTTG-3’
PCR program for genotyping:
   
    
  
94ºC                     5’
94ºC                    30’’
60ºC                    45’’          
	  
    x30 cycles
72ºC                     2’
72ºC                    10’
4ºC                       …
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The Arid3b flox/flox line was crossed with the following Cre-lines:
- Sox2-Cre (Hayashi S. et al., 2002) genotyping conditions to detect the Cre:
Forward primer: 5’-TGACGGTGGGAGAATGTTAA T-3’ 
Reverse primer: 5’-GCCGTAAATCAATCGATGAGT-3’
  
     
 
    
Expected PCR fragment: 286 pb
- Nkx2.5-Cre (Stanley E.G. et al., 2002) genotyping conditions:
Nkx2.5Cre Antisense: 5´ GCGCACTCACTTTAATGGGAAGAG 3´
Nkx2.5Cre Sense: 5´ GCCCTGTCCCTCAGATTTCACACC 3´
Nkx2.5Cre: 5´ GATGACTCTGGTCAGAGATACCTG 3´
   
   
Expected PCR fragment: a 264 pb fragment for the wild type allele and 583 pb fragment when a 
cre allele is present.
94ºC                     4’
94ºC                    30’’
56ºC                    30’’          
	  
    x32 cycles
72ºC                     1’
72ºC                    10’
4ºC                       …
94ºC                     5’
94ºC                    30’’
60ºC                    30’’          
	  
    x30 cycles
72ºC                     1’
72ºC                    10’
4ºC                       …
Figure 9. PCRs used to genotype Arid3bflox/flox embryos and adult mice. A. Schematic representation of 
the localization of the primers used for genotyping in the Arid3b gene. B. PCR with genomic DNA extracted 
from yolk sacs of E9.5 Arid3bflox/flox/Nkx2.5-Cre embryos. The first set of primers, which flank the 3’ loxP site, 
produces a PCR product of 323 pb in wild type alleles and a 365 pb in presence of a loxP site (right). The 
second set of primers are located upstream and downstream the two loxP sites. A 1320 pb band is synthetized 
in a wild type allele and a 1446 pb fragment when the second exon is flanked by loxP sites. In the presence 
of Cre, the second exon is deleted and a remaining 383 bp fragment is amplified.
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Embryo extraction and dehydration for whole-mount staining
Embryos were dissected in cold PBS (10 mM Na2HPO4·2H2O, 2 mM KH2PO4, 2.7 mM KCl, 
137 mM NaCl at pH 7.4) and fixed in 4% paraformaldehyde in PBS (PFA) overnight at 4ºC. 
Next day they were washed twice in PBT (0.1% Triton X-100 in PBS) and dehydrated through 
methanol:PBT (50%, 75%, 100%) series and finally stored in methanol 100% at -20ºC untill used.
Paraffin embedding
Embryos were dissected in PBS and fixed overnight in 4% PFA at 4ºC. After two rinses in PBS, 
embryos were dehydrated through ethanol:water series (30%, 50%, 70%, 85%, 90%, 96%, 100%) 
at room temperature. Then they were washed twice in xylol and two times in paraffin wax at 65ºC. 
Embryos were oriented in warm paraffin and the blocks left solidify overnight.
Gelatin-sucrose embedding for cryostat sectioning
Embryos were dissected in PBS and fixed overnight in 4% PFA at 4ºC. They were washed 
twice in PBS at 4ºC and transferred into a sucrose 15% in PBS at 4ºC till the samples went to the 
botton of the tube. Next they were incubated in sucrose 15% in PBS, gelatin 7.5% in PBS for 30-60 
minutes at 37ºC and embedded at room temperature. The blocks were left to cool at 4ºC and then 
frozen in isopentane at -72ºC for 1 minute and stored at -80ºC until cryostat sectioning.
Digoxigenin-labelled riboprobe synthesis
Total RNA from E9.5 and E10.5 mouse embryos was extracted with Qiagen extraction 
Rneasy Mini Kit (Qiagen, ref. 74106); cDNA was synthesized with High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, ref. 4368814). Specific PCR primers usually located in the 
3’ UTR were designed for each probe with primer 3 software. Sp6 or T7 promoter sequences were 
added to the 5’ of the reverse primer to generate anti-sense probes or to the 5’ of the forward primer 
to generate sense probes. Alternatively, plasmids containing the required DNA fragment were 
linearised and purified with Qiagen gel extraction kit. Digoxigenin-labelled riboprobe synthesis 
was performed according to manufacturer’s protocol (Roche). Table 1 depicts the riboprobes used 
in this thesis. In (Figure 10) the two riboprobes designed against Arid3b are depicted.
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GENE CUT Transcrition of 
a-probe
Origin
Anf BamHI T7 Robert Kelly
b-galactosidase PstI T7 Primers used 
for genotyping 
heterozygous mice 
(this thesis)
Bmp2 EagI T3 Ángela Nieto
Bmp4 EcoRI Sp6 Ángela Nieto
Cx40 XhoI T3 Robert Kelly
Fgf8 HindIII T7 Marián Ros
Fgf10 BgIII Sp6 Robert Kelly
Hand1 NotI T7 Robert Kelly
Hand2 EcoRI T7 Robert Kelly
Has2 SalI T3 J.L. de la Pompa
Hey1 EcoRI T3 J.L. de la Pompa
Hey2 SalI T3 J.L. de la Pompa
HeyL EcoRI T3 J.L. de la Pompa
Islet1 SacII Sp6 This thesis 
Mef2c NotI T7 J.L. de la Pompa
Mlc2a BanHI T7 J.L. de la Pompa
Mlc2v SmaI T7 J.L. de la Pompa
Nkx2.5 XbaI T7 J.L. de la Pompa
Snail1 XbaI T3 J.L. de la Pompa
Tbx1 KpnI T3 Robert Kelly
Tbx2 EcoRI T3 J.L. de la Pompa
Tbx3 PstI T3 Robert Kelly
Tbx5 EcoRV T7 J.L. de la Pompa
Tbx20 NotI T3 J.L. de la Pompa
Tbx18 HindIII T7 J.L. de la Pompa
Tgfb2 HindIII T7 J.L. de la Pompa
Twist1 SalI Sp6 J.L. de la Pompa
Table 1.1. List of probes used during the thesis cloned in plasmids.
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GENE PRIMERS Length Origin
Arid3b 5’-CAAGAACCCAGAGCAACACC-3’
5’-GAGTAGAGCCCGCAATGAGG-3’
1209 pb Casanova et 
al., 2011
Arid3b ex2 5’-GTTGAGAGCCATGCCAGTCT-3’
5’-AAGCTGCTCATCCAGACTCC-3’
460 pb This thesis
Bhlhb2 5’-GGATTTTGCCCACATGTACC-3’
5’-CCTTCTCCAATTCACCTCCA-3’
671 pb This thesis
Dkk3 5’-TTGGCTTCATAGGGGAAGTG-3’
5’-TTGTGTAGCCACTGCCTCAG-3’
537 pb Witte et al., 
2009
Gata4 5’-GTGATCCTAGAGTGGCTGTAG-3’
5’- GTCCTGGGAACAGTATTGTGC -3’
546 pb Robert Kelly
Insc 5’-GCAGGTAGACTCGGTTCAGC-3’
5’-AGCTCAATCAGGCGAGACAT-3’
1347 pb This thesis
Kcne3 5’-TTTCTGTCTGTGCCCATTTG-3’
5’-GGGCCTATCAGTCCCTCTTC-3’
644 pb This thesis
Kdm3a 5’-CCTGCAGACCATGACCCTAT-3’
5’-TTGAATGAGCTGTCCAGACG-3’
676 pb This thesis
Lims2 5’-CCGGCACTATGAGAAGAAGG-3’
5’-AGAGGTGGGTTTGCTGACAC-3’
784 pb This thesis
Nox4 5’-GGATTTCTGGACCTTTGTG-3’
5’-CAGATAAAGTACAGTCTTCTTA-3’
525 pb This thesis
Smyd1/BOP 5’-TCAGCATTGCATCAGAGGTC-3’
5’-ATGGTGGGATCTAGCACCTG-3’
569 pb This thesis
Sox7 5’-GCACAGCTGCTACCGCGAAGG-3’
5’-AATCCTACTGCAAACAGCTCCCAAGG-3’
859 pb Takash et al., 
2001
Unc45b 5’-TACGGCAGGCAGCCACCGAATGCATGTG-3’
5’-CAGTCTACAGCCCGTTATCTGGCCTGC-3’
755 pb Price et al., 
2002
Vggl2 5’-TACTTCCAGGGGGACATCAG-3’
5’-AAGGCTCAGTAGTCGCGTGT-3’
605 pb This thesis
Table 1.2. List of probes used during the thesis obtained by PCR.
Figure 10. Schematic representation of the localization of the probes used. The largest probe (black 
arrows) covers almost the whole length of the mRNA and was used to describe the pattern of expressión of 
Arid3b. The short probe (white arrows) is located in the second exon where the ATG is located and was used 
to check for its deletion.
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In situ hybridisation in whole mount embryos and on paraffin sections
Whole-mount in situ hybridisation was performed as previously described (Wilkinson D.G. 
and Nieto, 1993). Whole embryos were rehydrated and digested with proteinase K 10 µg/ml for 
4 minutes (E8.5-9.0) or 7 minutes (E9.5). The incubation with the probes was performed at 65ºC 
overnight. In situ hybridisation on sections (7 µm) was performed in paraffin-embedded embryos 
according to previously described protocols with some modifications (Jostarndt K. et al., 1994) 
(Kanzler B. et al., 1998). Sections were rehydrated and digested with proteinase K 10 µg/ml at 
37ºC for 10 minutes. Overnight hybridisation was performed at 65ºC. Both embryos and sections 
were washed next day, incubated with anti-DIG antibody and developed with BM-purple (Roche, 
ref. 11442074001). Images were acquired with a Nikon Eclipse 90i microscope and in a Leica 
MZ-12 dissecting microscope. 
Lac- Z staining
Tails and embryos from E7.5-E12.5 were dissected in PBS and fixed with 0.125 % glutaraldehide 
in PBS for 15 minutes. Samples were washed twice in PBS for 10 minutes each time and incubated 
in LacZ buffer (0.08 mM Na2HPO4·2H2O, 0.03 mM NaH2PO4·H2O, 2 mM MgCl2, 0.11% sodium 
deoxicholate, 0.0035 mM igepal, 0.02 mM TrisHCl pH=7.3 in water) for another 10 minutes. 
The developing solution contained 5% X-gal as substrate, K4[Fe(CN)6]·3H2O 500 mM and 
K3[Fe(CN)6]·3H2O 500 mM and the enzymatic reaction was let to develop for 30-40 minutes for 
tails or several hours for embryos. Samples were washed twice in PBS, fixed in 4% PFA and kept 
at 4ºC.
Immunohistochemistry
Embryos were collected and fixed in 4% PFA at 4ºC overnight, dehydrated and embebedded 
in paraffin. Alternatively, embryos were included in gelatine-sucrose and frozen for cryostate 
sections. Immunochemistry was performed on 5 µm paraffin sections and on 8 µm cryostate 
sections. Images were acquired on a Leica TCS SP-5 confocal microscope or on a Nikon Eclipse 
90i microscope.
Immunostaining for Troponin T, smooth muscle actin (SMA), sarcomeric myosin heavy 
chain, Islet1, Delta4 and periostin on paraffin sections
Slides were dewaxed and rehydrated, washed in distilled water and antigens retrieved by 
microwave heating for 15 minutes in 10mM citrate buffer, pH 6.0. They were left to cool at room 
temperature for another 15 minutes, washed in PBS and permeabilized with Triton X-100 0.5% for 
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10 minutes. Samples were washed twice in PBS and blocked for 1 hour in either 10% goat serum 
(Islet1, MF20) or in histoblock (3% BSA, 20 mM MgCl2, 0.3% Tween 20, 5% FBS in PBS). 
Slides were incubated overnight at 4ºC with the next primary antibodies:
Protein Troponin T Sarcomeric 
myosin heavy 
chain
Islet1 Delta4 Periostin Smooth 
muscle actin 
(SMA)
Dilution 1:20 1:20 1:100 1:100 1:10 1:100
Species Mouse 
monoclonal
Mouse 
monoclonal
Mouse 
monoclonal
Rabbit 
polyclonal
Rabbit 
polyclonal
Mouse 
monoclonal
Source Hybridoma 
bank
Hybridoma 
bank
Hybridoma 
bank
Santa Cruz Novuls 
Biologicals
Sigma
Reference Ref. CT3 
supernatant
Ref. MF20 
supernatant
Ref. 39.4D5 
supernatant
Ref. sc-
28915
Ref. NBP1-
30042
Ref. C6198
After washing in PBS, slides were incubated with secondary antibody for 1 hour at room temprature: 
biotin goat anti-mouse (1:500, Jackson, ref. 115-066-071) or biotin goat anti-rabbit (1:500, Jackson, 
ref. 111-066-003) and for another hour with streptavidin-DyLight594 (1/500, Jackson, ref. 016-
510-084), streptavidin-Cy3 (1/500, Jackson, ref. 016-160-084) or streptavidin-Alexa-488 (1:500, 
Invitrogen, S-11223) (except SMA, which is directly conjugated to Cy3). Finally, samples were 
washed in PBS and mounted with Vectashield containing DAPI (Vector Laboratories, H-1200). 
Alternativelly, they were incubated for 10 minutes with Dapi in PBS (1:1000, Invitrogen, ref. 
D1306), washed in PBS and mounted with Vectashield (Vector Laboratories, H-1000).
Immunostaining for Jagged1, phospho-SMAD1/5/8 (pSMAD1/5/8) and Islet1 on paraffin 
sections   
Slides were dewaxed and rehydrated, washed in distilled water and antigens retrieved by 
microwave heating for 15 minutes in 10mM citrate buffer, pH 6.0. They were left to cool at room 
temperature for another 15 minutes, washed in distilled water and incubated for 40 minutes in 1% 
H2O2 in methanol to block the endogenous peroxidase activity. Following two washes in PBS, 
samples were permeabilized in Triton X-100 0.5% in PBS for 10 minutes, washed in PBS again 
and blocked with histoblock for 1 hour at room temperature. Samples were incubated overnight 
with primary antibodies at 4ºC:
Jagged1 pSMAD1/5/8 Islet1
1:100 1:200 1:100
Rabbit polyclonal Rabbit polyclonal Mouse monoclonal
Cell Signalling Cell Signalling Hybridoma bank
Ref. 2620 Ref. 9511 Ref. 39.4D5 supernatant
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After washing in PBS, slides were incubated with secondary antibody HRP goat anti-rabbit (1:100, 
Dako, P0448) or anti-mouse (1:100, Dako, P0447) prepared in PBS-BSA 5% for 1 hour at room 
temperature. Following two washes in PBS, fluorescent detection was carried out and reaction was 
left to develop for 3.5 minutes in darkness at room temperature with TSA working solution (1:100 
TSA-Cy3, TSA-488 or TSA-Cy5 Stock Solution diluted in 1X Plus Amplification Diluent) (Perkin 
Elmer, ref. NEL744001KT). Samples were washed and mounted with Vectashield containing Dapi. 
Immunostaining for Notch1 intracellular domain (NICD) on paraffin sections
Embryos were collected and fixed in 4% PFA at 4ºC for 2 hours, dehydrated in ethanol series 
and embebedded in paraffin. Slides were dewaxed and rehydrated, washed in distilled water and 
antigens retrieved by microwave heating for 15 minutes in 10mM citrate buffer, pH 6.0. They were 
left to cool at room temperature for another 15 minutes, washed in distilled water and incubated 
for 40 minutes in 1% H2O2 in methanol to block the endogenous peroxidase activity. Following 
two washes in PBS, samples were permeabilized in Triton X-100 0.5% in PBS for 10 minutes, 
washed in PBS again and blocked with histoblock for 1 hour at room temperature. Samples were 
incubated overnight with primary antibody rabbit polyclonal anti-NICD (1:100, Cell Signalling, 
ref. 2421) at 4ºC. After washing in PBS, slides were incubated with secondary antibody biotin 
goat anti-rabbit (1:500, Jackson) diluted in PBS-BSA 5% for 1 hour at room temperature. After 
secondary antibody was washed with sequential PBS incubations, kit ABC (Vector labs, PK-6100) 
was added to the slides and left to reveal in darkness for 1 hour at room temperature. Following 
two washes in PBS samples were incubated in TSA working solution for 3.5 minutes in darkness 
at room temperature. Slides were washed again and mounted with Vectashield containing Dapi. 
Detection of cell proliferation by BrdU immunstaining on paraffin sections
Embryos at E8.5 were dissected and incubated in culture medium (DMEM, 10% FBS) with 10 
mg/ml BrdU for 1 hour at 37ºC 5% CO2. They were quickly transfered to ice cold PBS to stop the 
incorporation of BrdU and fixed overnight in 4% PFA at 4ºC. Embryos were embedded in paraffin 
and immunostaining was performed as described for Jagged1 and pSMAD1/5/8 with mouse anti-
BrdU primary antibody (1:30, BD, ref. 347580). 
Detection of cell proliferation by phospho-histone3 (PH3) immunostaining on paraffin 
sections
Slides were dewaxed and rehydrated, washed in distilled water and antigens retrieved by 
microwave heating for 15 minutes in 10mM citrate buffer, pH 6.0. They were left to cool at room 
temperature for another 15 minutes, washed in PBS and blocked for 1 hour in 10% goat serum in 
PBS. Slides were incubated for 1 hour at 37ºC with the primary antibody rabbit polyclonal anti-
PH3 (1:200, Miliipore, 06-570). Samples were washed with PBS and incubated for 1 hour at room 
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temperature with secondary antibody Alexa488 goat anti-rabbit (1:200, Molecular Probes, ref. 
A11034). After a couple of washes with PBS, slides were mounted with Vectashield containing 
Dapi. 
Detection of apoptosis by TUNEL on paraffin sections
Cell death was detected using a TUNEL kit from Roche (Ref. 03 333 574 001). Slides were 
dewaxed and rehydrated, washed in distilled water and permeabilazed with Triton X-100 0.5 % 
in PBS for 10 minutes. After two washes with PBS, samples were incubated for 15 minutes with 
TdT buffer 1x CoCl2 1mM at room temperature. Next, slides were incubated with TdT reaction 
mix, which contains the recombinant terminal transferase, at 37ºC for 1 hour. Next, they were 
incubated with TdT buffer 1x CoCl2 1mM for 10 minutes and the reaction was stopped with two 
washes in Tween 20 0.01% in PBS. After washing in PBS slides were incubated with streptavidin-
DyLight594, streptavidin-Cy3 or streptavidin-Alexa-488 (1:500, Jackson) for 1 hour at room 
temperature. Samples were washed again in PBS and mounted with Vectashield containing Dapi.
Immunostaining for CD31, b-galactosidase and nuclear b-catenin on cryostate sections 
Cryostate slides were left at room temperature for 20 minutes and gelatin was removed by 
15 minutes incubation in PBS at 37ºC. Slides were washed twice in TBST (0.1% Tween 20 in 
TBS), permeabilized with Triton X-100 0.5% in PBS for 10 minutes, washed again and blocked 
for 1 hour in 10% goat serum in TBST. Slides were incubated overnight at 4ºC with the following 
primary antibodies:  
CD31 b-galactosidase Nuclear b-catenin
1:50 1:10 1:10
Rat monoclonal Mouse monoclonal Mouse monoclonal
BD Hybridoma Bank Hybridoma Bank
Ref. 553370 Ref. 40-1a supernatant Ref. PY489 supernatant
Samples were washed with TBST and incubated with secondary antibodies: biotin goat anti-mouse 
for beta-galactosidase (1:500, Jackson), followed by an incubation of 1 hour with streptavidin-
DyLight594, streptavidin-Cy3 or streptavidin-Alexa-488 (1:500, Jackson); with Alexa488 goat 
anti-rat for CD31 (1:500, Molecular Probes, ref. A11006) and with Alexa488 goat anti-mouse 
for nuclear beta-catenin (1:500, Jackson). Samples were washed in TBST and mounted with 
Vectashield containing Dapi. 
Immunostaining of actin filaments with phalloidin on cryostate sections
Cryostate slides were left at room temperature for 20 minutes and gelatin was removed by 15 
minutes incubation in PBS at 37ºC. Slides were washed twice in PBS, permeabilized with Triton 
X-100 0.5% in PBS for 10 minutes, washed again and blocked for 1 hour with PBS-BSA 1%. 
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Slides were incubated with Alexa 488 conjugated phalloidin (1:200, Molecular Probes, A12397) 
for 45 minutes at room temperature. Sections were washed with PBS and mounted with Vectashield 
containing Dapi. 
Hypoxia detection
To detect hypoxia levels in embryos we used pimonidazole as previously described (Lee Y.M. 
et al., 2001) (Krohn K.A. et al., 2008). 1.5 mg of pimonidazol were injected in a pregnant mouse 
at the desired stage. 3 hours after the female was anesthetized with a mixture of xylacine (0.4 mg/
gr mouse weight) and ketamine (7.5 mg/gr mouse weight). The embryos were extracted and fixed 
immediately in PFA 4% to avoid inespesific hypoxia. Embryos were embedded in paraffin and 
immunostaining against pimonidazole (1:500, HPI, HP3-200Kit) was done following the same 
protocol as for Jagged1 and pSMAD1/5/8 antibodies.
Ink injection
Indian ink was injected following a modified version of a previously described protocol (Winnier 
G.E. et al., 1999). Embryos at stage E9.25 were dissected in warm culture medium (DMEM, 10% 
FBS) and Pelikan India Ink diluted 1:40 in PBS was injected into the left ventricle. Embryos were 
fixed in 4% PFA overnight and dehydrated to methanol. To visualize the ink, embryos were cleared 
for several hours in 2 vol benzyl benzoate/1 vol benzyl alcohol.
Atrio ventricular canal (AVC) explants
AVC explants were prepared as described previously (Luna-Zurita L. et al., 2010). A 1.5 mg/ml 
solution of rat-tail collagen type I (BD Bioscience, 354236) was prepared and allowed to solidify 
on 4-well micro culture dishes at 37ºC and 5% CO2. Gels were washed several times with DMEM 
(Sigma, D5796) containing 10% FBS, antibiotics, fungizone and non-essential aminoacids and 
left for at least 4 hours in the same medium supplemented with 1% insulin-transferin-selenium 
(ITS; GIBCO, 51300-044). Hearts from E9.5 embryos were dissected in the same medium and 
AVCs were isolated, cut and placed with the endocardium facing the collagen gel. Explants were 
left to attach overnight at 37ºC and 5% CO2. Complete medium was added and explants were 
left to grow for three days. Explants were fixed with 4% PFA for 30 minutes at room temperature 
and stained with phalloidin-Alexa 488 (1:100, Molecular Probes) to reveal the actin cytoskeleton 
and with anti-SMA-Cy3 (1:80, Sigma) to detect mesenchymal cells. Explants were mounted with 
Vectashield medium containing DAPI to stain the nuclei. For treatment of explants with BMP2, 
collagen gels were incubated 30 minutes before explant culture with medium containing 500 ng/
ml recombinant human BMP2 (R&D Biosciences, 355-BM) and the medium added to attached 
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explants was supplemented with the same concentration of BMP2. 2D migration (number of 
scattered cells) was counted with Imaris software. 3D migration (number of cells invading the gel) 
was determined by counting DAPI stained cells in the Z-stack using ImageJ. At least 17 explants 
were considered per condition.
DiI labelling and embryo culture
DiI labelling and embryo culture were performed as described previously (Franco D. et al., 
2001) (Domínguez J.N. et al., 2012). Embryos ranging from 4 to 11 somites were dissected in 
Hank’s solution (Sigma, H9269) without damaging the yolk sac. Long-chain carbocyanine dye 
(DiI, Molecular Probes) was dissolved in pure ethanol and diluted 1:9 in 0.3M sucrose containing 
0.1% Nile Blue Sulfate after heating at 42ºC for 10 min. To track the contribution to the inflow 
region, embryos with 4-7 pairs of somites were injected in a caudal position within the left lateral 
mesenchyme positive for Islet1 (pSHF). The position was determined by using a grid centred on 
the midline of the embryo. To track the contribution to the outflow tract (OFT), embryos from 
8 to 11 somites were injected beneath the heart tube in a rostral Islet1+ region (AHF). The time 
of injection was considered “t=0”. Labelled embryos were photographed under a Leica MZ12F 
dissecting microscope fitted with a fluorescent lamp and cultured in rolling-bottles for 24 hours in 
75% rat serum (Harlan, SR-0100D), 25% DMEM. For the first 12 hours a 5%CO2, 5%O2, 90%N2 
mixture was used; from then on a 5%CO2, 20%O2, 75%N2 mixture was employed. Two embryos 
were cultured per bottle, and could be distinguished by DiI injection into the head (embryo 2) or 
no dye (embryo 1). After 24 hours in culture embryos were collected in PBS, the yolk sac was 
removed and embryos were fixed in 4% PFA overnight at 4ºC. From the total number of labelled 
embryos, 51 were excluded due to abnormal development. We also excluded 70 embryos due to 
inappropriate labelling (cases that presented leakage of DiI into the pericardial cavity or the heart 
lumen during injection and cases when labelling was too deep and DiI appeared mostly in the 
pharyngeal endoderm but not in the heart OFT). A total of 43 wild-type embryos and 21 Arid3b 
mutants were considered for the analysis of embryos marked for IFT contribution, and a total of 
82 wild-type and 20 Arid3b-null embryos were analysed in the case of embryos labelled for OFT 
contribution. The contribution to the IFT was measured by determining whether DiI-labelled cells 
were observed in or outside of the heart tube (binomial distribution). The contribution to the OFT 
was classified into three regions: the length of the OFT was measured by ImageJ and divided 
into an upper half (distal OFT) and a lower half (proximal OFT). The third region was the right 
ventricle, defined using the outer curvature of the heart tube. The following analyses using R were 
used to assess the statistical significance of the results: A 2-sample test for equality of proportions 
with continuity correction was used to analyse the results of pSHF labelling, and a Fisher exact test 
was used to analyse the contribution to the OFT.
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Whole mount immunochemistry
Embryos were extracted in warm Hank’s medium and marked with DiI and image acquired as 
described above. Inmediately they were fixed in PFA 4% overnight.  Next day they were dehydrated 
to methanol and left overnight at -20ºC. Whole mount immunochemistry was performed according 
to standard protocol. Embryos were rehydrated, permeabilized with TritonX, left 1 hour in blocking 
solution and incubated overnight at 4ºC with anti-Islet1 antibody (1:100, Hybridoma Bank). The 
next two days embryos were washed in PBT four times and incubated overnight with biotin Sp 
anti-mouse IgG (1:500, Jackson) first and then with streptavidin Alexa 488 (1:500, Invitrogen). 
Embryos were stored in Vectashield and images acquired in Leica fluorescent scope.
DNA Microarray
E9.5 embryos were dissected in cold PBS. Three regions were separated: head (including 
head and first branchial arch); heart (including the heart tube and the pharyngeal mesoderm and 
endoderm located beneath); and trunk (including the body from the otic vesicle to somite 15). 
Four wild type and four mutant embryos were collected for each of the microarray triplicates. 
For E9.0 whole embryo microarray, four wild type and four mutant samples consisting of 3-4 
embryos each were used. RNA was extracted with the Qiagen extraction kit and RNA quality 
was checked by Nanodrop spectrophotometer measure and gel electrophoresis. Samples were 
labelled and hybridised to Agilent chips (Whole Mouse Genome Microarray 4 x 44K, G4112F 
and G4846A, Agilent Technologies). Functions were analysed with Ingenuity Pathway Analysis 
software (Ingenuity Systems®, www.ingenuity.com).  
Sample labelling and microarray hybridisation. 
RNA amplification and labelling
The One-Color Microarray-Based Gene Expression Analysis Protocol (Agilent Technologies, 
Palo Alto, CA, USA) was used to amplify and label RNA. Briefly, 200-800 ng of total RNA 
was reverse transcribed using T7 promoter Primer and MMLV-RT. cDNA was then converted to 
aRNA using T7 RNA polymerase, which simultaneously amplifies target material and incorporates 
cyanine 3-labeled CTP.
Hybridisation protocol
Samples were hybridised to Whole Mouse Genome Microarray 4 x 44K (G4112F and G4846A, 
Agilent Technologies). 1.65 mg of Cy3 labelled aRNA were hybridised for 17 hours at 65ºC in a 
hybridisation oven (G2545A, Agilent) set to 10 rpm in a final concentration of 1X GEx Hybridisation 
Buffer HI-RPM, according to the manufacturer’s instructions (One-Color Microarray-Based Gene 
Expression Analysis, Agilent Technologies).
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Washing protocol
Arrays were washed according to manufacturer’s instructions (One-Color Microarray-Based 
Gene Expression Analysis, Agilent Technologies). Arrays were dried by centrifugation.
Scan protocol
Arrays were scanned at 5mm resolution on an Agilent DNA Microarray Scanner (G2565BA, 
Agilent Technologies) using the default settings for 4x44k format one-color arrays.
Image analysis
Images provided by the scanner were analysed using Feature Extraction software version 
9.5.3.1 (Agilent Technologies).
Data analysis
Data files from Feature Extraction were imported into GeneSpring® GX software version 
9.0 (Agilent Technologies). Quantile normalization was performed and expression values (log2 
transformed) were obtained for each probe. Expression ratios (log2) were calculated using the wild 
type samples from each experiment as baseline.
Statistical analysis of differential gene expression between Arid3b mutant tissues and wild type 
tissues was assessed using two-class paired SAM 12.
Mouse embryonic fibroblasts, MEFs (RRJ028) 
MEFs extraction     
Mouse embryonic fibroblasts were obtained from E9.5 homozygous and control embryos 
due to the early mortality of this line. Dissection was performed in a tissue culture hood. Whole 
embryos were extracted in warm PBS and transferred to a cell strainer with 100 mm grid pore 
(BD Falcon, REF352360) on a 60 mm dish with complete culture medium (DMEM, FBS 20%, 
penicilin/streptavidin 1%) and gently smashed with a syringe piston. The mesh was washed with 
medium and all the liquid was collected into a Falcon and centrifuged 5 min at 1000 rpm. Cells 
coming from each embryo were cultured in a 24-well culture dish well individually to identify 
embryos by b-gal genotyping. The incubator where the cells were cultured was at 37ºC, 5% CO2, 
90% humidity.
Immunostaining of actin filaments with phalloidin on fixed MEFs
MEFs were fixed for 15 minutes at room temperature with 4% PFA. After two washes with 
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PBS, membranes were permeabilized with PBT (Triton-X 100 1% in PBS). Samples were blocked 
with PBS-BSA 1% for 30 minutes at room temperature. Next, cells were incubated for 30 minutes 
with Alexa 488 conjugated phalloidin (1:200, Molecular Probes) at 37ºC. Cells were washed with 
PBS and mounted with Vectashield mounting medium. 
Migration assay
For video recording, cells were cultured in 6 well culture plates, left to attach overnight and 
recorded for a minimum of three hours with a Nikon time-lapse microscope. Cell tracking was 
made with MetaMorph software using three hours windows for the analysis.     
MEFs (cKOArid3b) 
MEFs extraction
MEFs were obtained from embryos at E12.5 coming from crosses between Arid3bflox/+;Neo cassette 
mice. Dissection was performed in a tissue culture hood. Head, limbs and viscera were removed in 
warm PBS. The rest of the body was transfered to a cell strainer with 40 mm grid pore (BD Falcon, 
REF352340) on a 60 mm dish with complete culture medium (FBS 10%) and gently smashed with 
a syringe piston. The mesh was washed with medium and all the liquid was collected into a Falcon 
and centrifuged 5 min at 1000 rpm. Cells from each embryo were cultured in 12-well culture dish 
well individually and tails were used to obtain DNA and genotype each embryo. The medium used 
contained DMEM enriched in glucose and glutamate, 10% FBS, 1% penicillin/streptavidin.
Alternatively, for MEFs extraction from the Arid3bflox/flox line, male and female mice with 
two copies of floxed Arid3b were crossed and embryos were extracted at E13.5. Embryos were 
dissected in a tissue culture hood. Head and viscera were removed in PBS 1% antibiotic and the 
rest of the body was transferred to a dish with 1 ml of trypsin per embryo (Gibco, 25200-07). The 
digestion was left for 5 minutes at 37ºC. Then a syringe was used to disaggregate the cells. Culture 
medium with 10% FBS and antibiotics was added to stop the digestion. Cells were centrifuged ar 
1200 rpm for 5 minutes and cultured in p100 dishes (2-3 embryos per dish). 
Adenovirus infection for Cre expression in vitro
 Recombinant adenovirus expressing eGFP and Cre were second-generation vectors derived 
from Ad5ΔE1aΔE3 virus. Viral production was made by mid-scaling up stocks in HEK-293A 
cells as described (Palmer D.J. and Ng, 2008). Total IFU (infectious units) present in the eluate 
as purified virus was determined by infecting fresh HEK-293 cells with appropriated dilutions, 
and counting the cells positive for expression of the major capsid protein 48 hpi according to the 
Adeno-X Titer kit (Clontech). The viral titer (total IFU) from each pellet was determined. 
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For infection, MEFs extracted from Arid3bflox/flox;Neo cassette and Arid3bflox/flox lines were used. Both 
Arid3bflox/flox and Arid3bflox/+ MEF were infected with virus either containing eGFP alone or eGFP 
and Cre. The infection was carried out when cells were around 50-70% confluent. Adenoviruses 
were added to cells to achieve a multiplicity of infection of 10. Infection efficiency was evaluated 
the next day by GFP expression. Cells were left to achieve confluency, then tripsinized and sorted 
by flow citometry. Sorted cells were seeded and grown for several days. Aliquots of the cells were 
frozen in complete medium, used for RNA extraction or seeded for wound healing assay.
Wond healing assay
For the wound healing assay, cells were left to grow until confluency. Mitomycin C (Sigma, 
M4287) was used to inhibit cell proliferation. Mitomycin C was diluted in PBS to a final 
concentration of 1mg/ml and added to the culture medium (1/10). Cells were left for 2.5 hours at 
37ºC with the inactivation medium. The inhibition was stopped by PBS washes before the healing 
assay. The wound was done with a yellow tip, pictures were taken at “t=0” and cells were left in 
the incubator. Pictures were taken at the same point 24, 48 and 72 hours after the wound.
RT-PCR and qRT-PCR
To perform RT-PCR or qRT-PCR, total RNA was extracted either from embryos or from cells. 
Embryonic hearts at stage E9.0 were dissected in cold PBS in two regions: the first one containing 
the OFT with the pharyngeal endoderm and mesoderm located beneath and the second consistent 
of atria, ventricle and IFT. The dissected hearts were stored dry at -80ºC until the RNA extraction. 
A pool of 12 mutant and wild type embryos was used. For MEFs RNA extraction, p35, p60 or a 
third part of a p100 plates were lysated directly with the lysis buffer. The kit used for extraction 
was Rneasy Mini Kit (Qiagen, 74106). cDNA was synthetized with the High Capacity cDNA 
Transcription Kit (Applied Biosystems, 4368814). RT-PCR was performed on a standard thermal 
cycler, while qRT-PCR on a 7900HT Fast Real-Time PCR System (Applied Biosystems, 4329001) 
with SYBR green master mix (Life Technologies, 4309155). qBASE was used for data analysis. 
The following primers were used:
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Gene Primers Product 
lenght
Reference
b-Actin 5’-GGCACCACACCTTCTACAATG-3’
5’-TGGATGGCTACGTACATGGCT-3’
196 pb (Varona R. et al., 
2005)
Arid3b 
exon7
5’-AAGGTGATGGAGTCCCAGTG-3’
5’-TGCTCCTCCTCTGACAACCT-3’
166 pb This thesis
Arid3b 
exon2
5’-AGAGAGAAGCAGGGACCACA-3’
5’-GCTCATCCAGACTCCAGCTC-3’
460 pb This thesis
Arid3b 
ARID 
domain
5’-AGAGAGGCACCCCAATCAAC-3’
5’-CACCAGGCCTCCTTTCTCTG-3’
98 pb This thesis
Gapdh
5’-CATGGCCTTCCGTGTTCCTA-3’
5’-GCGGCACGTCAGATCCA-3’
55 pb From
RT
PrimerDB
Hprt 5’-CTGGTGAAAAGGACCTCTCG-3’
5’-TGGCAACATCAACAGGACTC-3’
219 pb This thesis
  
Human Arid3b cloning
Whole length human Arid3b was amplified with High Fidelity Phusion Polymerase (New 
England Biolabs, M0530S). The following primers were used:
5’-CTTGAGGCAAAAATGGAGCCAC-3’
5’-TGTGCATCAACTTCCTTCACTCTCG-3’
The following PCR program was used to amplify the fragment:
    
    
BamHI and EcoRI recognition sites were added at the ends to digest the PCR product. 
The PCR fragment was purified with Qiagen purification kit. EF-Flag plasmid and PCR 
fragment were digested with BamHI/EcoRI and purified with Qiagen purification kit. 
The plasmid was subjected to dephosphorilation with alcaline phosphotase to avoid self-
ligations. A mixture of plasmid and digested PCR fragment was ligated overnight at 4ºC with 
T4 ligase. Thermo-competent bacteria DHa were transformed with this mixture and the 
next day minipreps were done from a few colonies. The insertion was checked by double-
digestion with BamHI/EcoRI. The plasmids were sequenced and compared to NCBI database. 
94ºC                     5’
94ºC                    30’’
66ºC                    45’’          
	  
    x35 cycles
72ºC                     1’
72ºC                    10’
4ºC                       …
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Cell transfection
Human Embryonic Kidney 293 cells (HEK293) were used for transfection with JetPei using 
a standard protocol. Cells were cultured in p100 plates and transfected when 60-80% confluency 
was achieved. 10 mg of each plasmid were dissolved in 500 µl of NaCl 150 mM and 20 µl of 
JetPei per 10 mg of DNA were also diluted in 500 µl of NaCl 150 mM. The two solutions were 
mixed, vortexed for 2 seconds and incubated at room temperature for 20-30 minutes. The solution 
was added to the culture plate by drop fall. Cells were left for 24 hours and than the medium was 
changed. GFP fluorescence started to be detected at 48 hours approximately. For protein extraction 
cells were lysed. The following plasmids were used for transfection:
Human Arid3b-EF-FLAG (as described above)
Mouse Smad1-MYC (Singh R. et al., 2009) 
Mouse Smad5-FLAG (Singh R. et al., 2009) 
PCAGGS/GFP (Momose T. et al., 1999)
Protein extraction 
Non-denaturalizing lysis buffer (ND-lysis buffer: 20 mM Tris HCl pH8, 137 mM NaCL, 10% 
glycerol, 1% NP-40, 2 mM EDTA) supplemented with proteinase inhibitors cocktail (cOmplete 
ULTRA Tablets, Roche 05892970001) and phosphatase inhibitors (NaF, NaVO4) were used to 
lysate the cells. Cells were trypsinized and centrifuged, washed in cool PBS and resuspended in 
ND-lysis buffer. Samples were kept on ice for 30 minutes, pipetting each 5-7 minutes for cell lysis, 
centrifuged for 15 minutes at 12000 rpm at 4ºC and stored at -80C till used. Dc protein assay kit 
(BioRad 500-0111) was used to measure protein concentration. For embryonic protein extract, 
three Arid3bgt/gt embryos and a mixture of 14 wild type and Arid3bgt/+ embryos at E9.5 were used. 
The protocol for protein extraction was the same as for cells in culture and the amount of protein 
used for Western blot was the same for both wild type and mutant embryos.
Immunoprecipitation of Arid3b-Flag and Smad1-Myc
Beads directly conjugated to anti-FLAG antibody were used (anti-FLAG M2 affinity gel, Sigma 
A2220). 40 ul of beads were used for each immunoprecipitation experiment. They were washed 
in cold TBS 3 times and incubated with 400 mg of cell extracts on a wheel for 2 hours at 4ºC. The 
supernatant was collected and beads were washed 5 times with 1 ml of ND-lysis buffer for 8 minutes 
at 4ºC. Proteins were denaturalized with lysis buffer used for polyacrylamide gel electrophoresis at 
95ºC for 5 minutes. The supernatant which contained the denaturalized proteins was collected and 
either freezed or ran directly in acrylamide gel for western blot detection. Immunoprecipitation 
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was carried out with four different types of protein extracts, including the experimental one and 
the controls. The first extract contained both Smad1-Myc and hArid3b-Flag proteins and was 
used for the experiment to check the co-immunoprecipitation. Samples containing only Smad1-
Myc were used as a control of unspecific binding of Smad1-Myc to the beads; extracts containing 
only hArid3b-Flag, to confirm the antibodies specificity towards the antigen. And, finally, extracts 
transfected with GFP, as a control for unspecific protein binding to the beads.
Western blot protein detection
Western blot was carried out according to a standard protocol. 25 mg of protein were used 
per sample. The acrylamide concentration for the separating gels was 8-10%. While the gel was 
running, Immobilon®-P membrane (Millipore) was activated in methanol. The protein transference 
was carried out in Tris-Glycine 20% methanol at 100V for 1 hour at 4ºC. Next, the membrane was 
washed in TBST (Tween 20 1%), cut into pieces for the detection of different proteins and blocked 
for 1-2 hours in 3% milk/TBS. Overnight incubation was carried out with the following antibodies:
anti-ARID3b 1:5000 in TBST/2%BSA (Abcam, ab92328)
anti-b-actin 1:6000 in 5% BSA (Sigma, A5441)
anti-FLAG 1:1000 in TBST/2% BSA (Sigma, F7425)
anti-MYC 1:500 in TBST/2% BSA (Invitrogen, Clone 9E10)
anti-MYC 1:50 in TBST/2% BSA (A-14, Santa Cruz-789)
Next day membranes were washed in TBST and incubated with secondary antibodies (policlonal 
goat anti-mouse/rabbit inmmunoglobulin HRT; Dako, P0448/P0447) 1:5000 in 5% milk/TBS 
for 1 hour at room temperature. After several washes with TBST, membranes were subjected 
to chemiluminiscent assay with ECL™ Western Blotting Detection Reagents (GE Healthcare, 
RPN2106).
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Arid3b is expressed in the heart from early stages of development
During embryonic development, Arid3b shows a broad tissue-specific and dynamic pattern of 
expression (Casanova J.C. et al., 2011) (Takebe A. et al., 2006). We used RNA in situ hybridisation 
and b-galactosidase staining to analyse the expression pattern of the gene (Figure 11). Expression 
could be detected at E7.5 (Figure 11 A, a,b) in the neural ectoderm (Figure 11 B, d, arrow) and in 
the extraembryonic endoderm of the visceral yolk sac (Figure 11 B, d, arrowhead). Already from 
E8.0, expression becomes restricted to posterior and anterior regions. The strongest signal could 
be detected in the unsegmented paraxial mesoderm and in the less mature somites (Figure 11 A 
c-f). While development progresses, the expression persists in the more caudal regions and in the 
tail bud (Figure 11 A g-l, black arrowhead). Expression is also detected in rostral structures, such 
as the branchial arches and pharingeal pouches, the rombenchepalon, the otic vesicle, the cranial 
neural crest and the heart (Figure 11 A c-l, B e-l). We also observed expression in the developing 
limbs in the apical ectodermal ridge (AER) and in the underlying mesenchyme (Figure 11 A i-l, B 
i-l, arrows). The signal detected by b-galactosidase staining was broader that the one measured by 
RNA in situ hybridisation and persisted for longer. For instance, at E10.5 b-galactosidase staining 
showed a strong signal throughout the heart, while by in situ hybridisation at the same stage 
expression was barely detected (Figure 11, compare A k,l with B k,l). At E9.0, most of the 
somites were stained, while by in situ hybridisation the signal was detected only in caudal somites, 
well posterior to the forelimb level (Figure 11, compare A g,h with B g,h, white arrowheads). 
To address whether the b-galactosidase staining reflects the real expression of Arid3b RNA, we 
designed a probe against the b-geo cassette with the primers used to genotype heterozygous animals 
and performed an in situ hybridisation on wild type, heterozygous and mutant embryos at E9.5. We 
observed an RNA signal distribution similar to the one observed with the probe against Arid3b, 
with low levels in heart chambers and a gradually reduced signal in the maturing somites (Figure 
12). Thus, we confirm that the b-geo cassette expression reproduces the endogenous Arid3b RNA 
expression. 
In order to characterize the role of Arid3b during heart development, we analysed in detail its 
expression pattern in the heart by RNA in situ hybridisation. Arid3b was expressed from early stages 
in the heart crescent and in the heart precursors (Figure 13A). At E8.0 expression was observed 
throughout the primary heart tube myocardium and also strongly in the second heart field (SHF) 
(Figure 13 B-D). At E8.5 expression in the heart tube was fainter but remains strong in the SHF 
and the heart poles (Figure 13E). At E9.0 high-level expression persisted in the heart poles (inflow 
and outflow tracts; IFT and OFT) and in the SHF (Figure 13 F-J). However, expression gradually 
decreases in the heart chambers, whereas it is clearly observed in the atrioventricular canal (AVC) 
(Figure 13I). At E9.5 expression was still strong in the sinus venosus, dorsal mesocardium and 
OFT (Figure 13 K-O). At E10.5, expression in the heart myocardium was much fainter, but a 
clear signal is still seen in the OFT (Figure 13 P,Q). From E11.0 expression in the myocardium 
was no longer detected. From E10.5 Arid3b expression was also detected in the endocardium 
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Figure 11. Arid3b is expressed in a broad tissue-specific and dynamic way during development. A. 
RNA in situ hybridisation showing Arid3b expression from stage E7.5 to E10.5. Strong expression could be 
detected in the caudal (unsegmented paraxial mesoderm and immature somites) and rostral (branchial arches 
and pouches) regions, as well as in the limb (arrows) B. Lac-Z staining in Arid3bgt/+ embryos. Expression is 
observed in similar areas as by in situ hybridisation (in the caudal and rostral regions), but is stronger and is 
detected towards the middle region of the embryo, compared to the in situ hybridisation (arrowheads). Scale 
bars: panel A a-h, panel B a,c,e-h 500 mm; panel B b,d 150 mm; panel A i-l, panel B i-l 1 mm.
Figure 12. b-geo RNA shows a pattern of expression 
similar to Arid3b RNA. In situ hybridisation against 
the b-geo cassette in wild type, Arid3bgt/+ and 
Arid3bgt/gt embryos. The expression is restricted to the 
posterior (white arrowhead) and anterior regions of the 
embryo, reproducing the expression of Arid3b mRNA, 
rather that the b-galactosidase staining. The expressión 
in the heart is also similar to the Arid3b probe (black 
arrow). Scale bar: 1 mm.
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(Figure 13 P’) and at E11.5-E12.5 there was an especially strong signal in the valve cushions 
of the AVC and OFT (Figure 13 R-U), although expression is also seen throughout the whole 
endocardium. At E14.5 strong expression was detected in the arterial trunk, as well as in the wall 
of the aorta (Figure 13V). Expression was also present in the epicardium at these stages (Figure 
13 R,T). 
Figure 13. Arid3b is expressed in the heart from early stages of development. RNA in situ hybridisation 
showing Arid3b expression in the heart at different stages of mouse heart development in whole-mount 
embryos (A,B,E-G,K,L) and on paraffin sections (C,D,H-J,M-X). From early stages expression is observed 
throughout the heart tube and in the SHF (A-D, arrowheads). In the looping heart expression diminishes 
in the developing chambers but is maintained strong in the myocardium of the heart poles (asterisks: OFT 
in F,J and IFT in G,H) and in the SHF (E-O,Q, arrowheads in H, J, M and O). Expression can also be 
observed in the AVC myocardium at E9.0 (I, arrow), but not at E9.5. From E10.5 expression is observed 
in the endocardium, especially in the AVC cushions (P,P’,R,R’,S,S’,S’’) and later in the OFT cushions 
(T,U, arrows). We also observed expression in the epicardium at E12.5 (S’’ arrowheads). In the vessels 
Arid3b expression starts in the dorsal aorta at E9.5 (V,W,X white arrowheads) and later also appears in small 
vessels (arrows) and in veins (black arrowheads) (W,X). Scale bars: 150 µm C,D,H-J,M-O,V-X; 250 µm 
A,B,E,F,G,K,L,P-S’’; 500 µm T,U. Stages are indicated as embryonic day (E10.5) or pairs of somites, ps.
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In blood vessels, Arid3b was not expressed in the endothelium at early stages, neither in the 
embryo nor in the yolk sac, although expression was high in the yolk sac endoderm as detected by 
immunostaining against b-galactosidase (Figure 14). However, from E9.5, expression was readily 
seen in the vessels endothelium (Figure 13X). This expression was first seen in the aorta and great 
vessels, including veins, and later extended to smaller vessels (Figure 13 V-X).
Arid3b-null embryos show cardiac defects
Previous reports showed that Arid3b is essential during embryonic development and mouse 
embryos lacking Arid3b have severe cardiovascular defects and die at mid-gestation. To analyse 
the role of Arid3b in heart development we have used a mouse gene-trap line (see Materials and 
Methods). We first checked whether in our gene trap line, as expected from the insertion point, 
Arid3b lacked its known functional domains. In situ hybridisation with a probe against the whole 
length of Arid3b mRNA showed no signal in mutant embryos (Figure 15A); a RT-PCR with 
primers amplifying the whole length of the mRNA (Figure 15B), as well as a qRT-PCR with 
primers located in the exon 7 (Figure 15C) confirmed that in our gene-trap line the full length 
Arid3b is not transcribed. Thus, the line provided a good loss of function model to study the role 
of Arid3b. 
Embryos deficient for Arid3b die at E10.5 with multiple developmental defects, especially 
severe craniofacial and cardiovascular malformations. Most of the structures affected are regions 
with strong Arid3b expression. From E9.25 Arid3bgt/gt embryos show reduced size and an arrest in 
somitogenesis, although newly formed somites look abnormal from earlier stages. The craniofacial 
defects include hypoplastic branchial arches and smaller heads (Figure 16 A-B).  
Figure 14. Arid3b is not expressed in the endothelium but mutants fail to form mature vessels in the 
yolk sac. Immunostaining against b-galactosidase (red, tracking Arid3b expression) and CD31 (green) in 
Arid3bgt/+ and Arid3bgt/gt yolk sacs. (A-H) b-galactosidase could not be detected in the endothelium but was 
strongly expressed in the endoderm. Note that normal mature vessels (E’, arrows) are not observed in mutant 
yolk sac (G’, arrows).
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At E10.5 the cardiac defect was very pronounced with an abnormally dilated heart, altered 
looping and pericardial effusion (Figure 16 A-B). Moreover, the yolk sac lacked large mature 
blood vessels and presented haemorrhages, suggesting that appropriate vascular remodelling is 
impaired (Figure 14 and 16C). However, mutant hearts beat and Indian ink distributed to the 
body after injection into the heart at E9.25, confirming blood circulation (Figure 16 J,O), although 
vessels are smaller as shown by connexin 40 expression (Figure 16 T,Y). To determine whether 
earlier heart defects are observed before the development of the general severe cardiovascular 
phenotype, we closer examined mutant hearts at earlier stages. Already at E8.5 a shortening of the 
outflow and inflow tracts and defective looping could be detected (Figure 16 D,E). The defect in 
the elongation of the poles became more evident at E9.0 (Figure 16 F,G,K,L), and at E9.5 a severe 
hypoplasia of the OFT and IFT prevented the normal looping of the heart (Figure 16 H,I,M,N). To 
obtain a more precise information on the shortening of the poles, we measured OFT length along 
the inner curvature and IFT length along the outer curvature at E9.0 and E9.5, in both wild type 
and Arid3bgt/gt embryos (Figure 17 A,C,E,G). As can be observed, the reduction in length of both 
Figure 15. 
The Arid3bgt/gt mice lack 
Arid3b functional domains. 
A. In situ hybridisation with 
Arid3b probe on wild type, 
Arid3bgt/+ and Arid3bgt/gt 
embryos. A specific signal 
is detected in wild type and 
Arid3bgt/+ embryos but not 
in the mutants. B. RT-PCR 
with RNA extracted from 
pools of 12 wild type and 
mutant OFTs; the PCR was 
performed with the primers 
used to generate the probe 
for in situ hybridisation C. 
qRT-PCR with pools of 12 
wild type and mutant OFTs 
with primers against the 
exon 7 of Arid3b; no signal 
is detected in the mutant 
condition. Scale bar: 500 
µm.
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poles of the heart is indeed evident from E9.0 (Figure 17 B,F), and, while in the wild type embryos 
both poles continue their growth (the OFT almost doubles its length), very little elongation is 
observed in the mutant embryos (Figure 17 D,H).
On the other hand, in histological sections at E9.5, the mutant heart showed disorganized sinus 
horns, thinner myocardium walls in atria and ventricle and reduced trabeculation as compared 
with the wild type heart (Figure 16 P-S,U-X). Moreover, the mutant OFT was short and the 
Figure 16. Arid3b mutant embryos show early cardiac defects. b-gal staining of Arid3bgt/+ (A) and 
Arid3bgt/gt (B) embryos at E10.5. Major defects are seen in the mutant: smaller size (note the different 
scale), craniofacial and heart malformations. (C) Absence of normal vascular remodelling in the 
Arid3bgt/gt yolk sac at E10.5. (D,E) Defective looping and heart pole formation is seen as early as E8.5 in 
Arid3b-null embryos. (F,G,K,L) At stage E9.0, Arid3bgt/gt embryos show a substantial shortening of the 
OFT and IFT, which becomes more evident at E9.5 (H,I,M,N). (J,O) Injection of Indian ink into the heart 
confirms blood circulation in mutant embryos, although vessels are smaller than in wild type embryos, as 
shown by connexin40 expression (RNA in situ hybridisation in T,Y). (P-S,U-X) H&E staining on sections 
of E9.5 embryos, showing abnormal heart structure in Arid3b-null embryos. The poles appear disorganised 
(IFT, compare U with P; OFT, compare X with S). Note also the thinned myocardium (V,W arrows), reduced 
trabeculation in the ventricle (W, arrowheads) and absence of EMT in the AVC (W, asterisk). Scale bars: 
150 µm P-Y; 250 µm F,G,K,L; 500 µm A,B,H-J,M-O.
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atrioventricular canal was narrow and did not show the epithelial-to-mesenchymal transition 
(EMT) of the endocardium that was already evident in wild-type hearts, where mesenchymal 
cells were conspicuous. The expression pattern of Arid3b and the heart defects in the mutant 
embryos suggest that Arid3b is directly required for proper early heart morphogenesis, although 
the defective vasculature, both in the embryo and in the yolk sac (Figures 14 and 16 T,Y), could 
contribute to cardiovascular failure and lethality. 
The phenotype of Arid3b mutants is dependent on the genetic background of the mice
A previously published report showed that deletion of Arid3b during development leads to 
embryonic lethality but the phenotype observed is variable: at E10.5 40% of the embryos showed 
only growth retardation, while the rest displayed a severe phenotype similar to the one described 
above. On the other hand, they could recover mutant embryos at later stages (until E12.5) (Takebe 
A. et al., 2006). To elucidate whether the phenotype of Arid3b mutants might be dependent on 
the background, we backcrossed our Arid3bgt/gt line to C57BL/6 background, which was the one 
used in the previous report. We collected several embryos at different developmental stages and 
checked the phenotype. The results are depicted in Table 2. As can be observed, at E10.5 we 
obtained mutant embryos with no apparent developmental defects and could recover live embryos 
Figure 17. The poles of 
the heart are shortened 
in Arid3bgt/gt embryos. 
Pictures of the right side 
of wild type and mutant 
embryos at E9.0 (A) and 
E9.5 (C), where the blue 
line traces the measured 
inner curvature of the OFT. 
While already evident at 
E9.0 (B), the shortening 
is easier appreciated at 
E9.5 (D). Pictures of the 
left side of wild type and 
mutant embryos at E9.0 
(E) and E9.5 (G), with 
the blue line following the 
outer curvature of the IFT. 
Note that the shortening 
is already strong at E9.0 
(F) and the differences 
increased when stage E9.5 
is achieved (H). Scale 
bar: 500 µm. Results are 
expressed as mean +/- SD. 
**p<0.01; ***p<0.001, 
Student’s t-test.
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till stage E12.5. No viable mutants were found after E12.5, similar to what was observed in the 
previous study. 
To elucidate whether mutant embryos found at E12.5 display any heart defects, we performed 
haematoxylin and eosin staining on an Arid3bgt/gt embryo and its Arid3bgt/+ littermate recovered at 
E12.5 (Figure 18). The heart appeared smaller and a clear ventricular septum defect was observed 
(Figure 18 C-D, arrow). Curiously, the formation of endocardial cushions by EMT in the AVC, 
which is severely affected in the CD1 background, appeared normal in this mutant (Figure 18 A,B). 
Also, the septation of the OFT was delayed and formation of normal OFT valves was disrupted 
(Figure 18 E-H, asterisk). In conclusion, the results suggest that mouse background affects the 
severity of the phenotype derived from Arid3b mutation. All the following work was done using 
the gene-trap line on the CD1 background. 
Table 2. Embryos from Arid3bgt/+ crosses in C57BL/6 background collected at different 
developmental stages.
Figure 18. Arid3bgt/gt embryos on 
C57BL/6 background present a milder 
phenotype. Haematoxylin and eosin 
staining of E12.5 Arid3bgt/+ and Arid3bgt/gt 
embryos. Contrary to what is observed in 
mutant embryos on CD1 background, the 
endocardial cells of the AVC undergo EMT 
(A,B). The mutant heart appears smaller 
and a ventricular septum defect can be 
observed (C,D, arrows). The septation of 
the OFT is delayed and no remodelling of 
the valves is observed, a process already 
taking place in a wild type situation (E-H, 
asterisk). Scale bar: 500 µm.
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Chamber patterning and rates of proliferation and cell death are normal in the absence 
of Arid3b
To evaluate whether Arid3b deletion affects genes known to be important for heart formation, 
we performed in situ hybridisation to detect mRNA expression of cardiac transcription factors, 
signalling molecules and heart structural genes. We analysed hearts at E9.0 when the general 
appearance of the embryos is normal, but some cardiac defects, like heart poles shortening, are 
already visible. Two early cardiac master genes, later involved in the specification of chamber 
myocardium, Nkx2.5 and Gata4, showed similar patterns and levels of expression in wild type and 
mutant hearts at E9.0 (Figure 19 A-D). Chamber patterning also appeared to be unaltered in mutant 
hearts, since normal expression was detected for several chamber markers: Tbx5, which activates 
chamber differentiation programme (Figure 19 E,F); Mef2c, involved in proper formation of the 
right ventricle (Figure 19 G,H), Hand1 and 2, with important roles in ventricular cardiomyocyte 
expansion and heart chamber morphogenesis (Figure 19 I-L), Hey1 and Hey2, atrial and ventricular 
markers, respectively, which delimit the atrioventricular canal (Figure 19 M-P), Mlc2v and Mlc2a, 
expressed in the ventricle and atria (Figure 19 Q-T). These results suggest that the specification 
and patterning of different heart regions occur normally in Arid3bgt/gt embryos. 
Because a correct balance of cell division and apoptosis is important for normal heart 
development, we also analysed proliferation and cell death in the heart tube and the forming heart 
chambers between stages E8.0 and E9.5. There were no significant differences in proliferation in 
any region at the stages analysed, as measured both by pH3 staining and by BrdU incorporation 
(Figure 20A). Apoptotic cell death assessed by TUNEL labelling was also similar, except for a 
significantly higher level in the atria of mutant hearts at E9.5 (Figure 20B). These results suggest 
that an imbalance in proliferation and cell death is not the cause of heart phenotype of Arid3bgt/gt 
embryos.
Arid3b is required for AVC patterning
An important heart region affected in the mutant is the AVC, located between the forming 
chambers. Cells in this area are distinguished from atrial and ventricular neighbours by a distinct 
molecular code and will also undergo EMT to form the valves that separate the chambers. Expression 
of Bmp2, an upstream regulator of AVC fate, was similar in mutant and wild type hearts at E9.0 
(Figure 21A). However, Arid3b-null hearts showed significantly below-normal expression of Tbx2 
and Tbx3, targets of Bmp signalling and determinants of AVC specification through the repression 
of chamber-specific genes (Figure 21A). Notably, expression of the chamber myocardium marker 
Anf, repressed by Tbx2/3, was expanded to the AVC region (Figure 21A). These altered expression 
patterns persisted at E9.5 (Figure 21B), where almost no expression of Tbx3 could be detected 
in the inner curvature of the AVC and Anf signal was continuous through it. These alterations 
were now accompanied by a relative drop in the expression of Bmp2 (Figure 21B), indicating 
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disruption of the regulatory feedback loop between Tbx2/3 and Bmp2 and leading to abnormal 
AVC formation. Not only Anf, but also other genes expressed in the chamber myocardium, like 
Cx40, were expanded into the AVC in mutant embryos (Figure 21B). 
Figure 19. Patterning of the heart is not affected in Arid3bgt/gt embryos. Analysis of gene expression in 
E9.0 embryos by RNA in situ hybridisation. A-D. Expression of the cardiac master genes Nkx2.5 and Gata4 
is normal in mutant embryos. E-T. Chamber patterning is not altered in Arid3b mutants, as shown by normal 
expression of Tbx5 (E,F), Mef2c (G,H), Hand1/2 (I-L), Hey1/2 (M-P) and Mlc2v/2a (Q-T). Scale bars: 150 
µm A-J, Q-T; 250 µm K-R.
Figure 20. Proliferation and cell death are not affected in the hearts of Arid3bgt/gt embryos. A. Cell 
proliferation measured by pH3 immunostaining at different stages and in different heart regions (b,c,e,f; a 
shows the quantification of the results) and by BrdU incorporation at E8.5 (d,g); no statistically significant 
differences were detected between mutant and wild-type embryos B. Cell death measured by TUNEL; 
statistically significant differences are only observed at E9.5 in the atria (a,c,f). Results are expressed as 
mean +/- SD. ***p<0.001, Student’s t-test.
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To characterize the origin of the AVC alterations we analysed by immunostaining pSmad 
expression, which mediates BMP signalling. Consecutive sections were stained with Bmp2 to 
define the AVC region. In the AVC myocardium, similar nuclear localization of pSmad, indicative 
of pathway activation, was observed in wild type and Arid3bgt/gt hearts at E9.0 (Figure 22 C, D) and 
E9.5 (Figure 22 G-I), despite the lower Bmp2 expression in mutants at E9.5 as described above 
(compare Figure 22 A, B with E, F). On the other hand, pSmad nuclear localization was present in 
mutant AVC endocardium at E9.0 at a similar level then in wild type endocardium (Figure 22 C,D) 
but at E9.5 the number of pSmad-positive endocardial cells was lower in mutant than in wild type 
AVC (Figure 22 G,H,J). These results suggest that Arid3b acts in the myocardium downstream 
of pSmad nuclear translocation and that its absence disrupts the relay of Bmp2 signalling to the 
endocardium.
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Figure 21. Arid3b is required for patterning of the AVC. A. In situ hybridisation of molecules important 
for AVC patterning at E9.0 in whole mount. Bmp2 expression in E9.0 Arid3bgt/gt embryos is normal but Tbx2 
and Tbx3 (arrowheads) are below-normal and expression of the chamber marker Anf is expanded (arrowhead). 
B. In situ hybridisation at E9.5 on paraffin sections. In E9.5 Arid3bgt/gt embryos Bmp2 expression diminishes 
(arrowhead), Tbx2 and Tbx3 expression remains low (arrowhead), and expansion of Anf towards the AVC is 
more evident (arrowhead). Cx40, another marker of chamber myocardium, is also expanded towards AVC in 
the mutant. Scale bars: panel A 250 µm; panel B 150 µm.
Figure 22. pSmads 1/5/8 expression looks 
normal in the myocardium, but the 
number of pSmad+ cells is reduced in the 
endocardium. Expression of Bmp2 (RNA 
in situ hybridisation) and pSmad1/5/8 
(immunohistochemistry, red) in consecutive 
sections at E9.0 (A-D) and E9.5 (E-H). 
MF20 labelling (immunohistochemistry, 
green) was used to stain myocardium. No 
differences in pSmad nuclear localization
between wild type and Arid3bgt/gt embryos are seen in the myocardium at any stages analysed, 
but a much lower number of pSmad-positive nuclei is evident in Arid3bgt/gt endocardium 
at E9.5 (G,H, arrowheads), although not at E9.O (C,D, arrowheads). Graphs representing 
the per cent of pSmad+ nuclei in the myocardium (I) and in the endocardium (J) at E9.5 in 
wild type and Arid3bgt/gt embryos. While in the myocardium the proportion of pSmad+ cells 
is similar between the two conditions, in the endocardium there is a statistically significant 
reduction in the proportion of pSmad-expressing cells in the Arid3b-null embryos. Scale 
bars: 100 µm. Results are expressed as mean +/- SD. **p<0.01, Student’s t-test.
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Arid3b does not bind pSmad1 in vitro
The data shown above point to a normal activation of the Bmp2 pathway in the myocardium 
until the step of pSmad nuclear translocation; however, normal activation of Tbx2 and Tbx3 did not 
occur. Although it was recently shown that, at least in the case of Tbx2, a region located upstream 
Tbx2 promoter enriched in pSmad binding sites is sufficient to drive its expression, the regulation 
seems to be far more complex. For instance, Tbx20, also expressed in the myocardium, competes 
with Smad4 for binding to Smad1/5/8, thus inhibiting Tbx2 activation (Singh R. et al., 2009). 
On the other hand, pSmad DNA-binding is thought to be stabilized by other sequence specific 
DNA-binding proteins to ensure successful activation of its targets (Blitz I.L. and Cho, 2009). 
We wondered whether Arid3b could be involved in the proper activation of Tbx2 by directly 
interacting with pSmad proteins. To address this question we cloned human Arid3b into a Flag-
vector and co-transfected it together with mouse Smad1-Myc (Singh R. et al., 2009) into HEK 
cells to test whether they co-immunoprecipitate. 
Figure 23. Successful 
overexpression of hArid3b-
Flag and Smad1-Myc in HEK 
cells. A. Western blot with anti-
Myc antibody to detect Smad1 
overexpression in HEK293 
cells. A specific band of 50-
60 kDa is detected in samples 
transfected with Smad1-Myc 
plasmid (arrow). Smad1-Myc 
from previous transfections is 
used as a control for antibody 
B. Western blot with anti-Flag 
antibody to detect hArid3b 
overexpression in HEK293 
cells. A unique band of around 
60 kDa is visible in the three 
dishes that were transfected 
with the hArid3b-Flag plasmid. 
A truncated form of Arid3b 
of around 35kDa is used as a 
positive control for the antibody. 
C. Western blot with anti-
hArid3b commercially available 
antibody. A distinct band is   
detected only when cells are transfected with hArid3b-Flag plasmid. A truncated form of Arid3b of around 
35kDa is used as a positive control for the antibody. D. Western blot with anti-Arid3b antibody on protein 
extracts from the SW480 cell line (human colon adenocarcinoma cell line), 3T3 cell line (mouse fibroblast 
cell line) and chick embryos at stage HH26 (Hamburger V. and Hamilton, 1951). While in human and chick 
samples a band of expected size is detected, it does not appear in the mouse sample. E. Western blot with 
anti-Arid3b antibody on samples extracted from a pool of wild type and mutant embryos. Note that the 
pattern of bands is similar between the two samples and no specific band of the expected size is detected in 
the wild type extract. 
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We first checked whether overexpression was observed in cells by Western blot with anti-Myc-
tag, anti-Flag-tag and anti-human Arid3b antibodies (Figure 23 A-C). Western blot against Myc-
tag showed a specific band in the conditions where Smad1 was transfected (Figure 23A, arrow). 
Similarly, anti-Flag antibody detected a unique band of the expected size in cells transfected with 
hArid3b-containing plasmid (Figure 23B). Moreover, anti-hArid3b antibody recognizes a distinct 
band in cells transfected with hArid3b-Flag, a band not present in cells with only endogenous 
levels of Arid3b (Figure 23C). Indeed, it seems that endogenous levels of Arid3b in HEK cells 
are quite low, as we confirmed that the antibody recognized a band of the expected size for Arid3b 
in SW480 cells, where high levels of Arid3b have been detected in a previous study (Numata 
S. et al., 1999) (Figure 23D). However, the antibody did not recognize mouse Arid3b, since no 
specific band could be detected by Western blot in embryonic extracts from Arid3bgt/gt and wild 
type embryos (Figure 23E).       
Subsequently, immunoprecipitation was carried out with beads attached to anti-Flag antibody in 
samples co-transfected with hArid3b-Flag and Smad1-Myc and in control samples. We confirmed 
that the transfected Arid3b-Flag was binding to the beads both when transfected alone or co-
transfected with Smad1 (Figure 24A). Contrary, while a clear band was visible in the input, no 
band was detected with anti-Myc antibody in these samples (Figure 24B), suggesting that no co-
immunoprecipitation took place between hArid3b-Flag and Smad1-Myc. The result suggests that 
under these experimental conditions Arid3b does not bind pSmad1. 
Figure 24. Arid3b and Smad1 do not co-
immunoprecipitate in vitro. A. Western blot on 
samples immunoprecipitated with beads attached to 
anti-Flag antibody and revealed with a different anti-
Flag antibody. As expected, in samples transfected 
with hArid3b-Flag plasmid a band of the hArid3b-
Flag protein size (input) is detected. B. Western blot 
on samples immunoprecipitated with beads attached to 
anti-Flag antibody and revealed with anti-Myc antibody. 
Although present in the sample (input), Smad1-Myc 
does not co-immunoprecipitate with proteins recognized 
by anti-Flag beads. PAE-N1IC clone1 cell extract, which 
overexpress N1IC-Myc, is used as a positive control for 
the Myc antibody (Timmerman L.A. et al., 2004) 
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Defective EMT in Arid3bgt/gt AVC can be rescued by BMP2 in vitro
Bmp2 from the myocardium signals to the endocardium and through pSmad activation promotes 
EMT, an early step in valve formation. The reduction in the number of pSmad positive cells in 
the endocardium of the AVC in mutant embryos at E9.5 suggests that the process of EMT could 
be affected. To gain further insight into Arid3b function in the AVC, we analysed the expression 
of EMT markers, some of which are indeed known targets of Bmp signalling. Snail1 plays a 
central role in EMT by repressing cadherins necessary for cell adhesions, and is regulated by both 
Bmp2 and Notch pathway (Timmerman L.A. et al., 2004) (Luna-Zurita L. et al., 2010). Tgfb2 
is expressed in the myocardium, where it is a target of Bmp2 signalling and in the endocardium, 
where it is involved in EMT. Twist1 is also required for AVC EMT downstream of Bmp2 (Ma L. et 
al., 2005), while Tbx20 is strongly expressed in mesenchymal cells and is involved in later events 
of valve remodelling (Shelton E.L. and Yutzey, 2008). Has2 is a hyaluronic acid synthetase and its 
absence in the endocardium leads to decreased EMT (Camenisch T.D. et al., 2000). At E9.5 EMT 
is already detected in the wild type AVC, and transformed cells expressing the above mentioned 
mesenchymal markers are observed in the cardiac jelly (Figure 25A). In contrast, these cells are 
not present in Arid3b-deficient AVC (Figure 25A). Moreover, although Tgfb2 expression was 
detected in wild type and Arid3b-null AVC myocardium (Figure 25A), its expression in the mutant 
AVC endocardium was undetectable, as well as the expression of Snail1, Twist1 and Tbx20. By the 
contrary, Has2 was expressed normally in the Arid3bgt/gt endocardium (Figure 25A).
Because the Notch pathway has been described as playing a crucial role in AVC EMT, we 
decided to check whether this pathway was disrupted in the mutant endocardium. We analysed the 
expression of two Notch ligands, Delta4 and Jagged1, which act as activators of the Notch pathway 
in the AVC. No differences between wild type and mutants were observed (Figure 25B). Moreover, 
we checked whether the active form of Notch1 translocates into the nucleus by immunostaining 
against NICD1 (Figure 25B, arrowheads). NICD1 positive nuclei could be detected in Arid3bgt/gt 
endocardium, suggesting that the observed EMT disruption is independent of the Notch pathway.
The reduction of the number of pSmad1/5/8 positive nuclei in the endocardium suggests 
that the primary defect in these mutants is the incorrect relay of myocardial Bmp2 signal to the 
endocardium. To test this possibility, we cultured AVC explants on collagen gels in vitro. In 
these conditions, endocardial cells undergo EMT and invade the collagen gel, a process which 
can be measured and quantified as the transformation index (% invading cells/total number of 
transformed cells, see Materials and Methods). Compared with wild type AVC explants, mutant 
explants generated significantly fewer transformed cells and, more importantly, a significantly 
lower transformation index (Figure 26 A-C). Because the in vitro system reproduced the results 
observed in vivo, we decided to check whether Arid3bgt/gt endocardium is responsive to Bmp2. 
Indeed, addition of Bmp2 to the culture medium rescued the defects restoring the total number 
of transformed cells and the transformation index to values similar to those of wild type explants 
(Figure 26 A-C). This result confirms that the EMT deficiency in Arid3b mutant AVC is caused by 
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inefficient BMP2 signalling from the myocardium to the endocardium.
Figure 25. Disruption of EMT in Arid3b mutant hearts. A. In situ hybridisation of molecules involved 
in EMT in the AVC. Expression levels of Snail1, TGFbeta2, Twist1 and Tbx20 are significantly lower in the 
mutant AVC endocardium, whereas Has2 is unaltered; note also the almost total absence of mesenchymal 
cells invading the cushions in the mutant. B. Immunostaining against Notch1 active form, NICD1 (a,b, red), 
and Notch1 ligands present in the heart at this stage, Delta4 (c-f, red) and Jagged1 (g,h,red). MF20 is used 
to stain myocardium (green). Expression of the ligands of Notch1 is similar between wild type and mutant 
embryos and, consistent with it, NICD1 positive nuclei are detected in the AVC endocardium (arrowheads). 
Scale bars: panel A, panel B c,d,g,h 150 µm; panel B a,b,e,f 100 mm.
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Microarray analysis identifies candidate genes and processes mediating Arid3b effects on 
heart development
To identify the genes regulated by Arid3b that mediate its effects on heart development, we 
performed a microarray comparison of mRNA expression between wild type and mutant embryos. 
In two separate experiments, RNA was extracted from whole E9.0 embryos or from E9.5 hearts, 
heads and trunks and expression compared between the samples using Agilent chips (Figure 27 
Figure 26. EMT can be rescued in vitro 
by addition of Bmp2. AVC explants 
on collagen gels stained for SMA (red) 
and phalloidin (green) (A). The bottom 
small panels show a confocal Z section to 
detect invasive cells (arrowheads). Both 
the total number of mesenchymal cells 
and the number of cells invading the gel 
(transformation index, TI in %; arrowheads) 
were lower significantly in mutant explants 
(B,C show quantification of the results). 
After addition of BMP2, the total number 
of mesenchymal cells and the TI were 
restored to the levels in wild-type explants 
(B,C). Results are expressed as mean +/- 
SD. * p<0.05; ***p<0.001, Student’s t-test.
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A-C). As can be observed, if specific filters are applied (p value less than 0.05 and a fold change 
of <> +/-2), most of the differentially expressed genes are upregulated in whole E9.0 embryos. At 
E9.5, while not so dramatic, there are also more up-regulated genes in the three regions analysed. 
Of the genes showing differential expression in Arid3b-null embryos, 93 were altered in both 
E9.0 whole embryos and E9.5 hearts and 453 genes were common to the three tissues analysed in 
E9.5 embryos (Figure 27 D-E and Supplementary Tables 1-2). We used the Ingenuity software 
to analyse functionally the data and identify the top highly overrepresented functions in the sets 
of common genes, as well as in the separated regions. The results, shown in Tables 3 and 4, 
correspond to the five top molecular and cellular functions in each condition. As can be seen, cell 
morphology appears in all the conditions, while the top function in the common genes for heart, 
head and trunk at E9.5 is cellular movement. These results support a role for Arid3b in the control 
of cell motility and cellular rearrangements.
To validate the microarray data, we performed mRNA in situ hybridisation analysis of the genes 
that showed high differential expression (Figure 28). Selected genes included members of important 
signalling pathways, genes described to play roles in embryonic development and genes involved 
in vessel or muscle differentiation. Clear up- or downregulation of these genes was observed in 
agreement with the microarray result. Among the genes analysed were HeyL, a downstream effector 
of the Notch pathway (Fischer A. et al., 2007), which appeared completely downregulated in the 
entire embryo (Figure 28 E,J). Dkk3, a Wnt antagonist (Witte F. et al., 2009), was upregulated 
in the heart (Figure 28 K,L,P,Q). 
Figure 27. General information obtained from the microarray. Samples used for the microarrays. RNA 
was extracted from whole embryos at E9.0 (A) or from dissected heart, head and trunk regions of E9.5 
embryos as shown in colours (B). C. Analysis of the microarray expression data, using a 2 fold-change 
threshold and an adjusted p-value of less than 0.05 for false discovery rate, identified a total of 164 genes 
in E.9 whole embryos, 1462 genes in E9.5 hearts, 1558 genes in E9.5 trunk regions and 2167 in E9.5 heads 
as differentially expressed between mutant and control embryos. D-E. The lists of genes were compared to 
identify genes similarly altered in the different conditions; 93 were common to E9.0 whole embryos and 
E9.5 hearts (D) and 453 genes were similarly altered in the three tissues analysed in E9.5 embryos (E).
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Table 3. Top molecular functions overrepresented in the four different samples as analysed by 
Ingenuity.
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Other genes, such as the potassium channel Kcne3 (de Castro M.P. et al., 2006) or the 
transcription factor Sox7 (Takash W. et al., 2001), were up regulated in the vasculature and the 
endocardium (Figure 28 A-D, F-I). The chromatin remodelling protein Kdm3a, which regulates 
smooth muscle cell differentiation (Lockman K. et al., 2007), was also upregulated in the heart 
(Figure 28 M,N,R,S), as was Nox4, a NAPDH oxidase involved in myocardial differentiation (Li 
J. et al., 2006) (Figure 28 U,V,Z,A’). Outside the heart, Insc, a key regulator of mitotic spindle 
orientation (Carmena A. et al., 1998) and neutrophil chemotaxis (Kamakura S. et al., 2013), 
was practically absent in the dorsal root ganglia (Figure 28 O,T). The results of the microarray 
also point to a role of Arid3b in muscle differentiation, as genes related to this process were 
missexpressed in the mutant. In the somites, the expression of Vgll2 and the chaperone Unc45b, 
Table 4. Top molecular functions overrepresented in the set of common genes between Heart E9.5 and 
whole embryos at E9.0, between Heart, Head and Trunk at E9.5 and between the four conditions.
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both involved in muscle formation (Bonnet A. et al., 2010) (Price M.G. et al., 2002), was severely 
reduced (Figure 28 X,Y,C’,D’). However, levels of Vgll2 appeared normal in the branchial arches, 
although the signal did not expand as caudally as in wild type embryos (Figure 28 W,B’). 
Figure 28. Validation of microarray gene-expression profiling by RNA in situ hybridisation 
at E9.5. Whole-mount RNA in situ hybridisation showing differential expression of selected 
genes in Arid3bgt/gt embryos at E9.5. Kcne3 (A,B,F,G) Sox7 (C,D,H,I, white arrowheads), Dkk3 
(K,L,P,Q, white arrowheads), Kdm3a (M,N,R,S) and Nox4 (U,V,Z,A’) appeared upregulated in 
the mutant embryos. HeyL (E,J), Insc (O,T), Vgll2 (W,X,B’,C’) and Unc45b (Y,D’) were strongly 
downregulated in different regions of the embryo. Scale bar: 500 µm; E,J 1 mm.
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For more in depth analysis, we focused on two up-regulated genes that could provide mechanistic 
insight into Arid3b function. 
- Bhlhb2 (also known as Bhlhe40, Stra13, DEC1, Sharp2) is a transcription factor of the basic 
helix-loop-helix family expressed in a number of cell types during mouse embryogenesis. Several 
studies have revealed that it is involved in a variety of processes, such as cellular differentiation 
programs, cell cycle progression, senescence, apoptosis, immune responses, tissue regeneration 
and circadian rhythms (Sun H. and Taneja, 2000) (Honma S. et al., 2002) (Shen M. et al., 2002) 
(Miyazaki K. et al., 2002). It was also shown to be involved in muscular differentiation. Skeletal 
muscle stem cells express Bhlhb2 and its deletion leads to an increase in Notch activity and defective 
differentiation; in vitro Bhlhb2 antagonizes Notch activity (Sun H. et al., 2007). Interestingly, in 
heart progenitors, an up-regulation of Bhlhb2 was observed after b-catenin stabilization that led to 
repression of Smyd1/BOP, a histone methyltransferase essential for cardiomyocyte differentiation. 
Hence, it was proposed that Bhlhb2 regulates cardiac progenitor cell fate determination downstream 
of Wnt/b-catenin signalling (Kwon C. et al., 2009). 
Bhlhb2 was one of the most strongly upregulated genes in our microarray analysis, both in E9.0 
whole embryos and in all E9.5 regions. In situ hybridisation revealed much higher expression of 
Bhlhb2 in Arid3b-null embryos than in wild type littermates (Figure 29A). Increased levels of 
Bhlhb2 were observed in the somites, branchial arches, ventral region of the pharyngeal endoderm 
and in the forebrain. At the level of the heart, up-regulation could be observed in the SHF at E9.0 
(Figure 29A, c) and in the OFT at E9.5 (Figure 29A, d). High levels could also be detected in 
the IFT at both stages (Figure 29A, e-h). In situ hybridisation on sections (Figure 29B, a-h) 
confirmed that expression was particularly strong in the heart poles, especially in the IFT (Figure 
29B e,f, arrowheads; compare with a,b). As mentioned above, Wnt/b-catenin canonical pathway 
activates Bhlhb2 expression. We performed an immunostaining against nucleus b-catenin, which 
reflects the activation of the pathway, to check whether an excessive stabilization of b-catenin in 
the nuclear leads to upregulation of Bhlhb2 in Arid3bgt/gt embryos. We also performed an in situ 
hybridisation against Axin2, which is a target of the Wnt canonical pathway (Figure 30A). Nuclear 
b-catenin was indeed present in the nuclei of mutant embryos and the expression pattern looked 
similar to wild type hearts. Axin2 expression was also normal in mutant embryos. We conclude that 
Bhlhb2 overexpression does not seem to be caused by aberrant Wnt/b-catenin pathway activation 
in Arid3bgt/gt embryos. 
Because of the previously described repressive role of Bhlhb2 on Smyd1, we checked its 
expression in our mutants. Smyd1 levels were indeed reduced in mutant hearts, noticeably in the IFT, 
in the same area in which Bhlhb2 was highly expressed (Figure 29B, j-p, arrowhead). Unc45b, a 
chaperone expressed specifically in muscle and in the heart, also appeared down-regulated in the 
heart microarray. Its expression was also reduced in the IFT of the heart at E9.5 (Figure 29 B, i,m, 
arrowhead), providing more evidence that the differentiation of the IFT is impaired. 
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Figure 29. Microarray analysis reveals Bhlhb2 and as Arid3b target gene. A. RNA in situ hybridisation 
of Bhlhb2 in whole-mount embryos at E9.0 and E9.5. Upregulation of the gene can be observed in a wide 
range of tissues, including the head, the rombomeres, the branchial arches and the heart poles. B. Detection 
of Bhlhb2 mRNA on paraffin sections at E9.0 (a,e) and E9.5 (b-d, f-h). High levels of expression in the 
heart poles are evident in the Arid3bgt/gt embryos (f,h, arrowheads). In situ hybridisation of BOP/Smyd1, a 
marker for cardiomyocyte differentiation, in wild type (j-l) and Arid3bgt/gt (n-p) embryos. The overall level 
of expression is lower in Arid3bgt/gt myocardium and OFT and absent in the IFT (j,n, arrowheads). Unc45b, 
another factor involved in muscular differentiation, is also reduced in the sinus horns (i,m, arrowheads).
Figure 30. Lims2 is upregulated in the heart poles. A. Immunostaining for nuclear b-catenin and RNA 
in situ hybridisation for Axin2, a target of Wnt/b-catenin pathway. Both nuclear localization of b-catenin 
and levels of expression of Axin2 look normal in mutant embryos. B. Expression of Lims2 in wild type and 
Arid3bgt/gt hearts; note the upregulation in the OFT and atria of the mutants (arrows). Scale bars: sections 200 
µm, whole-mount 500 µm.
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To further characterize the differentiation defect of the poles, expression of smooth muscle actin 
(SMA) and troponin T (TnT) was analysed. Expression of SMA and TnT was observed at the heart 
poles in wild type and mutant embryos (Figure 31). However, mutant embryos lacked expression 
in the distal regions closer to the SHF, both in the IFT (at E9.5, Figure 31 A,B, e,f) and in the OFT 
(at E9.0, Figure 31 A,B, c,d and at E9.5, Figure 31 A,B g,h), suggesting defective differentiation 
or delayed maturation of heart precursors. These results suggest that Arid3b regulates cardiac 
precursor differentiation at the heart poles indirectly through repression of Bhlhb2.
Figure 31. Differentiation of cardiomyocytes in the heart poles is impaired in Arid3bgt/gt hearts. A. 
Smooth muscle actin (SMA) (green) and Islet1 (red) immunostaining on paraffin sections of Arid3bgt/gt 
and wild type embryos. Expression of SMA is reduced in the most distal part of the OFT at E9.0 and E9.5 
(white arrows, compare d with c and h with g). In the IFT, SMA expression in Arid3bgt/gt embryos is 
normal at E9.0, but at E9.5 less SMA positive cells are seen at the most dorsal region of the sinus horns (e,f 
white arrowheads). An accumulation of Islet1-positive cells can be observed at the entrance of the OFT of 
Arid3bgt/gt embryos (h, asterisks). B. Immunostaining for SMA (green) and troponin T (red) reveals defective 
differentiation of the distal-most cardiomyocytes added to the poles of the heart in the OFT at stage E9.0, as 
well as E9.5 (c,d,g,h, arrows) and in the IFT at E9.5 (a,b,e,f, arrowheads). Scale bar: 100 µm.
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- Lims2 (also known as Pinch2) is a LIM-domain adaptor protein involved in protein recruitment, 
assembly of protein complexes and their subcellular localization. Together with the integrin-
linked kinase (ILK) and parvin it forms IPP complexes, localized in focal adhesions, which serve 
as a link between integrins and the actin cytoskeleton and diverse signalling pathways. Along 
with Lims1, Lims2 is expressed during development and they both regulate proper cytoskeletal 
organization and adhesion (Legate K.R. et al., 2006) (Kovalevich J. et al., 2011). Interestingly, 
when Lims2 is overexpressed in HEK293 cells, it competes with Lims1 for ILK binding, blocking 
the transduction of integrin-mediated signals that control cell spreading (Zhang Y. et al., 2002). 
Similarly, in myoblasts, upregulation of Lims2 leads to decreased motility (Boudoukha S. et al., 
2010). Deletion of both Lims1/2 in the myocardium results in dilated cardiomyopathy and early 
death from heart failure, pointing to an important role of these proteins in heart development 
(Liang X. et al., 2009). 
Lims2 appeared upregulated in the E9.5 heart microarray. Although in situ hybridisation of 
Lims2 at E9.0 did not show a clear result, at E9.5 a noticeable upregulation was observed in 
Arid3b mutants. High levels of Lims2 were detected in the atria, OFT and SHF cells close to OFT 
in Arid3bgt/gt embryos (Figure 30D, arrows). Because of the above-mentioned role of Lims2 in 
cell adhesion and motility, the results suggest that its upregulation may also contribute to the heart 
defects observed in Arid3b mutants, interfering with proper cell movements and rearrangements. 
      
Specification of SHF and number of precursors are normal in Arid3bgt/gt embryos
  As has been shown above, some of the most striking defects in Arid3bgt/gt embryos are related 
to the poles of the heart, which derive from the SHF. We decided to look in more detail at this 
population of cells. Islet1 is the best known marker for SHF precursors and its absence leads to 
severe shortening of the poles of the heart (Cai C.L. et al., 2003). The expression of Islet1, as 
analysed by immunohistochemistry, revealed no differences between wild type and mutant hearts. 
Moreover, wild type and mutant hearts contained similar total numbers of Islet1+ precursors 
(Figure 32C). Also, no significant differences in proliferation of Islet1+ cells could be detected, as 
measured both by pH3 staining and by BrdU incorporation (Figure 32A). Cell death assayed by 
TUNEL, showed an increase at E9.5, which coincided with the only moment where we detected 
a reduction in the total number of Islet1+ cells in Arid3b mutants in the SHF (Figure 32 B,C) but 
could not explain the earlier defects observed in the poles of the heart. Expression of other genes 
reported to regulate SHF cardiac precursors and normal OFT formation, such as Fgf8 and Tbx1, 
was also unaltered (Figure 32D). These results suggest that the absence of Arid3b does not alter 
the specification of heart precursors in the SHF and that a difference in precursor cell number is 
not the primary cause of the observed defects in mutant hearts.
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Figure 32. Expression of SHF markers and proliferation and cell death of the precursors are not 
affected. A, B. Graphs showing cell proliferation (PH3 immunostaining and BrdU incorporation) and cell 
death (TUNEL staining) in the SHF, defined as Islet1+ population, of wild type and Arid3b-null embryos. 
No differences are observed except for an increase in cell death in mutant SHF at E9.5. Results are expressed 
as mean+/- SD. (*p<0.05, Student’s t test). C. Immunohistochemistry against Islet1 in wild type and 
Arid3bgt/gt embryos at E9.0. Islet1 is expressed in cardiac precursors and the quantification of total number 
of Islet1 positive cells shows that their number only decreases at E9.5 when an increase in cell death is 
observed. Results are expressed as mean+/- SD. (*p<0.01, Student’s t test). D. Analysis of gene expression 
in E9.0 embryos by RNA in situ hybridisation. Expression of genes involved in the regulation of SHF 
precursors (Fgf8 and Tbx1) showed no differences between Arid3bgt/gt and wild-type embryos. Scale bars: 
150 µm.
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As already mentioned, Islet1 is a marker of cardiac precursors in the SHF and Islet1-positive 
cells were indeed observed in the mutant SHF next to the heart poles, at both E9.0 and E9.5. 
Noticeably at this later stage, an accumulation of Islet1+ precursors was seen in the SHF in the 
OFT region (Fig 31A h asterisk). Additionally, the actin cytoskeleton of Islet1+ cells in the SHF 
and the overall tissue architecture of this region were abnormal in mutants. SHF cells in wild 
type hearts had a wide band of actin on the pericardial cavity side (which is thicker at the IFT 
region), suggestive of a polarized epithelium (Figure 33 A-D). In contrast, mutant SHF cells did 
not show such a clear actin band (Figure 33 E-H). Moreover, cells dorsal to the wall epithelium, 
which appear loose and mesenchyme-like in the wild type (Figure 33D), appeared more compact 
and epithelial-like in the mutant (Figure 33F,H). The disposition of the cells in the pharyngeal 
mesoderm also appeared more disorganised in the mutant embryos as compared to the wild type 
(Figure 33 G,H, arrows).
Figure 33. SHF shows abnormal 
architecture. Phalloidin (green) and Islet1 
(red) staining on longitudinal sections in 
E9.25 embryos. Mutant cells (F,H) appear 
more compact and epithelial-like than wild-
type cells (B,D, arrows). Also, the actin band 
facing the pericardial cavity, very conspicuous 
in wild type embryos (D, arrow), is less 
prominent in the mutant (H). Scale bars: 200 
µm (A,C,E,G), 100 µm (B,D,F,H).
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The results presented so far show that Islet1+ precursors are correctly specified in the mutant 
SHF, that proliferation and cell death are unaltered and that the early patterning of the heart is 
normal. However, the cellular architecture and tissue organization in the SHF are disrupted and 
eventually the poles of the heart are malformed. Moreover, Lims2, which regulates cell motility, 
is upregulated in the heart poles of Arid3b mutants. This suggests that abnormal incorporation 
of Islet1+ progenitors into the heart, probably due to defective cellular movements or cell 
rearrangements, is the cause of the phenotype at the heart poles.
Addition of SHF precursors to the heart poles is impaired in Arid3b mutant embryos
In order to directly analyse the fate of mutant SHF cells we DiI-labelled Islet1+ precursors, 
both in ventro-caudal positions at E8.0 (6 ps), which will contribute to the IFT (Figure 34) and 
in rostro-lateral positions at E8.5 (10 ps), which will contribute to the OFT and right ventricle 
(Figure 35). Cells were labelled, embryos cultured in vitro for 24 hours, and the position of DiI-
positive cells was recorded. 
In the case of DiI labelling to track the contribution to the IFT, a more caudal population of 
Islet1+ region was labelled, so that contribution was observed mostly in the sinus horns (Figure 
34 B-D). Labelling of IFT precursors led to the presence of DiI-positive cells in the IFT in 91% 
of wild type embryos, but in only 48% of Arid3b mutant embryos (Figure 34, E-T, summarised 
in U), thus showing that cardiac precursors in the absence of Arid3b do not reach the heart as 
efficiently as in the wild type situation.
To track SHF contribution to the OFT, Islet1+ cells located beneath the heart tube were labelled 
(Figure 35 A-D). In this case, three regions derived from the SHF precursors were differentiated: 
the right ventricle, the proximal OFT and the distal OFT (Figure 35E). Cryostat sections of cultured 
embryos showed an accumulation of DiI-labelled cells at the entrance of the OFT in Arid3bgt/gt 
embryos (Figure 35 F-G, arrow), consistent with Islet1+ cell accumulations observed previously 
(Figure 31A, h asterisk). Labelling of these precursors led to the presence of DiI-positive cells in 
the proximal OFT in most wild type embryos (66%), with a significant proportion showing cells 
in the right ventricle (13%); in contrast, in most mutant embryos (55%), DiI-positive cells were 
found in the distal OFT close to the SHF, and only reached the right ventricle in one embryo (5%) 
(Figure 35 H-M, summarised in N). 
Taken together these results suggest that Islet1+ precursors, although present in Arid3b mutant 
SHF, have an impaired capacity to contribute to the heart poles, which eventually causes the 
observed cardiac defects. 
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Mouse embryonic fibroblasts (MEFs) have reduced motility in vitro
To address the migratory and adhesive behaviour of Arid3bgt/gt cells, we obtained MEFs from 
wild type and mutant E9.5 embryos. While wild-type MEFs grew normally and filled the culture 
plate within days, Arid3bgt/gt MEFs failed to increase their number and never formed a confluent 
monolayer. Their general appearance was abnormal, with fewer protrusions and a more compact 
shape than wild-type MEFs. Staining for actin revealed an increase in stress fibres and an aberrant 
distribution of actin filaments (Figure 36A). To analyse their migratory behaviour, we performed 
time-lapse video microscopy, where individual cells were tracked in a time window of at least 3 
hours. Wild-type MEFs travelled extensively, changed the direction of their migration and explored 
the medium by producing filopodia. On the contrary, Arid3bgt/gt MEFs moved slower and the total 
distance covered in the same timespan was smaller than in the wild-type situation (Figure 36 
B,C). Some cells did not move at all, or did not advance, but stayed in the same position moving 
backwards and forwards. The number of protrusions emitted was lower than in the wild type MEFs 
and they were smaller than normal filopodia (Figure 36D). In some cases, migrating mutant cells 
left behind cell fragments, adhered to the plate; also, transient blebs protruding from the membrane 
could be observed. In summary, these results point to defective cell migration and alteration of the 
cytoskeleton in the absence of Arid3b. 
Figure 34. Addition of Islet1-positive precursors to the IFT is impaired in Arid3bgt/gt embryos. A. 
Ventral view of a 6 somite embryo, as used in DiI fate-mapping experiments, showing the left-right and 
cranial-caudal axes for orientation. B. Example of DiI labelling of the pSHF to study the contribution 
of Islet1+ cells to the IFT. A grid was used to map the position of the injection; for the analysis shown 
here, positions 3 and 4 (caudo-lateral) were considered. DiI (red fluorescence, B,C) was injected into the 
region known to contain Islet1+ cells, later detected by whole-mount immunochemistry (D, green). (E-H) 
Arid3bgt/gt and wild-type embryos labelled with DiI at similar positions (t=0) and (I-L) the resulting label 
seen in whole dissected hearts after 24 hours of in vitro culture. Images show wild type (E,F,I,J) and 
Arid3bgt/gt (G,H,K,L) embryos. Those with DiI-labelled cells in the heart IFT (I,K) were recorded as “IN” 
and those with labelled cells outside the heart (J,L) recorded as “OUT”. (M-P) Additional examples of 
DiI labelling in the pSHF at t=0; in this case, 24 hours after labelling embryos were cryosectioned and 
DiI staining observed on longitudinal sections (Q-T). DiI labelled cells could be detected in the heart IFT 
in some wild-type (Q) and Arid3bgt/gt (S) embryos. In other cases DiI labelled cells appear outside the 
IFT (R, wild type; T, Arid3bgt/gt). U. Summary of the contributions of the pSHF to the IFT in normal and 
Arid3bgt/gt embryos expressed as the percentage of embryos with labelling in or out of the IFT. A 2-sample test 
for equality of proportions was used to compare the two groups. The percentage of embryos with labelling in 
the IFT is significantly higher in the wild-type than the Arid3bgt/gt group (p value= 0.0001903).
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Figure 35. Normal contribution of precursors to the OFT is altered in Arid3bgt/gt. A. Ventral view of 
DiI labelling in a representative embryo at t=0. B. Lateral view after 24 hours in vitro culture. C-D. DiI 
labelling is performed in the Islet1 positive region (D, immunostaining with Islet1 antibody). E. Scheme 
illustrating the three regions in which the heart was subdivided for data analysis. F-G. Cryosections of wild 
type and mutant embryos 24 hours after labelling; note the accumulation of DiI-labelled cells at the entrance 
of the heart in the mutant (arrowhead). H-M. Examples of the three locations of the DiI staining 24 hours 
after labelling in wild-type and mutant embryos. N. Summary of the contributions of the AHF to the heart 
in Arid3bgt/gt and normal embryos expressed as the percentage of embryos with labelled cells in each of the 
regions. Fisher’s test was used to compare the two groups. The difference in the distribution between wild 
type and Arid3bgt/gt embryos is statistically significant (p value= 0.01149). Scale bar: 250 µm
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Generation of an Arid3bflox/flox line
The early lethality of Arid3bgt/gt embryos prevented the study of the potential roles of Arid3b 
in some later developmental processes. Besides, part of the phenotype observed in the gene-trap 
line can be secondary to the general cardiovascular failure of the embryo and we might miss some 
defects directly dependent on Arid3b function. In order to address more precisely tissue-specific 
functions of Arid3b, we decided to generate a line with the Arid3b allele flanked by loxP sites, 
recognition sites for Cre-mediated recombination (a floxed line). Thus, crosses with mouse driver 
lines with tissue-specific expression of a cre transgene would result in Arid3b loss in that particular 
tissue. Cre activity can also be controlled temporally by using a fusion protein of Cre and a mutant 
ligand-binding domain of the estrogen receptor (CreER or CreERT2), which only translocates to 
the nucleus in the presence of 4-hydroxytamoxifen administrated by food, water or intraperitoneal 
injection (Doetschman T. and Azhar, 2012). These strategies could enable us to study Arid3b 
functions not only in specific cardiac populations but also determine the critical developmental 
stages in which its function is required.  
The Arid3bflox/flox;Neo cassette construct was generated by Gene Bridges and the transgenic 
Figure 36. Mouse embryonic fibroblasts 
(MEFs) have reduced mobility in vitro. 
A. Phalloidin staining of actin cytoskeleton 
of wild type and mutants MEFs isolated 
from E9.5 embryos. Note the shortening and 
aberrant distribution of the actin filaments 
in Arid3bgt/gt MEFs. B. Cell trajectory and 
travelled distance were determined by a time-
lapse filming of MEFs cells. Representative 
recording and cell trajectories for both wild 
type and mutant cells are shown. Blebbing 
cells could be observed in mutant fibroblasts 
(arrows) C. Quantification of travelled 
distance; 48 wild-type and 54 Arid3b-null 
cells were used. Results are expressed as 
mean +/- SD. **p<0.01, Student’s t-test. D. 
Quantification of the number of cells with 
lamelipodia in wild type and mutant MEFs. A 
total number of 198 wild type and 133 mutant 
cells were analysed. Results are expressed as 
mean +/- SD. *p<0.05, Student’s t-test.
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mouse line was generated at CNIC by the gene targeting and transgenesis facilities. When the 
first germ line transmission was detected, we crossed Arid3bflox/+; Neo cassette offsprings to obtain 
Arid3bflox/flox; Neo cassette mice. Unexpectedly, almost no viable double homozygous floxed mice 
were obtained. To determine whether Arid3bflox/flox;Neo cassette mice died before birth, we collected 
embryos at different developmental stages. We could recover Arid3bflox/flox;Neo cassette embryos, 
but already at E10.5 the number of mutants was half of the expected and at E11.5 only one 
Arid3bflox/flox; Neo cassette embryo could be recovered. Some embryos showed developmental defects, 
although most of them looked normal (Figure 37 A,B). We also found some reabsorbed embryos 
in these litters. As a possible explanation of the reduced number of homozygous embryos, we 
wondered whether Arid3b expression was normal and to address this question we performed in 
situ hybridisation against Arid3b at E10.5 in Arid3bflox/flox;Neo cassette, Arid3bflox/+;Neo cassette and wild type 
littermates. As can be seen in (Figure 37C) Arid3b levels are gradually reduced as the number 
of Arid3bflox copies increased. We confirmed this result by RT-PCR against the Arid3b exon 7 
(Figure 37D). The low levels of Arid3b in Arid3bflox/flox;Neo cassette embryos might explain the observed 
embryonic lethality. 
Figure 37. Arid3bflox/flox;Neo cassette mice are embryonically lethal because of reduced levels of Arid3b. A. 
Table depicting the number of embryos recovered at different stages after crossing Arid3bflox/+ mice. B. 
Example of Arid3bflox/+ and Arid3bflox/flox E10.5 embryo with developmental defects. C. Whole-mount RNA 
in situ hybridisation against Arid3b in wild type, Arid3bflox/+and Arid3bflox/flox embryos. Note the gradual 
reduction of the levels of expression. D. RT-PCR with RNA extracted from wild type, Arid3bflox/+ and 
Arid3bflox/flox embryos showing the reduction of Arid3b levels correlating with the increase in the number of 
the floxed copies. Scale bars: B 1 mm; C 1.5 mm.
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Because it has been reported that the Neo cassette might interfere with normal gene 
expression (Chen L. et al., 1999) (Rucker E.B. et al., 2000) (Xu X. et al., 2001), we crossed 
Arid3bflox/flox;Neo cassette females with males carrying the flipase transgene, which recognizes the Flp 
sites (Schaft J. et al., 2001). In this way, the resistance cassette is eliminated and we can expect to 
obtain viable Arid3bflox/flox mice. In the absence of the Neo cassette normal proportions of viable and 
fertile double flox mice were obtained (Table 5), suggesting that the presence of the Neo cassette 
indeed interfered with normal Arid3b expression. These mice were used to cross with specific Cre 
lines.
Analysis of the phenotype of the Arid3bflox/flox/Sox2-Cre line
To confirm the lethal phenotype of Arid3b deficient embryos, produced in a conditional manner, 
we crossed our Arid3bflox/flox line with Sox2-Cre line, which deletes genes from the epiblast stage 
(Hayashi S. et al., 2002). We collected embryos at different points of development to determine 
the stage of embryonic death (Table 6). We could detect some variability in the phenotype: while 
some mutant embryos looked normal at E10.5, others were already necrotic at this stage. No 
Arid3bflox/flox/Sox2-Cre live embryos were recovered on day E12.5. This phenotype was similar to 
the described for Arid3b knockout in C57BL/6 strain background described previously (Takebe A. 
et al., 2006) and to the phenotype we observed with our gene-trap line on C57BL/6 background. 
To confirm the deletion, we performed an in situ hybridisation with an Arid3b probe against 
the coding mRNA (starting from the second exon, where the ATG is located to the ninth exon 
which codifies partially for the REKLES domain). Strikingly, using this probe, we could detect 
robust expression of Arid3b in the mutant embryos similar to the control (Figure 38). Because 
the flox sites flank the second exon of Arid3b (Figure 7), we designed a probe against this exon. 
In situ hybridisation in wild type and mutant embryos confirmed a total deletion of this region in 
Arid3bflox/flox/Sox2-Cre embryos (Figure 38). Together, these data suggests that a successful 
deletion of the ATG region of Arid3b occurs in Arid3bflox/flox/Sox2-Cre line, and the consequent 
Table 5. Number of embryos of different genotypes obtained from crosses between 
Arid3bflox/+ mice after the deletion of the resistance cassette.
Table 6. The expected and observed ratios of embryos collected at E10.5 from crosses between 
Arid3bflox/+/Sox2-Cre and Arid3bflox/flox mice.
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mid-gestational lethality of the embryos supports the idea that no functional protein is synthetized, 
although we can detect Arid3b mRNA.
Analysis of the phenotype of Arid3bflox/flox and Arid3bflox/flox;Neo cassette derived MEFs 
We isolated MEFs from E12.5 Arid3bflox/+ and Arid3bflox/flox embryos from two different lines: 
from embryos that still carried the Neo cassette and from embryos in which the cassette was 
deleted by crossing the line with a flipase transgenic line. Both types of cells, independently of 
the genotype, grew normally. Part of the Arid3bflox/flox MEFs was infected with an adenovirus 
expressing Cre and the infected cells were sorted based on GFP expression from the viral vector. 
We confirmed a successful deletion by RT-PCR with primers against the second exon; however, 
when the RT-PCR was done with primers located in the 3’-region (exon 7) or in the ARID 
domain (exon 5), a band still could be detected in cells infected with adenovirus with cre (Figure 
39 A,B). This is consistent with the results observed in the in situ hybridisation performed in 
Arid3bflox/flox/Sox2-Cre embryos. The phenotype of the Arid3bflox/flox;Neo cassette and Arid3bflox/flox MEFs 
was different after the addition of Cre and deletion of the second exon. While Arid3bflox/flox;Neo-cassette 
+Cre MEFs were still able to grow and fill the plate, Arid3bflox/flox +Cre MEFs did not expand and 
no increase in the number of cells could be detected after several days on the culture dish. This 
is reminiscent on the phenotype obtained in Arid3bgt/gt MEFs. Because of this limitation, we used 
Arid3bflox/flox;Neo-cassette MEFs for further experiments.
      An in vitro wound-healing assay was performed with those MEFs to test whether a motility 
phenotype is present, similarly to MEFs from Arid3bgt/gt embryos (Figure 39C). Mitomycin C 
was used to inhibit proliferation. When plates were examined 48 hours after the wound, control 
Arid3bflox/flox;Neo-cassette MEFs showed almost complete closure of the gap, confirming that cells 
migrated and covered the free space. On the contrary, when Arid3b  was deleted from the cells, 
the wound looked very similar to the starting moment of the experiment, t=0 (Figure 39C). Cells 
Figure 38. 
Expression of Arid3b RNA in Arid3bflox/flox/Sox2-Cre 
embryos. RNA in situ hybridisation in wild type and 
Arid3bflox/flox/Sox2-Cre embryos with two different probes 
against Arid3b. Expression was similar when a probe 
against the whole mRNA was used, while no expression 
was detected in Arid3bflox/flox/Sox2-Cre embryos with a 
probe against the second exon, which is the floxed region. 
Scale bar: 1 mm. 
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extended protrusions towards the gap, but failed to cover the cell-free surface, as they did in the 
absence of Cre. Because proliferation was inhibited in both conditions, disruption of normal cell 
motility and/or adhesion looks as the main reason for the phenotype observed. Thus, we confirm 
that MEFs isolated from our Arid3bflox/flox;Neo-cassette mice line, after Arid3b deletion, display similar 
defects to the ones observed in MEFs from Arid3bgt/gt embryos, including a migration capacity 
impairment.
Figure 39. MEFs derived from Arid3bflox/flox embryos show a phenotype similar to Arid3bgt/gt MEFs. A. 
Scheme of the Arid3b mRNA with the pairs of primers used to detect the its expression: pair1 – exon2 (460 
pb); pair2 – ARID domain (98 pb); pair3 – exon7 (166 pb); pair4 – exon5 - exon7 (664 pb); b-actin was 
used as control B. RT-PCR with RNA extracted from Arid3bflox/+, Arid3bflox/flox and Arid3bflox/flox + Cre MEFs 
with different pairs of primers as shown above. C. Wound-healing experiment in Arid3bflox/flox;Neo cassette MEFs. 
While in a control situation 48 hours after the experiment the wound is almost closed, when Arid3b is deleted 
from the cells the wound remains very similar to t=0.
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Analysis of the phenotype of the Arid3bflox/flox /Nkx2.5-Cre line
Arid3bflox/flox females were crossed with Arid3bflox/+/Nkx2.5-Cre males to obtain mice with a 
deletion of Arid3b in the Nkx2.5+ population. As can be seen in Table 7, only about half of the 
expected Arid3bflox/flox/Nkx2.5-Cre mice were recovered at weaning. Those that survived reached 
adulthood (6 month) without any particular phenotype. The expected and obtained numbers of 
animals for each genotype were separated depending on the particular male used in the cross and 
the results are depicted in Table 8. Note that the recovery rate of Arid3bflox/flox/Nkx2.5-Cre mice 
was essentially reduced only in some of the crosses, while others showed a proportion according 
to the one expected. To detect whether deletion of Arid3b had occurred, we performed an in situ 
hybridisation at E9.5 with the two probes against Arid3b and observed a similar result to the 
obtained with the Arid3bflox/flox/Sox2-Cre line: no differences in the expression with the full-lenght 
Arid3b 1209 pb probe between wild type and mutant embryos (Figure 40A), but a complete 
absence of signal with the Arid3b exon2 probe in the regions of expression of Nkx2.5 (myocardium, 
pharyngeal mesoderm and ventral part of the pharyngeal endoderm) (Figure 40B, arrows). These 
results confirm that the deletion of the second exon was successful.
Figure 40. Arid3bflox/flox/Nkx2.5-Cre embryos show a successful deletion of Arid3b second exon. A. RNA 
in situ hybridisation against the whole Arid3b mRNA. The expression is similar between wild type and 
Arid3bflox/flox/Nkx2.5-Cre embryos B. RNA in situ hybridisation against Arid3b second exon; note the absence 
of signal in the region of expression of Nkx2.5 (arrows). Scale bar: 200 µm.
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To determine whether mutant embryos show any cardiac phenotype, we collected embryos 
at different developmental stages, from E9.5 to E16.5. Table 9 shows the proportions of the four 
genotypes obtained at E9.5 and at E16.5. Interestingly, while at E16.5 the number of embryos 
recovered for each genotype was similar to the expected, at E9.5 the number of Arid3bflox/flox/
Nkx2.5-Cre embryos was slightly reduced. When analysed in more detail, taking into account from 
which crosses each litter came, we observed that all the embryos collected at E9.5 were offsprings 
of the male that produced a reduced number of viable adult Arid3bflox/flox/Nkx2.5-Cre mice. On the 
other hand, embryos collected at E16.5 came from different crosses, including those where normal 
proportions of the four genotypes were observed at weaning. Hence, the result seems to reflect 
the variability in the phenotype dependent on the male used to collect embryos. Also, we cannot 
exclude that increasing the number of litters at each stage, would let us observe a similar tendency 
in both groups. 
Table 9. Number of embryos coming from Arid3bflox/+/Nkx2.5-Cre x Arid3bflox/flox crosses of different genotype 
collected at E9.5 and E16.5.
Table 7. Total number of live adult mice of different genotypes obtained from distinct crosses between 
Arid3bflox/+/Nkx2.5-Cre and Arid3bflox/flox mice.
Table 8. Number of live adult mice obtained for each genotype per Arid3bflox/+/Nkx2.5-Cre male; the red 
circles points to a reduced number of Arid3bflox/flox/Nkx2.5-Cre live adult mice obtained in two of these 
crosses. In others the proportions were similar to the expected.
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Arid3bflox/flox /Nkx2.5-Cre embryos show right ventricle and valve defects
At E16.5, Arid3bflox/flox/Nkx2.5-Cre embryos looked grossly similar to their littermates (Figure 
41A). To obtain detailed information on the possible cardiac defects, we performed haematoxylin 
and eosin staining on four different Arid3bflox/flox/Nkx2.5-Cre embryos. Two of the mutant embryos 
showed mild defects in the affected regions of the heart. Interestingly, they came from the cross 
where the survival rate of the Arid3bflox/flox/Nkx2.5-Cre mice was normal (Table 8). The other two 
embryos showed a number of more severe cardiac defects (Figure 41B). The heart looked less 
developed than in the wild type for the stage analysed. The compact myocardium of the right 
ventricle was thinner (Figure 41B i,j, brackets) and the ventricular septum was not properly 
formed and presented holes (Figure 41B i,j, asterisk). However, the defect of the septum was 
variable and in other embryos was not observed. The most severe and clear defects were related to 
the valves. They were much bigger than in the wild type embryos, with a higher content of fibrotic 
tissue and with low or no remodelling. The pulmonary and aortic valve defect was similar and 
consistent between the different mutants (Figure 41B a-d, arrowheads), while the phenotype on 
the tricuspid and mitral valves was more variable, ranging from very big fibrotic valves in one of 
the Arid3bflox/flox/Nkx2.5-Cre embryos (as shown in Figure 41B g,h, asterisk; i,j, arrowhead), to 
a much milder defects observed in embryos with less severe phenotype.
Analysis of expression of mesenchymal and endocardial markers
To better characterise the observed valve defects, we checked for two molecules involved in 
normal valve development. Periostin is a secreted matricellular protein, which plays an important 
role in the differentiation and remodelling of cushion mesenchymal cells (Norris R.A. et al., 
2008). On the other hand, Tbx20 is strongly expressed in the endocardial cushion mesenchyme 
and its up-regulation leads to increased cell proliferation and abnormal valve remodelling 
(Chakraborty S. et al., 2010). Both molecules were present in the Arid3bflox/flox/Nkx2.5-Cre valves 
and their expression looked normal (Figure 42 A,B). Hence, the valvular phenotype observed in 
Arid3bflox/flox/Nkx2.5-Cre embryos is dependent on other molecules.
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Figure 41. Histological analysis of Arid3bflox/flox/Nkx2.5-Cre embryos revealed cardiac 
defects at E16.5. A. Whole-mount Arid3bflox/flox/Nkx2.5-Cre embryos look grossly similar to 
their control littermates (right and left views are shown) B. Haematoxylin and eosin staining 
of wild type and Arid3bflox/flox/Nkx2.5-Cre embryos. The myocardium of the right ventricle is 
thinner (i,j, brackets), the ventricular septum is abnormal (i,j, asterisk). Valves are bigger, not 
properly remodelled and with increased content of fibrotic tissue, both the great vessels valves 
(a-d, arrowheads), as well as tricuspid and mitral valves (g,h, asterisk; i,j, arrowhead) show 
this phenotype. Scale bar: panel A 3 mm; panel B 500 µm.
RESULTS
122
Figure 42. Periostin and Tbx20 expression are normal in Arid3bflox/flox/Nkx2.5-Cre embryos. A. 
Immunostaining against periostin (red) and myocardial marker MF20 (green) in wild type and mutant 
embryos at E16.5. Expression of periostin in the Arid3bflox/flox/Nkx2.5-Cre embryos is grossly normal and 
reflects the increase of mesenchymal tissue in the valves. B. RNA in situ hybridisation against Tbx20 in 
consecutive sections. No differences are observed in Arid3bflox/flox/Nkx2.5-Cre embryos compared to wild 
type. Scale bars: 400 µm, magnifications 200 µm.
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Arid3b is essential for mouse embryonic development, but its precise functions are not well 
characterised. In this thesis we analysed the role of Arid3b in heart development.
Arid3b is expressed in the heart in a dynamic fashion
A previous report (Takebe A. et al., 2006) dismissed a direct role for Arid3b in cardiac 
development on the basis that Arid3b expression was barely detected in the developing wild type 
heart. We reanalysed the expression of this gene by RNA in situ hybridisation. Our results, indeed, 
show a dynamic pattern of expression of Arid3b in different structures of the heart. At the stage of 
cardiac crescent strong expression could be detected in the myocardium and in heart precursors not 
yet added to the heart. The expression in the myocardium starts to vanish when the looping begins, 
but remains strong in the SHF and its derivatives, the poles of the heart. When the looping process 
finishes, Arid3b expression starts to be detected in the endocardium, being especially strong in the 
endocardium of the valve cushions. We could also detect expression of the gene in the epicardium. 
The failure to detect Arid3b signal in the heart by Takebe et al. might be explained by its dynamic 
expression and the fact that the strongest expression in the myocardium is detected only briefly at 
very early stages. Interestingly, the most severe heart defects observed are in accordance with the 
regions of strongest expression of Arid3b.
We could also confirm the expression of Arid3b in the heart by b-gal staining using our gene-
trap line. While in general the pattern of expression is similar, important differences are observed 
between Arid3b RNA detection and b-gal staining. For instance, while in situ hybridisation at 
E10.5 shows almost no expression in the myocardium, a strong signal of b-gal activity can be 
detected through the whole myocardium. These differences could be the result of the different 
techniques used. While in situ hybridisation detects the levels of mRNA, a molecule that usually 
has a high turnover, b-gal staining shows the result of a enzymatic reaction where the levels of 
the product increase catalytically. Besides, b-gal is a stable protein with a low turnover, which 
enables it to remain in cells for longer time (Strange, 1966), even if it is not translated anymore. 
In this way, the high levels of staining observed in the heart at later stages reflect the earlier 
expression of Arid3b in the myocardium. Moreover, in situ hybridisation against the b-geo cassette 
revealed a similar pattern of expression to Arid3b RNA, confirming that the cassette reproduces 
the endogenous expression of Arid3b.
The observed vessel defect might be secondary to impaired heart function
Heart beating and circulation are present in mutant embryos, as was confirmed by ink injection 
in the heart. However, vasculature is abnormal in Arid3bgt/gt embryos: vessels are much smaller, 
remodelling of the primitive network in the yolk sac is not accomplished and bleeding is observed 
in the yolk sac. Vascular endothelial cells are formed but they fail to undergo remodelling. 
Interestingly, both in our study, as well as in the previous report (Takebe A. et al., 2006), no 
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expression of Arid3b could be detected in the endothelium at these early stages, when defects in 
vessel remodelling are observed. This result suggests that these defects are non-cell-autonomous. 
In fact, in the yolk sac, while no expression is detected in the endothelium of the vessels, Arid3b 
is indeed expressed in the endoderm. The yolk sac endoderm is an important signalling centre for 
hematopoietic and endothelial differentiation (Damert A. et al., 2002), and Arid3b might have 
an indirect role in vessel maturation through signalling from the yolk sac endoderm. The lack of 
normal vessel formation might also be partially due to impaired heart function. Hemodynamic 
forces are necessary for vessel remodelling and mutations that alter early cardiac function lead 
to a failure in normal vessel remodelling as a secondary consequence (Udan R.S. et al., 2013). 
Although heart beating is observed in Arid3bgt/gt embryos, the severe cardiac malformations 
observed, such as pole shortening and disrupted AVC patterning, might lead to defective beating, 
which affects normal blood circulation and, thus, vessels remodelling. We believe that defective 
circulation might contribute to the early lethality of the embryos.
Later on, from E9.5, Arid3b is indeed expressed in the endothelium, first appearing in the aorta 
and veins and later expanding to smaller vessels. This suggests that it may have additional roles 
in the maintenance or physiology of this tissue, once the early events are accomplished. The first 
disperse vascular plexus is gradually reorganized into a functional network. As vessels begin to 
be remodelled, they undergo localized proliferation and regression, branching and migration, as 
well as recruit supporting cells (smooth muscle cells and pericytes) involved in stabilization and 
maturation of the newly formed network (Coultas L. et al., 2005) (Herbert S.P. and Stainier, 2011). 
The early death of mutant embryos precludes study of these processes in our Arid3bgt/gt embryos, 
so a conditional deletion of Arid3b in the endothelium (using the Tie2-Cre driver (Kisanuki Y.Y. et 
al., 2001)) would be necessary to address its role in this tissue. 
Differences in phenotype with the previously described mutant 
The phenotype observed in Arid3b-null embryos confirms the important role of this gene in 
embryonic development. However, some important phenotypic differences exist between our null 
model and the knock-out described by Takebe et al. One of the possible explanations for the 
differences might be the mouse background, which differs from one model to the other. The null-
mice described in Takebe’s study (C57BL/6 strain) survive until E12.5, and 40% of the knock-out 
embryos showed no abnormality in their development, only a growth delay. Our null-mice (CD1 
strain) never managed to survive later than E10.5 and all embryos displayed a severe phenotype. 
This might indicate that background differences between the two strains can alter the phenotype 
they show. The influence of the genetic background on the resulting phenotypes has been described 
previously (Threadgill D.W. et al., 1995) (Tanabe L.M. et al., 2012) (Montagutelli, 2000). We 
have generated Arid3bgt/gt embryos on a C57BL/6 background and evidence obtained from them 
supports this idea. We were able to recover embryos at E9.5 with apparently no defects, as well 
as mutant embryos at E12.5, similarly to what Takebe et al. observe. Hence, it looks that on 
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CD1 background Arid3b deletion gives a more severe phenotype that on C57BL/6 background. 
Interestingly, considering that CD1 is an outbred strain, while C57BL/6 is an inbred strain, more 
variability and a less penetrant phenotype would be expected on CD1 background, where the 
presence of genetic variations can modify the phenotype (Beck J.A. et al., 2000) (Chia R. et al., 
2005). Our results suggest that on C57BL/6 background some modifier can partially compensates 
for the loss of Arid3b.
On the other hand, the genetic strategies by which the mutants were generated are different in 
each case and might also influence on the phenotypes observed. The mutant published by Takebe 
et al. presents a substitution of the first exon by a construction consistent on an IRES (internal 
ribosome entry site) and the LacZ gene. This strategy prevents the transcription of any region of 
Arid3b. In our case, a mutational insertion (gene-trap) in the intron2-3 leads to the disruption of the 
gene transcript, but allows the expression of the second exon fused to b-geo. Although this exon 
has not been related to any function, no specific studies were done to address its possible roles. 
Hence, we cannot completely exclude the possible formation of a short truncated form of Arid3b 
fused to b-geo, which could act as a dominant negative form of the protein, bind other factors and 
disrupt their normal function, thus leading to a more severe phenotype. 
Patterning defects in the heart
Despite the early Arid3b expression in the myocardium, the expression of genes involved in 
specification of chamber myocardium (Nkx2.5 and Gata4) and several chamber patterning markers 
(such as Tbx5, Hand1/2, Hey1/2) is normal in Arid3bgt/gt embryos. In fact, the defects observed 
are mostly related to SHF derivatives and precursor cells, where a more prolonged expression 
is observed. This is somehow reminiscent of the phenotype of Islet1 mutants: despite an early 
brief expression of Islet1 in the heart tube, the mutant phenotype mainly reflects a defect in SHF 
contribution (Cai C.L. et al., 2003) (Vincent S.D. and Buckingham, 2010). However, the patterning 
of the AVC is affected in Arid3bgt/gt embryos: it seems to be properly specified, since early Bmp2 
expression is normal, but expression of transcription factors that define the AVC myocardium 
(Tbx2, Tbx3) is markedly impaired from E9.0, and this is accompanied by expansion of the 
chamber marker Anf. The AVC is partially derived from the SHF. In our DiI labelling experiments 
we mostly studied the contribution to the more posterior part of the heart, the IFT and the sinus 
horns, so we do not know whether the SHF contribution to the AVC is normal in Arid3b-null 
embryos or not. On the other hand, Tbx2+ cells fate tracing with Tbx2Cre/+;R26R line shows that 
the E8.0 to E8.5 inflow tract population gives rise to the E9.0-9.5 AVC (Aanhaanen W.T.J. et al., 
2009). In our mutants, Tbx2 expression in the inflow region at E8.5 looks normal, suggesting 
that the precursors of AVC are present in Arid3bgt/gt embryos (Supplementary Figure 1). Also, 
normal levels of Bmp2 at E9.0 as well as correct expression of Hey1 and Hey2, which specify the 
atrioventricular boundary, further support normal early patterning of the AVC. However, because 
a clear signal of Arid3b is detected in the AVC myocardium at E9.0, it seems reasonable to suggest 
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that it might play an additional direct role in some steps of AVC patterning. 
As mentioned above, Tbx2 and Tbx3 expression is reduced in the developing AVC of Arid3b 
mutants. BMP signal transduction appears to be normal in the myocardium, since pSmad1/5/8 
is localised in the nucleus of myocardial cells. Tbx2 has been shown to be a direct target of 
Bmp2 in the AVC; an upstream 380 pb fragment enriched in pSmad binding sites is enough to 
drive Tbx2 expression in the AVC and the OFT. Although such a direct regulation has not been 
shown for Tbx3, deletion of Bmp2 leads to strong reduction of Tbx3 in the AVC (Singh R. et 
al., 2012). Because we detect normal Bmp2 and pSmad expression in the AVC myocardium of 
Arid3bgt/gt embryos, we suggest that Arid3b functions downstream pSmad in this tissue and that the 
defect in Arid3b mutants is due to improper function of transcriptional complexes that drive the 
expression of Tbx2. DNA-binding by pSmad proteins is sometimes dependent on stabilization by 
other sequence specific DNA-binding proteins to ensure successful activation of its targets (Blitz 
I.L. and Cho, 2009). Hence, one possibility is that Arid3b plays such a role, forming a complex 
with pSmad proteins. Although preliminary, our in vitro results of co-immunoprecipitation of 
Arid3b and pSmad1 do not seem to support this idea. However, Arid3b might still be forming a 
complex with pSmad proteins, although without binding directly to them. It might also have an 
indirect role that favours pSmad activity; for instance, it might bind or compete with Tbx20, which 
inhibits the formation of Smad1/5-Smad4 complexes and, thus, represses Tbx2 expression. Further 
experiments would be necessary to address these questions.
Early EMT defects seem to be non-cell-autonomous
EMT disruption is one of the most noticeable defects observed in Arid3b mutant hearts. The 
EMT process is dependent on the crosstalk between the endocardium and myocardium with 
different pathways operating in each of the tissues (Notch pathway from the endocardium and 
Bmp pathway from the myocardium). We could not detect Arid3b expression in the endocardium 
at the stages when EMT starts, but it is expressed in the myocardium at E9.0, when the process 
of EMT begins, although no cells are yet detected in the endocardial cushions. This is the stage 
when we start to observe the AVC myocardium patterning defect (reduction of Tbx2 and Tbx3 and 
expansion of Anf). This defect is present at E9.5, when Arid3b expression has diminished greatly 
in the AVC. We think that one of the consequences of this abnormal patterning is the narrowing 
of the canal. Also, the expression of Bmp2 is reduced at E9.5, possibly as a consequence of the 
reduction of Tbx2 and Tbx3 levels which act in a positive feedback loop with Bmp2 (Singh R. et 
al., 2012). It is interesting that, while in the myocardium the number of pSmad positive nuclei 
is still similar between wild type and mutant embryos, their number is significantly reduced in 
the endocardium at E9.5 coinciding with the decrease in Bmp2 expression. As could be expected 
from the histological EMT defects observed (great reduction of mesenchymal cells on the AVC), 
expression of several genes involved in this process (such as Snail1, Twist1, Tgfb2 and Tbx20) 
is reduced. Snail1 and Twist1 have been shown to be controlled by Bmp2 from the myocardium 
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(Luna-Zurita L. et al., 2010) (Ma L. et al., 2005). Because Bmp2 has been described as a key EMT-
inducing factor (Sugi Y. et al., 2004), the low levels of this factor in Arid3bgt/gt myocardium could 
explain the defective EMT observed. This proposal is strongly supported by the rescue of EMT 
in AVC explants in vitro by application of Bmp2; this result suggests that the defective response 
of endocardial cells is not caused directly by the lack of Arid3b but is secondary to the patterning 
defect in the myocardium. Thus, Arid3b would play a non-cell-autonomous role in the early events 
of valve formation, although we cannot completely discard that a low level of expression in the 
endocardium not detected by in situ hybridisation could play an additional role.
While not detected early in the endocardium, we observe a robust expression of Arid3b in this 
layer from E10.5, including the endocardium of the valves. This expression might reflect a later 
role of Arid3b in valve formation. However, early lethality of Arid3bgt/gt embryos precludes the 
study of this possibility, making necessary the use of conditional mutants. 
Microarray analysis reveals a large set of genes with altered expression in Arid3bgt/gt 
embryos 
Our microarray experiments revealed a large number of genes differentially expressed in 
Arid3bgt/gt versus wild type embryos. When the standard filter of p value less than 0.05 and a 
fold change of +/-2 is applied, we observe that the number of genes differentially expressed after 
Arid3b deletion is higher in the microarray performed at E9.5 than at E9.0. One explanation is the 
fact that for the microarray at E9.0 whole embryos are used, and genes that are only up- or down-
regulated in one particular region become diluted and might not reach the established threshold. 
At E9.5 the embryos are subdivided in three regions and genes specifically missregulated in the 
heart, head or trunk become apparent. On the other hand, the phenotype is more severe at E9.5 
than at E9.0 and some genes that appear differentially expressed at this stage are probably not 
primary targets of Arid3b, but are secondary to the cardiovascular failure. For instance, expression 
of HIF1a is upregulated at E9.5 but not at E9.0; HIF1a encodes for one of the subunits of HIF1, 
a transcription factor which responds to hypoxia activating the transcription of genes involved in 
angiogenesis, energy metabolism and apoptosis (Majmundar A.J. et al., 2010). Immunostaining 
against pimonidazole, a marker of hypoxia, confirmed an increase in hypoxic regions in E9.5 
mutant embryos (Supplementary Figure 2). We believe that upregulation of HIF1a and its targets 
is secondary to the cardiovascular failure. In this way, genes that appear misexpressed at E9.5 must 
be analysed carefully and their expression checked at earlier stages to make sure they respond 
directly to the absence of Arid3b.
A functional analysis with Ingenuity software of the filtered sets of genes enabled us to discover 
that the top highly overrepresented functions included cell morphology and cell movements. 
These results support a role for Arid3b in the control of cell motility and cellular rearrangements. 
However, the classification parameters used by the Ingenuity pathway, while proved to be very 
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useful for data analysis, must be considered critically. Some of the genes, although might have been 
described as being involved in cellular movement, might be playing a different role in our system. 
Moreover, some of the molecules included in the lists of genes involved in motility are related 
to movement of endothelial cells or leukocytes and might reflect some of the secondary effects 
of Arid3b deletions. One of the genes related to cell movement upregulated in the microarray 
that drew our attention was Lims2. Lims2 expression appears upregulated only in the heart, and 
again very conspicuous at the heart poles. It is involved in signal transduction from integrins to 
their targets, including the actin cytoskeleton to control cell shape and motility; its upregulation 
in cells leads to decreased cell motility (Boudoukha S. et al., 2010). Because of these previously 
described functions, we suggest that Lims2 it as a good candidate mediator of Arid3b effects. We 
observed that increased expression of Lims2 is especially strong in the atria and OFT, but do not 
detect increased levels in the SHF cells. It might be that the upregulation of Lims2 impairs cell 
rearrangements or movements once they have ingressed into the heart tube, but does not seem to 
be responsible for the defect in their recruitment to the heart poles. A further detailed analysis of 
the expression of other genes related to cell motility or cell morphology is necessary to find more 
targets of Arid3b and determine its involvement in this cellular process.
An interesting result obtained from the microarray experiments is the possible effect on 
muscular differentiation, since several genes are downregulated in the somites. Arid3b is expressed 
in the caudal paraxial mesoderm and the newly formed somites and expression gradually 
diminishes as the somites mature. In Arid3b mutants, the expression of Vggl2, Unc45b, Smyd1 
and Myf5 (Supplementary Figure 3) is reduced in the somites, suggesting that Arid3b is required 
for the expression of muscular markers. Not much is known about Arid3b implication in cell 
differentiation. Two reports have recently described a change in Arid3b expression upon ES and iPS 
cells differentiation. Interestingly, according to (Kobayashi K. et al., 2013) Arid3b is upregulated 
when neural cells are dedifferentiated, while (Wang J. et al., 2006) observe that Arid3b is among 
the genes most upregulated on ES cells differentiation. This would suggest that Arid3b does not 
have an exclusive role as repressor or activator of differentiation, but acts dependently on the 
cellular context, as has been shown for its Drosophila homologous (Häder T. et al., 2000). It might 
be also favouring differentiation towards a particular cellular fate, for instance, muscular cells. On 
the other hand, microarrays with RNA extracted from the head, also shows a large number of genes 
differentially expressed in this region. We observe alteration of genes related to neurogenesis and 
neuronal differentiation (such as Cend1, Neurog3 and Npcd), as well as genes related to neuronal 
morphogenesis (Nyap1, Nefh or Gprin1). Interestingly, Arid3b expression is upregulated in the 
midbrain of RPB-Jk mutants, which lack activity of the Notch pathway (Andersson E.R. et al., 
2011) (Supplementary Figure 4). RBP-jk mutants show increased expression of some neuronal 
differentiation markers and excess of committed neuronal precursors (de la Pompa J.L. et al., 
1997). Whether Arid3b is involved in neuronal differentiation and is repressed by the Notch 
pathway remains to be elucidated.
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Upregulation of Bhlhb2 and cardiomyocyte differentiation 
Bhlhb2 drew our attention as it appeared as one of the most upregulated genes at both E9.0 
and E9.5. Indeed, in situ hybridisation confirms high levels of expression in the somites, branchial 
arches, ventral region of the pharyngeal endoderm and in the forebrain. In the heart its expression 
is especially strong in the SHF, in the dorsal region of the sinus horns, in the atria and in the 
OFT, regions where higher levels of expression of Arid3b are observed. These results suggest that 
Arid3b might act as a repressor of Bhlhb2. Differentiation of the poles of the heart is impaired, as 
shown by the reduction of early myocardial markers, SMA and Troponin T. This is consistent with 
the impaired muscular differentiation observed in the somites. Also, Smyd1 expression, which is 
necessary for cardiac differentiation and morphogenesis, is reduced throughout the myocardium 
and is absent in the inflow region, where the higher levels of Bhlhb2 are observed. Since Bhlhb2 
was shown to act as a repressor of Smyd1 (Kwon Ch. et al., 2009), we propose that its upregulation 
is responsible for the impaired differentiation of the poles. Bhlhb2 expression is directly regulated 
by Wnt/b-catenin pathway; although nuclear b-catenin expression is normal in Arid3bgt/gt embryos, 
we cannot exclude that Arid3b acts downstream b-catenin stabilization in the nucleus, for instance, 
blocking or modulating its binding to DNA to activate Bhlhb2 expression. According to (Kwon C. 
et al., 2009), Bhlhb2 is regulated through a Lef/Tcf consensus site located in the 5’ UTR of Bhlhb2 
gene. Using the Jaspar database we could detect multiple putative Arid3b binding sites in this 
region; however, whether they are biologically relevant needs further investigation. 
Pole defects in Arid3b-null embryos
A major defect in Arid3b mutant embryos is the shortening and abnormal morphology of the 
heart poles. This phenotype was not described in a previous article where Arid3b mutants were 
characterised. In that report, Takebe et al. explained the early lethality of Arid3b-null embryos by 
massive cranial neural crest cell death and proposed that Arid3b acts as surviving factor. In a later 
study, the same authors showed that Arid3b protects ES cells from MYCN induced apoptosis. 
Since the pool of precursors in the SHF is the main source of cells for heart growth at these stages, 
it seemed reasonable to think that progenitors’ survival is compromised in Arid3b-null embryos 
and might be the cause of the shortening of the poles. However, cell death levels in SHF are similar 
in wild type and mutant embryos. The only increase is observed at E9.5, while the shortening of 
the poles starts to be detected already from E8.5. So increased apoptosis cannot be considered 
as the primary cause of the phenotype, although it might contribute to its severity at E9.5. Cell 
proliferation is also unaffected in Arid3bgt/gt SHF cells. In support of this data, the total number of 
precursors is similar in mutant and wild type embryos at all stages analysed, except at E9.5, when 
we observe the increase in cell death. 
Since a difference in cell number does not seem to be the primary cause of the poles shortening, 
we wondered whether cell deployment might be affected by absence of Arid3b. Some previous 
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reports suggested that Arid3b might play a role in cell motility. In malignant ovarian cancer, Arid3b 
promotes mesenchymal transformation of the ovarian epithelium, while in breast cancer cells it 
is necessary for cell migration (Cowden Dahl K.D. et al., 2009) (Akhavantabasi S. et al., 2012). 
In Arid3bgt/gt embryos we have shown that defective cell rearrangements in the apical ectodermal 
ridge (AER) of the limb leads to aberrant maturation of this structure (Casanova J.C. et al., 2011); 
similar results are obtained in chick AER electroporated with dominant-negative forms of Arid3b 
which inhibit its function. Our in vitro studies with MEF cells derived from Arid3bgt/gt embryos 
further support the involvement of Arid3b in regulating normal cell movement. Mutant cells present 
increased levels of actin stress fibres, extensive membrane blebbing and breakage of cells upon 
detachment from substrate; moreover, they form less protrusions and show reduced cell motility. 
Based on this data we decided to address a possible role of Arid3b in SHF cell deployment. 
At present, little is known about the cellular mechanisms by which cells leave the pharyngeal 
mesoderm and are added to the heart tube. One recent report suggests the existence of a caudal 
proliferative centre in the caudal coelomic wall from which cells move cranially via the dorsal 
pericardial mesoderm to contribute to the arterial pole (van den Berg G. et al., 2009). (Sinha T. et 
al., 2012) suggest that Wnt5a-activated planar cell polarity (PCP) signalling activates a protrusive 
behaviour in the caudal splachnic mesoderm to promote the incorporation of SHF into a cohesive 
epithelial-like sheet, which eventually pushes the sheet rostrally and favours the ingression of cells 
into the OFT. The proposed model would be similar to convergent extension movements that occur 
during gastrulation in zebrafish and Xenopus, which are regulated by PCP pathway (Wallingford 
J.B. et al., 2002). We observe that Arid3bgt/gt cells in the caudal splachnic mesoderm seem to form 
more compact clusters with less protrusions that in the wild type embryos, a phenotype reminiscent 
to the observed in Wnt5a and Dvl1/2 mutants, where PCP signalling is disrupted. Interestingly, we 
proposed that Arid3b also somehow regulates a similar process of intercalation and compactation 
in the AER, as far as both in chick and mice loss of Arid3b function leads to an AER which is 
shorter in the AP axis and broader in the DV axis (Casanova J.C. et al., 2011). Whether Arid3b 
is involved in the non-canonical Wnt/PCP signalling needs further investigation, but we believe 
that the primary cause of shortening of the poles of the heart is related to Arid3b-regulated cell 
rearrangements and movements. 
The DiI fate-mapping experiments confirm a defect in the contribution of SHF precursors to 
the heart in Arid3b mutant embryos. These experiments also show that the ingression of precursors 
into the heart tube is differently affected in the arterial and venous poles. When cells are labelled 
in the pSHF, only half of the mutant embryos display DiI staining in the heart IFT. On the contrary, 
we always see labelled cells in the OFT, although the contribution to its more proximal region and 
the right ventricle is impaired in Arid3bgt/gt embryos. One possible explanation is the difference in 
cell death rates between the two regions of the SHF. As mentioned above, an increase in apoptosis 
is observed in the SHF cells at E9.5; when analysed in more detail, we detect that most of the cells 
that undergo cell death are located in the proximity of the sinus horns. It might be that cells from 
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the pSHF that are not able to ingress into the IFT are eliminated by apoptosis. Consistent with that, 
we cannot find clear accumulation of cells near the IFT, as we do at the entrance of the OFT. There 
are several possible explanations for these different behaviours. One important point is the stage of 
labelling. The pSHF injections were done between 4-6 pairs of somites (ps) (although addition of 
cells to IFT is already occurring at 2 ps stage), while for AHF we used embryos between 8-10 ps. 
Another difference is the population that was marked. Our labelling of pSHF cells corresponds to 
a more caudal region, which contributes mostly to the sinus venosus and partially to the atria. We 
centred our attention in this population of cells because the more cranially derived region coming 
from the pSHF – the AVC – is present in mutant embryos according to Bmp2 expression. On the 
contrary, labelling of the OFT precursors is not so restricted and most likely includes a broader 
region of SHF cells in the anterio-posterior axis. In this case we can see contribution to all the 
AHF-derived regions, but in Arid3bgt/gt embryos cell progression towards the most distant zone 
(the right ventricle) is disrupted and cells accumulate closer to the entrance of the OFT. The lack 
of specific markers that distinguish the right ventricle from the OFT at these early stages limits our 
possibilities to address to what extent the right ventricle formation is affected, as we can do for the 
AVC. With our current approach we also do not know whether the cells, which are added later and 
will form the most distal OFT, are going to be added to the heart tube or undergo cell death before 
reaching it, similarly to what happens in the IFT. With these considerations in mind, we propose 
two possible hypothesis for the differences observed:
- The phenotype is similar between the two poles, with the most proximal cells being added 
to the heart tube and the most caudal failing and undergoing apoptosis. In this case, if we labelled 
a broader population of cells in the pSHF (more rostral), we should observe a decrease in DiI 
labelled cells in the AVC, similar to that observed in the right ventricle. On the other hand, DiI 
labelling of the AHF at later stages would result in a decreased proportion of mutant embryos with 
DiI+ cells in the distal OFT (as happens in the IFT) and to the observation of an important increase 
in cell death in the AHF. 
- The absence of Arid3b in the pSHF only affects a subpopulation of cells, while in the AHF 
a broader group of cells is affected. In this case, labelling of a more cranial population of pSHF 
would result in normal contribution of cells to the AVC.
One unexpected observation made by Domínguez et al. is that cells from the pSHF contribute 
to the OFT. At 2 ps stage the posterior-most SHF has a predominantly OFT fate. Later, at 4-6 
ps, the most cranial portion of the pSHF contributes partially to the arterial pole in a sequential 
pattern (cells labelled at earlier stages migrate to the boundary between the OFT and the right 
ventricle, while cells labelled at later stage migrate to the boundary between OFT and the aortic 
sac). These cells seem to move via the dorsal pericardial mesoderm (Domínguez J.N. et al., 2012). 
Whether this process is affected in Arid3bgt/gt embryos is not known, but we must bear in mind 
that part of the labelled AHF cells are in fact derived from the pSHF on their way to the OFT and 
these different populations might be affected differentially by the absence of Arid3b. This also 
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reflects the fact that we currently do not know whether the cellular mechanisms underlying cell 
deployment to the arterial and venous poles are the same. It might be that, for example, cells which 
contribute to the arterial pole from the pSHF must move by migration, while cells situated in the 
border of the inflow tract and the heart tube incorporate through cell intercalation. The requirement 
and implication of Arid3b could then vary in these different situations. 
 
Three different MEFs types?
To investigate the function of Arid3b at the cellular level, we isolated embryonic fibroblasts 
from three genetically different mouse lines. The first MEFs type, from Arid3bgt/gt embryos display 
a series of defects related to cell movement and adhesion. These cells are also incapable of 
expanding and increase their number. It was previously described that overexpression of Arid3b 
in MEFs leads to their immortalization (Kobayashi K. et al., 2006), so most probably, our MEFs 
cells deficient for Arid3b suffer an impairment in proliferation or become prematurely senescent. 
Interestingly, Arid3a, the closest homologue of Arid3b in mammals, has a different effect on MEFs, 
as this factor was shown to repress the expression of pluripotency factors and MEFs deficient for 
Arid3a bypassed senescence and were enhanced for reprograming (Popowski M. et al., 2014). We 
also cannot exclude that some of the defects observed in Arid3bgt/gt MEFs appear as a consequence 
of the absence of Arid3b in other cell types, which may have compromised these fibroblasts in the 
embryo before their isolation. 
The other two types of MEFs came from the Arid3bflox/flox line and, in that cases, Arid3b is 
deleted by infection with Cre-expressing viral vectors after MEFs are isolated and expanded. 
This system permits us to avoid the possible influence of other tissues deficient for Arid3b in the 
embryo. The genetic difference between these two types of MEFs is the presence of the NEO 
cassette in one of the MEFs lines (we refer to it as Arid3bflox/flox;NEO cassette MEFs), while in the other 
line the gene is directly flanked by loxP sites (Arid3bflox/flox MEFs). As we mentioned in the results, 
Arid3bflox/flox;NEO cassette embryos are not viable and show a reduction of Arid3b RNA expression even 
in the absence of any Cre. It has been described that the neo cassette might interfere with gene 
expression and in some conditional lines the presence of the neo cassette leads to embryonic 
lethality (Chen L. et al., 1999) (Rucker E.B. et al., 2000) (Xu X. et al., 2001). Consistent with that, 
removal of the NEO cassette by crosses with mice carrying Flp (the Neo cassette is flanked by FRT 
sites) enabled us to obtain viable and fertile Arid3bflox/flox mice. Interestingly, MEFs cells obtained 
from Arid3bflox/flox;NEO cassette embryos, which can be considered hypomorphs for Arid3b, do not show 
any obvious defective phenotype and behave similarly to wild type MEFs. This suggests that the 
reduced levels of Arid3b expression are sufficient for MEFs survival at this stage of development. 
Moreover, these MEFs display a milder phenotype than Arid3bflox/flox MEFs upon addition of Cre 
and total deletion of the gene. Arid3bflox/flox;NEO cassette MEFs are still able to grow, but show a motility 
defect similar to the one observed in Arid3bgt/gt derived MEFs, as we assayed by wound healing 
experiments. Contrary, Arid3bflox/flox MEFs stop growing after infection with adenovirus containing 
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Cre, and seem to acquire a senescent phenotype, similar to the one observed in Arid3bgt/gt MEFs. 
We speculate that MEFs derived from Arid3bflox/flox;NEO cassette embryos, which present reduced levels 
of Arid3b from the beginning, are more adapted to overcome the absence of this gene. It might be 
that from the beginning cells more resistant to low levels of Arid3b are selected and later, when 
Arid3b is totally deleted, are able to overcome the growth arrest, although not the motility defect. 
We do not know what is the role of Arid3b in cell proliferation in MEFs, but maybe another 
factor can compensate for its function, and this factor is overexpressed in Arid3bflox/flox;NEO cassette cells 
from the moment of their isolation to overcome the reduced levels of Arid3b. On the other hand, 
Arid3bflox/flox MEFs are not under stress of shortage of this factor and, thus, are more sensitive 
when the gene is totally deleted. However, we have not performed any specific experiments to 
determine to which extent cell proliferation is normal in Arid3bflox/flox;NEO cassette cells; we can only 
say that these MEFs, contrary to what happens in the other two types, are able to grow. Because 
cytoskeleton changes and cell adhesion also play very important roles in normal cell division, we 
cannot exclude that the defects, that lead to decreased motility and abnormal cellular shape in the 
absence of Arid3b, can also affect cell division. To which extent Arid3b is required for this process 
and what is the molecular basis for the disrupted cell migration in Arid3b-null cells, needs further 
studies.
Phenotypic differences between Arid3bflox/flox/Sox2-Cre and Arid3bgt/gt lines
The Sox2-Cre line allows us to delete Arid3b in the whole embryo from the epiblast stage 
(Hayashi S. et al., 2002) and compare the obtained phenotype with the one observed in Arid3bgt/gt 
embryos. No viable Arid3bflox/flox/Sox2-Cre embryos are found at E12.5 but the general phenotype 
observed is milder than in the case of Arid3bgt/gt embryos. The Arid3bflox/flox/Sox2-Cre embryos 
resemble more the phenotype described in Takebe et al., 2006 and our own Arid3bgt/gt embryos on 
C57BL/6 background. Our Arid3bflox/flox/Sox2-Cre line is on mixed background of C57BL/6 and 
129 (R1) strains. As already discussed, it seems that the phenotype obtained after Arid3b deletion 
is sensible to genetic background differences between strains. We think this might explain the 
distinct defects we observe between the two mice lines.
Another important observation is that we could detect Arid3b RNA in our conditional mutant 
line after Cre-directed recombination. The conditional allele was designed to delete the second 
Arid3b exon, where the initiator ATG is located. However, we still observe transcription of part of 
the gene, as can be detected by in situ hybridisation with a probe against the whole mRNA and RT-
PCR with primers located in exons 5 and 7, downstream of the deletion. We do not know exactly 
which regions are transcribed and whether this mRNA is translated. An ATG in the first non-coding 
exon of the gene exists and is preceded by a consensus Kozak sequence. Moreover, if this ATG 
was used, the Arid3b reading frame would be maintained from splicing with exon3 and a putative 
Arid3b protein lacking the second exon could in theory be translated. Since the Arid3b antibodies 
used do not recognize the mouse protein, we have not been able to experimentally test the presence 
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of Arid3b in the conditional deletion. However, based on the functional defects observed using the 
Sox2-Cre driver line, where the severe cardiovascular defects and lethality are comparable to the 
full knock out mice, we suggest that if translation occurs, an unstable protein is formed and rapidly 
degraded. In any case, with our current results we cannot exclude an alternative situation, where 
a truncated form of Arid3b is translated that could somehow influence the phenotypes observed.
Differences in cardiac phenotype between Arid3bflox/flox/Nkx2.5-Cre and Arid3bgt/gt lines 
We generated an Arid3bflox/flox/Nkx2.5-Cre line to determine the specific role of Arid3b in 
the Nkx2.5+ population. The Nkx2.5-Cre is a good driver to study the role of Arid3b in cardiac 
development and has been widely used for this purpose with other genes (Ma L. et al., 2005) (Luna-
Zurita L. et al., 2010). Nkx2.5-Cre expression starts to be detected in the cardiac mesoderm already 
at E7.75, both in the heart tube, as well as in the SHF and efficient recombination was reported in 
the cardiac crescent and heart tube (Stanley E.G. et al., 2002). We checked for deletion of Arid3b 
exon2 and indeed observed its absence in the SHF and in the OFT at E9.5. The phenotype we 
obtain upon deletion of Arid3b in the Nkx2.5 population is variable. First, more than half of the 
conditionally deleted mice are viable, reach adulthood and do not present any noticeable phenotype. 
The rest of the animals die before weaning, but normal proportions of Arid3bflox/flox/Nkx2.5-Cre 
embryos are still observed at E16.5. Several explanations exist for these data. As we mentioned 
above, the Arid3bflox/flox mice line is on mixed C57BL/6 and 129 (R1) background. We have shown 
that Arid3bgt/gt embryos on C57BL/6 background present a later lethality and apparently fewer 
defects in the poles of the heart, suggesting that some of the heart defects might be attenuated 
by modifier loci on this background. The influence of the genetically mixed background on the 
phenotype is further supported by the fact that embryonic or perinatal lethality is only observed in 
some of the Arid3bflox/flox/Nkx2.5-Cre crosses, while in others normal proportions of homozygous 
mutant adult mice are obtained. The variability between different crosses makes it very difficult to 
determine the exact amplitude and penetrance of the heart defects. We propose that backcrossing 
the Arid3bflox/flox/Nkx2.5-Cre line to C57BL/6 background, for instance, would be necessary to 
obtain more homogeneous and reproducible phenotypes and, thus, more reliable information on 
the roles of Arid3b in the Nkx2.5 population.
On the other hand, the Nkx2.5-Cre driver might not be the most suitable Cre line to study 
the role of Arid3b in all aspects of heart development. As already mentioned, Nkx2.5-Cre 
recombination starts to be observed in the cardiac crescent at E7.75 and later through the whole 
myocardium, the SHF and in the endocardium in a mosaic way (Stanley E.G. et al., 2002). We 
observe strong Arid3b expression in the myocardium from the cardiac crescent stage, but already 
from E8.5 expression in the myocardium starts to vanish. On the contrary, expression in the SHF is 
maintained at high levels through the looping process, while expression in the endocardium is not 
detected till E10.5, when septation starts. The temporal patterns of expression of the Nkx2.5-Cre 
transgene and of Arid3b suggest that recombination might be too late to detect the role of Arid3b 
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in the myocardium. It is also important to mention that it was observed that the Z/AP locus showed 
transient resistance to deletion in caudal heart progenitors with the Nkx2.5-Cre and the authors 
suggested that Cre-mediated deletion in myocardium might be locus-dependent (Stanley E.G. et 
al., 2002). Our results show an efficient deletion of Arid3b at E9.5, but we have not checked 
whether at earlier stages the deletion is complete or shows a similar transient resistance. The use of 
other drivers, such as Mesp1-Cre, which recombines already at the stage of the cardiac mesoderm 
and has been proposed as the earlier molecular marker for the myocardial and endocardial lineages 
(Saga Y. et al., 2000), might enable us to address more precisely the role of Arid3b in the developing 
myocardium. The use of other Cre lines, which recombine in a specific cardiac tissues, such as 
the Islet1-Cre (specific for the SHF lineage (Yang L. et al., 2006)) or Tie2-Cre (deletion in the 
endocardium and endothelium (Kisanuki Y.Y. et al., 2001)) could complete this study and dissect 
the diverse tissue-specific roles of Arid3b in heart development.
 
Deletion of Arid3b in the endocardium might be responsible for the defects observed in 
Arid3bflox/flox/Nkx2.5-Cre embryos
The two most prominent defects observed in Arid3bflox/flox/Nkx2.5-Cre E16.5 embryos are 
thinning of the compact myocardium of the right ventricle and disrupted valve remodelling. The 
defect on the right ventricle is consistent with the high levels of Arid3b in the SHF and might 
reflect the requirement for Arid3b in this population of precursors for later proper development 
of the right ventricle. However, another possibility is that myocardial thinning is due to deletion 
of Arid3b in the endocardium and the disruption of the normal crosstalk between the two tissues. 
Different molecules acting from the endocardium have been shown to be critical for normal 
ventricular myocardium development, such as Jumonji or the Notch pathway. Deletion of either 
Jumonji (Mysliwiec M.R. et al., 2001);| or Notch1 and Delta4 (Grego-Bessa J. et al., 2007) from 
the endocardium leads to myocardial thinning and disruption of normal trabeculation. If this is the 
case, we would expect a similar or even more severe phenotype on the ventricles when using Tie2-
Cre or Nfat-Cre drivers (Wang Y. et al., 2013) to delete Arid3b only in the endocardium.
Another striking phenotype is the failure of valve remodelling. Curiously, while in the 
Arid3bgt/gt we observe an early defect in valve formation with EMT disruption and decreased number 
of mesenchymal cells in the AVC cardiac cushions, deletion of Arid3b by Nkx2.5-Cre gives rise to 
a later phenotype, where valves appear bigger and the number of mesenchymal cells seems to be 
increased. As already discussed above, we believe that the early EMT defect in Arid3bgt/gt embryos 
is due to disruption of myocardial patterning. The valve defects we observe in Arid3bflox/flox/Nkx2.5-
Cre embryos could be related to the deletion of Arid3b in the endocardium, similarly to what we 
observe in the right ventricle. Arid3b is detected in the endocardium from E10.5, suggesting that 
it might be involved in some of the post-EMT processes of valve remodelling and maturation. The 
valves look bigger and not properly remodelled in the mutant embryos suggesting an alteration of 
the proliferation and differentiation balance. So far, the mesenchymal markers analysed, periostin 
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and Tbx20, are expressed normally in the valves. It would be interesting to look at the expression 
of other molecules, for instance from the Notch and the Bmp pathways. Disruption of Notch 
signalling by deletion of its ligand Jagged1 in the endothelium leads to a set of cardiac defects 
including hypertrophic, not remodelled valves (Hofmann J.J. et al., 2012). The Bmp pathway 
promotes proliferation of mesenchymal cells and deletion of the inhibitory Smad, Smad6, leads 
to hyperplasia of both AVC and OFT valves and pre-weaning death of some of the mutant mice 
(Galvin K.M. et al., 2000) (Combs M.D. and Yutzey, 2009). Whether Arid3b is involved in the 
normal function of these pathways or is affecting other molecules important for normal valve 
formation requires further research.
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1. Arid3b is expressed in a dynamic way in the mouse heart, suggesting multiple roles at 
different stages of heart development.
Arid3b se expresa de manera dinámica en el corazón de ratón, sugiriendo múltiples 
funciones en diferentes estadios de desarrollo.
2. Deletion of Arid3b in mouse embryos leads to early embryonic death with severe 
cardiovascular defects, including shortening of the poles of the heart and lack of EMT in 
the AVC.
La eliminación del gen Arid3b en embriones de ratón causa letalidad temprana con severos 
defectos cardiovasculares, que incluyen acortamiento de los polos cardiacos y ausencia de 
EMT en el canal atrioventricular.
3. The phenotype of Arid3b-deficient animals is dependent on the mouse genetic background, 
suggesting the presence of modifier loci interacting with Arid3b functions.
El fenotipo de embriones deficientes para Arid3b depende del fondo genético del ratón, lo 
cual sugiere la presencia de loci modificadores que interfieren en la función del gen. 
4. Myocardial AVC patterning is disrupted in Arid3bgt/gt embryos and an expansion of chamber 
specific markers to the AVC is observed. 
El establecimiento de patrón del canal atrioventricular está alterado en los embriones 
Arid3bgt/gt y se observa una expansión de los marcadores específicos de cámaras hacia 
aquel.
5. The EMT defect in the AVC can be rescued in vitro by addition of Bmp2, suggesting that it 
is non-cell-autonomous and secondary to the patterning defect in the myocardium.
El defecto en EMT puede ser rescatado in vitro al añadir Bmp2, lo cual sugiere que el 
defecto de EMT es secundario al defecto de establecimiento de patrón del miocardio.
 6. An RNA microarray analysis of wild type versus mutant embryos at different developmental 
stages reveal a set of differentially expressed genes and top molecular functions related to 
cellular movement and cell morphology, which could mediate Arid3b function.
El análisis de microarray de RNA, realizado en embriones salvajes y mutantes a diferentes 
estadios de desarrollo, ha revelado una serie de genes diferencialmente expresados, además 
de evidenciar que las funciones moleculares más representadas están relacionadas con 
motilidad y morfología celular, funciones que podrían estar mediadas por Arid3b. 
7. The differentiation of the poles of the heart is impaired in Arid3bgt/gt embryos, and Bhlhb2, 
one of the genes upregulated in the microarray, might be involved in this process.
La diferenciación de los polos del corazón está afectada en embriones Arid3bgt/gt, y 
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Bhlhb2, uno de los genes sobreexpresados en el microarray, podría estar involucrado en 
este proceso.
8. Cell deployment of SHF cells to the heart poles is disrupted in Arid3b mutants, as shown 
by DiI labelling 
Marcajes de DiI de células de SHF en las regiones de salida y entrada muestran una 
deficiencia en el ingreso de las células al corazón en los embriones mutantes para Arid3b.
9. Mouse embryonic fibroblasts show reduced motility in the absence of Arid3b.
Fibroblastos embrionarios de ratón muestran una motilidad reducida en ausencia de 
Arid3b.
10. Specific deletion of Arid3b in Nkx2.5+ cell population (with Nkx2.5-Cre) leads to cardiac 
defects including thinning of the right ventricle and failure in valve remodelling.
La eliminación específica de Arid3b en la población Nkx2.5+ (con Nkx2.5-Cre) da lugar a 
defectos cardiacos, incluyendo reducción del grosor del miocardio del ventrículo derecho 
y fallo en la remodelación de las válvulas.
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Bertrand N., Roux M., Ryckebüsch L., Niederreither K., Dollé P., Moon A., Capecchi M. and 
Zaffran, S. (2011). Hox genes define distinct progenitor sub-domains within the second heart field. 
Developmental Biology 353, 266-274.
Binda O., C Nassif C. and Branton, P. E. (2008). SIRT1 negatively regulates HDAC1-dependent 
transcriptional repression by the RBP1 family of proteins. Oncogene 27, 3384-3392.
Blitz I.L. and Cho, K. W. Y. (2009). Finding partners: how BMPs select their targets. Developmental 
Dynamics 238, 1321-1331.
Bondue A. and Blanpain, C. (2010). Mesp1: a key regulator of cardiovascular lineage commitment. 
Circulation Research 107, 1414-1427.
Bondue A., Lapouge G., Paulissen C., Semeraro C., Iacovino M., Kyba M. and Blanpain, C. (2008). 
Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. . Cell Stem 
Cell 3, 69-84.
Bonnet A., Dai F., Brand-Saberi B. and Duprez, D. (2010). Vestigial-like 2 acts downstream of MyoD 
BIBLIOGRAPHY
148
activation and is associated with skeletal muscle differentiation in chick myogenesis. Mechanism 
of Development 127, 120-136.
Boudoukha S., Cuvellier S. and Polesskaya, A. (2010). Role of the RNA-binding protein IMP-2 in muscle 
cell motility. Molecular and Cellular Biology 30, 5710-5725.
Bressan M., Liu G. and Mikawa, T. (2013). Early mesodermal cues assign avian cardiac pacemaker fate 
potential in a tertiary heart field. Science 340, 744-748.
Bruneau B.G., Nemer G., Schmitt J.P., Charron F., Robitaille L., Caron S., Conner D.A., Gessler M., 
Nemer M., Seidman C.E., et al. (2001). A murine model of Holt-Oram syndrome defines roles of 
the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 709-721.
Buckingham M., Meilhac S. and Zaffran, S. (2005). Building the mammalian heart from two sources of 
myocardial cells. Nature Reviews Genetics 6, 826-835.
Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J. and Evans, S. (2003). Isl1 identifies a cardiac 
progenitor population that proliferates prior to differentiation and contributes a majority of cells to 
the heart. Developmental Cell 5, 877-889.
Cai S., Zhu L., Zhang Z. and Chen, Y. (2007). Determination of the three-dimensional structure of the 
Mrf2-DNA complex using paramagnetic spin labeling. Biochemistry 46, 4943-4950.
Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A. Jr., 
Kubalak S., Klewer S.E. and McDonald, J. A. (2000). Disruption of hyaluronan synthase-2 
abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to 
mesenchyme. Journal of Clinical Investigation 106, 349-360.
Carmena A., Murugasu-Oei B., Menon D., Jiménez F. and Chia, W. (1998). Inscuteable and numb mediate 
asymmetric muscle progenitor cell divisions during Drosophila myogenesis. Genes&Development 
12, 304-315.
Casanova J.C., Uribe V., Badía-Careaga C., Giovinazzo G., Torres M. and Sanz-Ezquerro, J. J. (2011). 
Apical ectodermal ridge morphogenesis in limb development is controlled by Arid3b-mediated 
regulation of cell movements. Development 138, 1195-1205.
Catchpole S., Spencer-Dene B., Hall D., Santangelo S., Rosewell I., Guenatri M., Beatson R., Scibetta 
A.G., Burchell J.M. and Taylor-Papadimitriou, J. (2011). PLU-1/JARID1B/KDM5B is required 
for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ 
breast cancer cells. Int. J. Oncol 38, 1267-1277.
Chakraborty S., Wirrig E.E., Hinton R.B., Merrill W.H., Spicer D.B. and Yutzey, K. E. (2010). Twist1 
promotes heart valve cell proliferation and extracellular matrix gene expression during development 
in vivo and is expressed in human diseased aortic valves. Developmental Biology 347, 167-179.
Chen L., Adar R., Yang X., Monsonego E.O., Li C., Hauschka P.V., Yayon A. and Deng, C. X. (1999). 
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis 
and osteogenesis. Journal of Clinical Investigation 104, 1517-1525.
Chia R., Achilli F., Festing M.F. and Fisher, E. M. (2005). The origins and uses of mouse outbred stocks. 
Nature Genetics 37, 1181-1186.
Christensen J., Agger K., Cloos P.A., Pasini D., Rose S., Sennels L., Rappsilber J., Hansen K.H., 
Salcini A.E. and Helin, K. (2007). RBP2 belongs to a family of demethylases, specific for tri-and 
dimethylated lysine 4 on histone 3. Cell 128, 1063-1076.
Christoffels V.M., Habets P.E.M.H., Franco D., Campione M., Jong F. de, Lamers W.H., Bao Z.-Z., 
Palmer S., Biben Ch., Harvey R.P., et al. (2000). Chamber formation and morphogenesis in the 
developing mammalian heart. Developmental Biology 223, 266-278.
Christoffels V.M., Hoogaars W.M.H., Tessari A., Clout D.E.W., Moorman A.F.M. and Campione, 
M. (2004). T-Box transcription factor Tbx2 represses differentiation and formation of the cardiac 
chambers. Developmental Dynamics 229, 763-770.
Christoffels V.M., Mommersteeg M.T., Trowe M.O., Prall O.W., de Gier-de Vries C., Soufan A.T., 
Bussen M., Schuster-Gossler K., Harvey R.P., Moorman A.F., et al. (2006). Formation of the 
BIBLIOGRAPHY
149
venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18. Circulation 
Research 98, 1555-1563.
Cohen E.D, Wang Z., Lepore J.L, Lu M.M., Taketo M.M., Epstein D.J. and Morrisey, E. E. (2007). 
Wnt/beta-catenin signaling promotes expansion of Islet-1 - positive cardiac progenitor cells through 
regulation of FGF signaling. The Journal of Clinical Investigation 117, 1794-1804.
Cohen E.D., Miller M.F., Wang Z., Moon R.T. and Morrisey, E. E. (2012). Wnt5a and Wnt11 are 
essential for second heart field progenitor development. Development 139, 1931-1940.
Combs M.D. and Yutzey, K. E. (2009). Heart valve development: regulatory networks in development and 
disease. Circulation Research 105, 408-421.
Coultas L., Chawengsaksophak K. and Rossant, J. (2005). Endothelial cells and VEGF in vascular 
development. Nature 438, 937-945.
Cowden Dahl K.D., Dahl R., Kruichak J.N. and Hudsonn, L. G. (2009). The epidermal growth factor 
receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. 
Neoplasia 11, 1208-1215.
Damert A., Miquerol L., Gertsenstein M., Risau W. and Nagy, A. (2002). Insufficient VEGFA activity 
in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 
129, 1881-1892.
de Boer B.A., Berg G., de Boer P.A.J., Moorman A.F.M. and Ruijter, J. M. (2012). Growth of the 
developing mouse heart: An interactive qualitative and quantitative 3D atlas. Developmental 
Biology 368, 203-213.
de Castro M.P., Aránega A. and Franco, D. (2006). Protein distribution of Kcnq1, Kcnh2, and Kcne3 
potassium channel subunits during mouse embryonic development. Anat Rec A Discov Mol Cell 
Evol Biol 288, 304-315.
de la Cruz M.V., Sánchez Gómez C., Arteaga M.M. and C.Argüello (1977). Experimental study of the 
development of the truncus and the conus in the chick embryo. J Anat. 123, 661-686.
de la Pompa J.L. and Epstein, J. A. (2012). Coordinating tissue interactions: Notch signaling in cardiac 
development and disease. Developmental Cell 22, 244-254.
de la Pompa J.L., Wakeham A., Correia K.M., Samper E., Brown S., Aguilera R.J., Nakano T., 
Honjo T., Mak T.W., Rossant J., et al. (1997). Conservation of the Notch signalling pathway in 
mammalian neurogenesis. Development 124, 1139-1148.
de Vlaming A., Sauls K., Hajdu Z., Visconti R.P., Mehesz A.N., Levine R.A., Slaugenhaupt S.A., 
Hagège A., Chester A.H., Markwald R.R., et al. (2012). Atrioventricular valve development: 
new perspectives on an old theme. Differentiation 84, 103-116.
del Monte G., Grego-Bessa J., González-Rajal A., Bolós V. and de la Pompa, J. L. (2007). Monitoring 
Notch1 activity in development: evidence for a feedback regulatory loop. Developmental Dynamics 
236, 2594-2614.
Doetschman T. and Azhar, M. (2012). Cardiac-specific inducible and conditional gene targeting in mice. 
Circulation Research 110, 1498-1512.
Domínguez J.N., Meilhac S.M., Bland Y.S., Buckingham M.E. and Brown, N. A. (2012). Asymmetric 
fate of the posterior part of the Second Heart Field results in unexpected left/right contributions to 
both poles of the heart. Circulation Research 26, 1323-1335.
Eisenberg L.M. and Markwald, R. R. (1995). Molecular regulation of atrioventricular valvuloseptal 
morphogenesis. Circulation Research 77, 1-6.
Fahed A.C., Gelb B.D., Seidman J.G. and Seidman, C. E. (2013). Genetics of congenital heart disease: 
the glass half empty. Circulation Research 112, 707-720.
Fischer A., Steidl C., Wagner T.U., Lang E., Jakob P.M., Friedl P., Knobeloch K.P. and Gessler, M. 
(2007). Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired 
epithelial to mesenchymal transition. Circulation Research 100, 856-863.
Flores-Alcantar A., Gonzalez-Sandoval A., Escalante-Alcalde D. and Lomelí, H. (2011). Dynamics of 
BIBLIOGRAPHY
150
expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle. 
Cell Tissue Res 345, 137-148.
Franco D., Kelly R., Moorman A.F., Lamers W.H., Buckingham M. and Brown, N. A. (2001). MLC3F 
transgene expression in iv mutant mice reveals the importance of left-right signalling pathways 
for the acquisition of left and right atrial but not ventricular compartment identity. Developmental 
Dynamics 221, 206-215.
Galvin K.M., Donovan M.J., Lynch C.A., Meyer R.I., Paul R.J., Lorenz J.N., Fairchild-Huntress V., 
Dixon K.L., Dunmore J.H., Gimbrone M.A. Jr., et al. (2000). A role for smad6 in development 
and homeostasis of the cardiovascular system. Nature Genetics 24, 171-174.
Garritano S., Inga A., Gemignani F. and Landi, S. (2013). More targets, more pathways and more clues 
for mutant p53. Oncogenesis 2, 1-7.
Ghatak S., Misra S., Norris R.A., Rodriquez R.M., Hoffman S., Levine R.A., Hascall V.C. and 
Markwald, R. R. (2014). Periostin induces intracellular cross talk between kinases and hyaluronan 
in atrioventricular valvulogenesis. Journal of Biological Chemistry.
Goddeeris M.M., Schwartz R., Klingensmith J. and Meyers, E. N. (2007). Independent requirements 
for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract 
development. Development 134, 1593-1604.
Grego-Bessa J., Luna-Zurita L., del Monte G., Bolós V., Melgar P., Arandilla A., Garratt A.N., Zang 
H., Mukouyama Y.S., Chen H., et al. (2007). Notch signaling is essential for ventricular chamber 
development. Developmental Cell 12, 415-429.
Gregory S.L., Kortschak R.D., Kalionis B. and Saint, R. (1996). Characterization of the dead ringer gene 
identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Molecular 
and Cell Biology 16, 792-799.
Habets P.E.M.H., Moorman A.F.M., Clout D.E.W., van Roon M.A., Lingbeek M., van Lohuizen 
M., Campione M. and Christoffels, V. M. (2002). Cooperative action of Tbx2 and Nkx2.5 
inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. 
Genes&Development 16, 1234-1246.
Häder T., Wainwright D., Shandala T., Saint R., Taubert H., Brönner G. and Jäckle, H. (2000). 
Receptor tyrosine kinase signaling regulates different modes of Groucho-dependent control of 
Dorsal. Current Biology 10, 51-54.
Hamburger V. and Hamilton, H. L. (1951). A series of normal stages in the development of the chick 
embryo. J Morphology 88, 49-92.
Hansen F.T., Madsen C.K., Nordland A.M., Grasser M., Merkle T. and Grasser, K. D. (2008). A novel 
family of plant DNA-binding proteins containing both HMG-box and AT-rich interaction domains. 
Biochemistry 47, 13207-13214.
Hata K., Takashima R., Amano K., Ono K., Nakanishi M., Yoshida M., Wakabayashi M., Matsuda 
A., Maeda Y., Suzuki Y., et al. (2013). Arid5b facilitates chondrogenesis by recruiting the histone 
demethylase Phf2 to Sox9-regulated genes. Nature Communication 4, 2850.
Hayashi S., Lewis P., Pevny L. and McMahon, A. P. (2002). Efficient gene modulation in mouse epiblast 
using a Sox2Cre transgenic mouse strain. Mechanism of Development 119.
Healy J., Richer C., Bourgey M., Kritikou E.A. and Sinnett, D. (2010). Replication analysis confirms 
the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 
95, 1608-1611.
Herbert S.P. and Stainier, D. Y. R. (2011). Molecular control of endothelial cell behaviour during blood 
vessel morphogenesis. Nature reviews Molecular Cell Biology 12, 551-564.
Herrscher R.F., Kaplan M.H., Lelsz D.L., Das C., Scheuermann R. and Tucker, P. W. (1995). The 
immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific 
trans-activator that describes a new DNA-binding protein family. Genes&Development 9, 3067-
3082.
BIBLIOGRAPHY
151
High F.A, Jain R., Stoller J.Z., Antonucci N.B., Lu M.M., Loomes K.M., Kaestner K.H., Pear W.S. 
and Epstein, J. A. (2009). Murine Jagged1/Notch signaling in the second heart field orchestrates 
Fgf8 expression and tissue-tissue interactions during outflow tract development. The Journal of 
Clinical Investigation 119, 1986-1996.
Hiroi Y., Kudoh S., Monzen K., Ikeda Y., Yazaki Y., Nagai R. and Komuro, I. (2001). Tbx5 associates 
with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nature Genetics 28, 276-
280.
Hoffmann A.D., Peterson M.A., Friedland-Little J.M., Anderson S.A. and Moskowitz, I. P. (2009). 
Sonic hedgehog is required in pulmonary endoderm for atrial septation. Development 136, 1761-
1770.
Honma S., Kawamoto T., Takagi Y., Fujimoto K., Sato F., Noshiro M., Kato Y. and Honma, K. (2002). 
Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419, 841-844.
Hoogaars W.M., Tessari A., Moorman A.F., de Boer P.A., Hagoort J., Soufan A.T., Campione M. and 
Christoffels, V. M. (2004). The transcriptional repressor Tbx3 delineates the developing central 
conduction system of the heart. Cardiovascular Research 62, 489-499.
Hoogaars W.M.H., Engel A., Brons J.F., Verkerk A.O., Lange F. de, Wong L.Y.E., Bakker M.L., Clout 
D.E., Wakker V., Barnett P., et al. (2007). Tbx3 controls the sinoatrial node gene program and 
imposes pacemaker function on the atria. Genes&Development 21, 1098-1112.
Hutson M.R., Zhang P., Stadt H.A., Sato A.K., Li Y.X., Burch J., Creazzo T.L. and Kirby, M. L. (2006). 
Cardiac arterial pole alignment is sensitive to FGF8 signaling in the pharynx. Developmental 
Biology 295, 486-497.
Ilagan R., Abu-Issa R., Brown D., Yang Y.-P., Jiao K., Schwartz R.K., Klingensmith J. and Meyers, 
E. N. (2006). Fgf8 is required for anterior heart field development. Development 133, 2435-2445.
Iwahara J. and Clubb, R. T. (1999). Solution structure of the DNA binding domain from Dead ringer, a 
sequence-specific AT-rich interaction domain (ARID). EMBO J 18, 6084-6094.
Iwahara J., Iwahara M., Daughdrill G.W., Ford J. and Clubb, R. T. (2002). The structure of the Dead 
ringer-DNA complex reveals how AT-rich interaction domains (ARIDs) recognize DNA. EMBO J 
21, 1197-1209.
Iwase S., Lan F., Bayliss P., de la Torre-Ubieta L., Huarte M., Qi H.H., Whetstine J.R., Bonni A., 
Roberts T.M. and Shi, Y. (2007). The X-linked mental retardation gene SMCX/JARID1C defines 
a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088.
Jensen L.R., Amende M., Gurok U., Moser B., Gimmel V., Tzschach A., Janecke A.R., Tariverdian 
G., Chelly J., Fryns J.P., et al. (2005). Mutations in the JARID1C gene, which is involved in 
transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am J Hum 
Genet 76, 227-236.
Jia Q., McDill B.W., Li S.Z., Deng C., C. C. P. and Chen, F. (2007). Smad signaling in the neural 
crest regulates cardiac outflow tract remodeling through cell autonomous and non-cell autonomous 
effects. Developmental Biology 311, 172-184.
Joseph S., Deneke V.E. and Dahl, K. D. C. (2012). ARID3B induces tumor necrosis factor alpha mediated 
apoptosis while a novel ARID3B splice form does not induce cell death. PLos One 7, 1-16.
Jostarndt K., Puntschart A., Hoppeler H. and Billeter, R. (1994). The use of 33P-labelled riboprobes 
for in situ hybridizations: localization of myosin alkali light-chain mRNAs in adult human skeletal 
muscle. Histochem J. 26, 32-40.
Kamakura S., Nomura M., Hayase J., Iwakiri Y., Nishikimi A., Takayanagi R., Fukui Y. and Sumimoto, 
H. (2013). The cell polarity protein mInsc regulates neutrophil chemotaxis via a noncanonical G 
protein signaling pathway. Developmental Cell 26, 292-302.
Kanzler B., Kuschert S.J., Liu Y.H. and Mallo, M. (1998). Hoxa-2 restricts the chondrogenic domain and 
inhibits bone formation during development of the branchial area. Development 125, 2587-2597.
Kaplan M.H., Zong R.T., Herrscher R.F., Scheuermann R.H. and Tucker, P. W. (2001). Transcriptional 
BIBLIOGRAPHY
152
activation by a matrix associating region-binding protein. contextual requirements for the function 
of bright. Journal of Biological Chemistry 276, 21325-21330.
Kelly R.G., Brown N.A. and Buckingham, M. E. (2001). The arterial pole of the mouse heart forms from 
Fgf10-expressing cells in pharyngeal mesoderm. Developmental Cell 1, 435-440.
Kelly, R. G. (2012). The Second Heart Field. Current Topics in Developmental Biology 100.
Kim D., Probst L., Das Ch. and Tucker, P. W. (2007). REKLES is an ARID3-restricted multifunctional 
domain. The Journal of Biological Chemistry 282, 15768–15777.
Kim D. and Tucker, P. W. (2006). A regulated nucleocytoplasmic shuttle contributes to Bright’s function 
as a transcriptional activator of immunoglobulin genes. Molecular and Cell Biology 26, 2187-2201.
Kim R.Y., Robertson E.J. and Solloway, M. J. (2001). Bmp6 and Bmp7 are required for cushion formation 
and septation in the developing mouse heart. Developmental Biology 235, 449-466.
Kim T.G., Chen J., Sadoshima J. and Lee, Y. (2004). Jumonji represses atrial natriuretic factor gene 
expression by inhibiting transcriptional activities of cardiac transcription factors. Molecular and 
Cell Biology 24, 10151-10160.
Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A. and Yanagisawa, M. (2001). 
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Developmental 
Biology 230, 230-242.
Kitajima S., Takagi A., Inoue T. and Saga, Y. (2000). MesP1 and MesP2 are essential for the development 
of cardiac mesoderm. Development 127, 3215-3226.
Kobayashi K., Era T., Takebe A., Jakt L.M. and Nishikawa, S. (2006). ARID3B induces malignant 
transformation of mouse embryonic fibroblasts and is strongly associated with malignant 
neuroblastoma. Cancer Res 66, 8331-8336.
Kobayashi K., Jakt L.M. and Nishikawa, S. I. (2013). Epigenetic regulation of the neuroblastoma genes, 
Arid3b and Mycn. Oncogene 32, 2640-2648.
Kokubo H., Tomita-Miyagawa S., Hamada Y. and Saga, Y. (2007). Hesr1 and Hesr2 regulate 
atrioventricular boundary formation in the developing heart through the repression of Tbx2. 
Development 134, 747-755.
Kortschak R.D., Tucker P.W. and Saint, R. (2000). ARID proteins come in from the desert. Trends 
Biochem Sci 25, 294-299.
Kovalevich J., Tracy B. and Langford, D. (2011). PINCH: more than just an adaptor protein in cellular 
response. J Cell Physiol 226, 940-947.
Krohn K.A., Link J.M. and Mason, R. P. (2008). Molecular imaging of hypoxia. J Nucl Med. 49, 
129S-148S.
Kruithof B.P., Krawitz S.A. and Gaussin, V. (2007). Atrioventricular valve development during late 
embryonic and postnatal stages involves condensation and extracellular matrix remodeling. 
Developmental Biology 302, 208-217.
Kwon C., Qian L., Cheng P., Nigam V., Arnold J. and Srivastava, D. (2009). A regulatory pathway 
involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nature Cell Biology 11, 
951-957.
Kwon Ch., Qian L., Cheng P., Nigam V., Arnold J. and Srivastava, D. (2009). A regulatory pathway 
involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nature Cell Biology 11, 
951-957.
Lahoud M.H., Ristevski S., Venter D.J., Jermiin L.S., Bertoncello I., Zavarsek S., Hasthorpe S., 
Drago J., Kretser D. de, Hertzog P.J., et al. (2001). Gene targeting of Desrt, a novel ARID 
class DNA-binding protein, causes growth retardation and abnormal development of reproductive 
organs. Genome Research 11, 1327-1334.
Lai A., Kennedy B.K., Barbie D.A., Bertos N.R., Yang X.J., Theberge M.C., Tsai S.C., Seto E., Zhang 
Y., Kuzmichev A., et al. (2001). RBP1 recruits the mSIN3-histone deacetylase complex to the 
pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the 
BIBLIOGRAPHY
153
nucleus at growth arrest. Molecular and Cellular Biology 21, 2918-2932.
Lai A., Lee J.M., Yang W.M., Decaprio J.A., Kaelin W.G.Jr., Seto E. and Branton, P. E. (1999). RBP1 
recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma 
family proteins. Molecular and Cellular Biology 19, 6632-6641.
Landeira D., Sauer S., Poot R., Dvorkina M., Mazzarella L., Jørgensen H.F., Pereira C.F., Leleu 
M., Piccolo F.M., Spivakov M., et al. (2010). Jarid2 is a PRC2 component in embryonic stem 
cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to 
developmental regulators. Nature Cell Biology 12, 618-625.
Lee Y., Song A.J., Baker R., Micales B., Conway S.J. and Lyons, G. E. (2000). Jumonji, a nuclear 
protein that is necessary for normal heart development. Circulation Research 86, 932-938.
Lee Y.M., Jeong C.H., Koo S.Y., Son M.J., Song H.S., Bae S.K., Raleigh J.A., Chung H.Y., Yoo M.A. 
and Kim, K. W. (2001). Determination of hypoxic region by hypoxia marker in developing mouse 
embryos in vivo: a possible signal for vessel development. Developmental Dynamics 220, 175-186.
Legate K.R., Montañez E., Kudlacek O. and Fässler, R. (2006). ILK, PINCH and parvin: the tIPP of 
integrin signalling. Nature Molecular Cell Biology 7, 20-31.
Li G., Margueron R., Ku M., Chambon P., Bernstein B.E. and Reinberg, D. (2010). Jarid2 and PRC2, 
partners in regulating gene expression. Genes&Development 24, 368-380.
Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charnay Y., Steger K., Krause K.H. and Jaconi, 
M. E. (2006). The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac 
transcription factors and MAP kinase activation. Mol Biol Cell 17, 3978-3988.
Liang X., Sun Y., Ye M., Scimia M.C., Cheng H., Martin J., Wang G., Rearden A., Wu C., Peterson 
K.L., et al. (2009). Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in 
dilated cardiomyopathy and early postnatal lethality. Circulation 120, 568-576.
Lin C.J., Lin C.Y., Chen C.H., B., Z. and Chang, C. P. (2012). Partitioning the heart: mechanisms of 
cardiac septation and valve development. Development 139, 3277-3299.
Lindsley R.C., Gill J.G., Murphy T.L., Langer E.M., Cai M., Mashayekhi M., Wang W., Niwa 
N., Nerbonne J.M., Kyba M., et al. (2008). Mesp1 coordinately regulates cardiovascular fate 
restriction and epithelialmesenchymal transition in differentiating ESCs. . Cell Stem Cell 3, 55-68.
Liu W., Selever J., Wang D., Lu M.F., Moses K.A., R.J., S. and Martin, J. F. (2004). Bmp4 signaling is 
required for outflow-tract septation and branchial-arch artery remodeling. PNAS 101, 4489-4494.
Lockman K., Taylor J.M. and Mack, C. P. (2007). The histone demethylase, Jmjd1a, interacts with the 
myocardin factors to regulate SMC differentiation marker gene expression. Circulation Research 
101, 115-123.
Luna-Zurita L., Prados B., Grego-Bessa J., Luxán G., del Monte G., Benguría A., Adams R.H., Pérez-
Pomares J.M. and de la Pompa, J. L. (2010). Integration of a Notch-dependent mesenchymal gene 
program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. Journal of 
Clinical Investigation 120, 3493-3507.
Ma L., Lu M.F., Schwartz R.J. and Martin, J. F. (2005). Bmp2 is essential for cardiac cushion epithelial-
mesenchymal transition and myocardial patterning. Development 135, 5601–5611.
Ma Q., Zhou B. and Pu, W. T. (2008). Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-
based reporter of Cre activity. Developmental Biology 323, 98-104.
Madsen B., Spencer-Dene B., Poulsom R., Hall D., Lu P.J., Scott K., Shaw A.T., Burchell J.M., Freemont 
P. and Taylor-Papadimitriou, J. (2002). Characterisation and developmental expression of mouse 
Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast 
cancer. Mechanism of Development 119, 239-246.
Majmundar A.J., Wong W.J. and Simon, M. C. (2010). Hypoxia-inducible factors and the response to 
hypoxic stress. Molecular Cell 40, 294-309.
McCulley D.J., Kang J.O., Martin J.F. and Black, B. L. (2008). BMP4 is required in the anterior heart 
field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar 
BIBLIOGRAPHY
154
valve development. Developmental Dynamics 237, 3200-3209.
Meilhac S.M., Esner M., Kelly R.G., Nicolas J.-F. and Buckingham, M. E. (2004). The clonal origin 
of myocardial cells in different regions of the embryonic mouse heart. Developmental Cell 6, 685-
698.
Mesbah K., Harrelson Z., Théveniau-Ruissy M., Papaioannou V.E. and Kelly, R. G. (2008). Tbx3 is 
required for outflow tract development. Circulation Research 103, 743-750.
Miyazaki K., Kawamoto T., Tanimoto K., Nishiyama M., Honda H. and Kato, Y. (2002). Identification 
of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. 
Journal of Biological Chemistry 277, 47014-47021.
Mjaatvedt C.H., Nakaoka T., Moreno-Rodriguez R., Norris R.A., Kern M.J., Eisenberg C.A., Turner 
D. and Markwald, R. R. (2001). The outflow tract of the heart is recruited from a novel heart-
forming field. Developmental Biology 238, 97-109.
Momose T., Tonegawa A., Takeuchi J., Ogawa H., Umesono K. and Yasuda, K. (1999). Efficient 
targeting of gene expression in chick embryos by microelectroporation. Dev Growth Differ 41, 
335-344.
Montagutelli, X. (2000). Effect of the genetic background on the phenotype of mouse mutations. J Am Soc 
Nephrol. 11, S101-105.
Moorman A., Webb S., Brown N.A., Lamers W. and Anderson, R. H. (2003). Develoment of the heart: 
(1) Formation of the cardiac chambers and the arterial trunks. Heart 89, 806–814.
Moorman A.F.M., Christoffels V.M., Anderson R.H. and van den Hoff, M. J. B. (2007). The heart-
forming fields: one or multiple? Phil. Trans. R. Soc. B 362, 1257-1265.
Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., Qyang Y., Bu L., Sasaki M., 
Martin-Puig S., et al. (2006). Multipotent embryonic Isl1+ progenitor cells lead to cardiac, smooth 
muscle, and endothelial cell diversification. Cell 126, 1151–1165.
Mysliwiec M.R., Bresnick E.H. and Lee, Y. (2001). Endothelial Jarid2/Jumonji is required for normal 
cardiac development and proper Notch1 expression. Journal of Biological Chemistry 286, 17193-
17204.
Nagl N.G.Jr., Wang X., Patsialou A., Van Scoy M. and Moran, E. (2007). Distinct mammalian SWI/SNF 
chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 26, 752-763.
Nijmeijer R.M., Leeuwis J.W., DeLisio A., Mummery C.L. and ChuvadeSousaLopes, S. M. (2009). 
Visceral endoderm induces specification of cardiomyocytes in mice. Stem Cells Research 3, 170-
178.
Nixon J.C., Rajaiya J.B., Ayers N., Evetts S. and Webb, C. F. (2004). The transcription factor, Bright, is 
not expressed in all human B lymphocyte subpopulations. Cell Immunology 228, 42-53.
Norris R.A., Potts J.D., Yost M.J., Junor L., Brooks T., Tan H., Hoffman S., Hart M.M., Kern M.J., 
Damon B., et al. (2009). Periostin promotes a fibroblastic lineage pathway in atrioventricular valve 
progenitor cells. Developmental Dynamics 238, 1052-1063.
Norris R.A., M.-R. R. A., Sugi Y., Hoffman S., Amos J., Hart M.M., Potts J.D., Goodwin R.L. and 
Markwald R.R. (2008). Periostin regulates atrioventricular valve maturation. Developmental 
Biology 316, 200-213.
Numata S., Claudio P.P., Dean C., Giordano A. and Croce, C. M. (1999). Bdp, a new member of a 
family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res 59, 
3741-3747.
Palmer D.J. and Ng, P. (2008). Methods for the production of first generation adenoviral vectors. Methods 
Mol Biol 433, 55-78.
Pardo M., Lang B., Yu L., Prosser H., Bradley A., Babu M.M. and Choudhary, J. (2010). An expanded 
Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem 
Cell 6, 382–395.
Park E.J., Ogden L.A., Talbot A., Evans S., Cai C.L., Black B.L., Frank D.U. and Moon, A. M. (2006). 
BIBLIOGRAPHY
155
Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 
133, 2419-2433.
Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E., Anderson P., Mason C.A., 
Collins J.S., Kirby R.S., et al. (2010). Updated National Birth Prevalence estimates for selected 
birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 12, 1008-1016.
Pasini D., Cloos P.A.C., Walfridsson J., Olsson L., Bukowski J.P., Johansen J.V., Bak M., Tommerup 
N., Rappsilber J. and Helin, K. (2010). JARID2 regulates binding of the Polycomb repressive 
complex 2 to target genes in ES cells. Nature 464, 306-311.
Patsialou A., Wilsker D. and Moran, E. (2005). DNA-binding properties of ARID family proteins. 
Nucleic Acids Research 33, 66-80.
Peng J.C., Valouev A., Swigut T., Zhang J., Zhao Y., Sidow A. and Wysocka, J. (2009). Jarid2/Jumonji 
coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 
139, 1290-1302.
Popowski M., Templeton T.D., Lee B.K., Rhee C., Li H., Miner C., Dekker J.D., Orlanski S., Bergman 
Y., Iyer V.R., et al. (2014). Bright/Arid3A acts as a barrier to somatic cell reprogramming through 
direct regulation of Oct4, Sox2, and Nanog. Stem Cell Reports 2, 26-35.
Prall O.W.J., Menon M.K., Solloway M.J., Watanabe Y., Zaffran S., Bajolle F., Biben Ch., McBride 
J.J., Robertson B.R., Chaulet H., et al. (2007). An Nkx2-5/Bmp2/Smad1 negative feedback loop 
controls heart progenitor specification and proliferation. Cell 128, 947-959.
Price M.G., Landsverk M.L., Barral J.M. and Epstein, H. F. (2002). Two mammalian UNC-45 isoforms 
are related to distinct cytoskeletal and muscle-specific functions. J Cell Science 115, 4013-4023.
Qyang Y., Martin-Puig S., Chiravuri M., Chen S., Xu H., Bu L., Jiang X., Lin L., Granger A., Moretti 
A., et al. (2007). The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled 
by a Wnt/b-catenin pathway. Cell Stem Cell 1, 165-179.
Rivera-Feliciano J., Lee K.H., Kong S.W., Rajagopal S., Ma Q., Springer Z., Izumo S., Tabin C.J. and 
Pu, W. T. (2006). Development of heart valves requires Gata4 expression in endothelial-derived 
cells. Development 133, 3607-3618.
Rucker E.B., Dierisseau P., Wagner K.U., Garrett L., Wynshaw-Boris A., Flaws J.A. and Hennighausen, 
L. (2000). Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during 
embryogenesis. Mol Endocrinol 14, 1038-1052.
Ryckebusch L., Wang Z., Bertrand N., Lin S.C., Chi X., Schwartz R., Zaffran S. and Niederreither, 
K. (2008). Retinoic acid deficiency alters second heart field formation. PNAS 105, 2913-2918.
Saga Y., Kitajima S. and Miyagawa-Tomita, S. (2000a). Mesp1 expression is the earliest sign of 
cardiovascular development. Trends Cardiovasc Med 10, 345-352.
Saga Y., Miyagawa-Tomita, Tagaki A., S. Kitajima S., Miyazaki J. and Inoue T. (2000b). MesP1 is 
expressed in the heart precursor cells and required for the formation of a single heart tube. Trends 
Cardiovasc Med 10, 345-352.
Saga Y., Miyagawa-Tomita S., Takagi A., Kitajima S., Miyazaki J. and Inoue, T. (1999). MesP1 
is expressed in the heart precursor cells and required for the formation of a single heart tube. 
Development 126, 3437–3447.
Sakabe M., Kokubo H., Nakajima Y. and Saga, Y. (2012). Ectopic retinoic acid signaling affects 
outflow tract cushion development through suppression of the myocardial Tbx2-Tgfβ2 pathway. 
Development 139, 385-395.
Satin J., Fujii S. and DeHaan, R. L. (1988). Development of cardiac beat rate in early chick embryos is 
regulated by regional cues. Developmental Biology 129, 103-113.
Schaft J., Ashery-Padan R., van der Hoeven, F., Gruss P. and Stewart, A. F. (2001). Efficient FLP 
recombination in mouse ES cells and oocytes. Genesis 31, 6-10.
Shandala T., Kortschak R.D., Gregory S. and Saint, R. (1999). The Drosophila dead ringer gene is 
required for early embryonic patterning through regulation of argos and buttonhead expression. 
BIBLIOGRAPHY
156
Development 126, 4341-4349.
Shandala T., Kortschak R.D. and Saint, R. (2002). The Drosophila retained/dead ringer gene and ARID 
gene family function during development. Int. J. Dev. Biol 46, 423-430.
Shandala T., Takizawa K. and Saint, R. (2003). The dead ringer/retained transcriptional regulatory gene 
is required for positioning of the longitudinal glia in the Drosophila embryonic CNS. Development 
130, 1505-1513.
Sharov A.A., Masui S., Sharova L.V., Piao Y., Aiba K., Matoba R., Xin L., Niwa H. and Ko, M. S. 
H. (2008). Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical 
confidence by applying a novel algorithm to time course microarray and genome-wide chromatin 
immunoprecipitation data. . BMC Genomics 9, 1-19.
Shelton E.L. and Yutzey, K. E. (2007). Tbx20 regulation of endocardial cushion cell proliferation and 
extracellular matrix gene expression. Developmental Biology 302, 376-388.
Shelton E.L. and Yutzey, K. E. (2008). Twist1 function in endocardial cushion cell proliferation, migration, 
and differentiation during heart valve development. Developmental Biology 317, 282-295.
Shen M., Yoshida E., Yan W., Kawamoto T., Suardita K., Koyano Y., Fujimoto K., Noshiro M. and 
Kato, Y. (2002). Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the 
early and terminal stages. Journal of Biological Chemistry 277, 50112-50120.
Shirai M., Imanaka-Yoshida K., Schneider M.D., Schwartz R.J. and Morisakie, T. (2009). T-box 
2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgf2 expression and 
endocardial cushion formation. PNAS 106, 18604-18609.
Singh M.K., Christoffels V.M., Dias J.M., Trowe M.O., Petry M., Schuster-Gossler K., Bürger A., 
Ericson J. and Kispert, A. (2005). Tbx20 is essential for cardiac chamber differentiation and 
repression of Tbx2. Development 132, 2697-2707.
Singh R., Hoogaars W.M., Barnett P., Grieskamp T., Rana M.S., Buermans H., Farin H.F., Petry 
M., Heallen T., Martin J.F., et al. (2012). Tbx2 and Tbx3 induce atrioventricular myocardial 
development and endocardial cushion formation. Cellular and Molecular Life Sciences 69, 1377–
1389.
Singh R., Horsthuis T., Farin H.F., Grieskamp T., Norden J., Petry M., Wakker V., Moorman A.F.M., 
Christoffels V.M. and Kispert, A. (2009). Tbx20 interacts with Smads to confine Tbx2 expression 
to the atrioventricular canal. Circulation Research 105, 442-452.
Sinha T., Wang B., Evans S., Wynshaw-Boris A. and Wang, J. (2012). Disheveled mediated planar cell 
polarity signaling is required in the second heart field lineage for outflow tract morphogenesis. 
Developmental Biology 370, 135-144.
Sirbu I.O., Zhao X. and Duester, G. (2008). Retinoic acid controls heart anteroposterior patterning by 
down-regulating Isl1 through the Fgf8 pathway. Developmental Dynamics 237, 1627-1635.
Soufan A.T., van den Berg G., Ruijter J.M., de Boer P.A.J., van den Hoff M.J.B. and Moorman, A. F. 
M. (2006). Regionalized sequence of myocardial cell growth and proliferation characterizes early 
chamber formation. Circulation Research 99, 545-552.
Stanley E.G., Biben C., Elefanty A., Barnett L., Koentgen F., Robb L. and Harvey, R. P. (2002). 
Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3’UTR-ires-Cre allele of 
the homeobox gene Nkx2-5. Int. J. Dev. Biol 46, 431-439.
Strange, R. E. (1966). Stability of beta-galactosidase in starved Escherichia coli. Nature 209, 428-429.
Sugi Y., Yamamura H., Okagawa H. and Markwald, R. R. (2004). Bone morphogenetic protein-2 can 
mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. 
Developmental Biology 269, 505-518.
Sun H., Li L., Vercherat C., Gulbagci N.T., Acharjee S., Li J., Chung T.K., Thin T.H. and Taneja, R. 
(2007). Stra13 regulates satellite cell activation by antagonizing Notch signaling. J Cell Biology 
177, 647-657.
Sun H. and Taneja, R. (2000). Stra13 expression is associated with growth arrest and represses transcription 
BIBLIOGRAPHY
157
through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. PNAS 97, 
4058-4063.
Sun Y., Liang X., Najafi N., Cass M., Lin L., Cai C.L., Chen J. and Evans, S. M. (2007). Islet 1 is 
expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. 
Developmental Biology 304, 286-296.
Takash W., Cañizares J., Bonneaud N., Poulat F., Mattéi M.G., Jay P. and Berta, P. (2001). SOX7 
transcription factor: sequence, chromosomal localisation, expression, transactivation and 
interference with Wnt signalling. Nucleic Acids Research 29, 4274-4283.
Takebe A., Era T., Okada M., Martin Jakt L., Kuroda Y. and Nishikawa, S. (2006). Microarray analysis 
of PDGFR alpha+ populations in ES cell differentiation culture identifies genes involved in 
differentiation of mesoderm and mesenchyme including ARID3b that is essential for development 
of embryonic mesenchymal cells. Developmental Biology 293, 25-37.
Takeuchi J.K. and Bruneau, B. G. (2009). Directed transdifferentiation of mouse mesoderm to heart 
tissue by defined factors. Nature 459, 708-712.
Takeuchi T., Watanabe Y., Takano-Shimizu T. and Kondo, S. (2006). Roles of jumonji and jumonji 
family genes in chromatin regulation and development. Developmental Dynamics 235, 2449-2459.
Tanabe L.M., Martin C. and Dauer, W. T. (2012). Genetic background modulates the phenotype of a 
mouse model of DYT1 dystonia. PLos One 7, 1-9.
Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton 
T., Herrup K., Harris R.C., et al. (1995). Targeted disruption of mouse EGF receptor: effect of 
genetic background on mutant phenotype. Science 269, 230-234.
Tian Y., Yuan L., Goss A.M., Wang T., Yang J., Lepore J.J., Zhou D., Schwartz R.J., Patel V., Cohen 
E.D., et al. (2010). Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway 
required for cardiac inflow tract development. Developmental Cell 18, 275-287.
Tidwell J.A., Schmidt C., Heaton P., Wilson V. and Tucker, P. W. (2011). Characterization of a new 
ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated 
immunoglobulin gene transcription. Molecular Immunology 49, 260-272.
Timmerman L.A., Grego-Bessa J., Raya A., Bertrán E., Pérez-Pomares J.M., Díez J., Aranda S., Palomo 
S., McCormick F., Izpisúa-Belmonte J.C., et al. (2004). Notch promotes epithelial-mesenchymal 
transition during cardiac development and oncogenic transformation. Genes&Development 18, 99-
115.
Toyofuku T., Yoshida J., Sugimoto T., Yamamoto M., Makino N., Takamatsu H., Takegahara N., Suto 
F., Hori M., Fujisawa H., et al. (2008). Repulsive and attractive semaphorins cooperate to direct 
the navigation of cardiac neural crest cells. Developmental Biology 321, 251-262.
Udan R.S., Vadakkan T.J. and Dickinson, M. E. (2013). Dynamic responses of endothelial cells to 
changes in blood flow during vascular remodeling of the mouse yolk sac. Development 140, 4041-
4050.
van den Berg D.L.C., Snoek T., Mullin N.P., Yates A., Bezstarosti K., Demmers J., Chambers I. and 
Poot, R. A. (2010). An Oct4-centered protein interaction network in embryonic stem cells. . Cell 
Stem Cell 6, 369-381.
van den Berg G., Abu-Issa R., de Boer B.A., Hutson M.R., de Boer P.A.J., Soufan A.T., Ruijter J.M., 
Kirby M.L., van den Hoff M.J.B. and Moorman, A. F. M. (2009). A caudal proliferating growth 
center contributes to both poles of the forming heart tube. Circulation Research 104, 179-188.
van den Berg G. and Moorman, A. F. M. (2009). Concepts of cardiac development in retrospect. Pediatr 
Cardiol. 
Varona R., Cadenas V., Gómez L., Martínez-A. C. and Márquez, G. (2005). CCR6 regulates CD4+ 
T-cell-mediated acute graft-versus-host disease responses. Blood 106, 18-26.
Vincent S.D. and Buckingham, M. E. (2010). How to make a heart: the origin and regulation of cardiac 
progenitor cells. Curr Top Dev Biol 90, 1-41.
BIBLIOGRAPHY
158
von Gise A. and Pu, W. T. (2012). Endocardial and epicardial epithelial to mesenchymal transitions in 
heart development and disease. Circulation Research 110, 1628-1645.
Wagner M. and Siddiqui, M. A. Q. (2007). Signal transduction in early heart development (I): cardiogenic 
induction and heart tube formation. Experimental Biology and Medicine 232, 852-865 
Waldo K.L., Hutson M.R., Ward C.C., Zdanowicz M., Stadta H.A., Kumiskic D., Abu-Issa R. and 
Kirby, M. L. (2005). Secondary heart field contributes myocardium and smooth muscle to the 
arterial pole of the developing heart. Developmental Biology 281, 78-90.
Waldo K.L., Kumiski D.H., Wallis K.T., Stadt H.A., Hutson M.R., Platt D.H. and Kirby, M. L. (2001). 
Conotruncal myocardium arises from a secondary heart field. Development 128, 3179-3188.
Wallingford J.B., Fraser S.E. and Harland, R. M. (2002). Convergent extension: the molecular control 
of polarized cell movement during embryonic development. Developmental Cell 2, 695-706.
Wang J., Greene S.B., Bonilla-Claudio M., Tao Y., Zhang J., Bai Y., Huang Z., Black B.L., Wang 
F. and Martin, J. F. (2010). Bmp signaling regulates myocardial differentiation from cardiac 
progenitors through a MicroRNA-mediated mechanism. Developmental Cell 19, 903-912.
Wang J. and Orkin, S. H. (2008). A protein roadmap to pluripotency and faithful reprogramming. Cells 
Tissues Organs 188, 23-30.
Wang J., Rao S., Chu J., Shen X., Levasseur D.N., Theunissen T.W. and Orkin, S. H. (2006). A protein 
interaction network for pluripotency of embryonic stem cells. Nature 444, 364-368.
Wang Y., Wu B., Chamberlain A.A., Lui W., Koirala P., Susztak K., Klein D., Taylor V. and Zhou, B. 
(2013). Endocardial to myocardial notch-wnt-bmp axis regulates early heart valve development. 
PLoS One 8, 1-8.
Watanabe M., Layne M.D., Hsieh C.M., Maemura K., Gray S., Lee M.E. and Jain, M. K. (2002). 
Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors 
Mrf2alpha and Mrf2beta. Circulation Research 91, 382-389.
Webb C.F., Bryant J., Popowski M., Allred L., Kim D., Harriss J., Schmidt C., Miner C.A., Rose 
K., Cheng H.L., et al. (2011). The ARID family transcription factor bright is required for both 
hematopoietic stem cell and B lineage development. Molecular and Cell Biology 31, 1041-1053.
Webb C.F., Yamashita Y., Ayers N., Evetts S., Paulin Y., Conley M.E. and Smith, E. A. (2000). The 
transcription factor Bright associates with Bruton’s tyrosine kinase, the defective protein in 
immunodeficiency disease. Journal of Immunology 165, 6956-6965.
Wilkinson D.G. and Nieto, M. A. (1993). Detection of messenger RNA by in situ hybridization to tissue 
sections and whole mounts. Methods Enzymol 225.
Wilsker D., Patsialou A., Dallas P.B. and Moran, E. (2002). ARID proteins: a diverse family of DNA 
binding proteins implicated in the control of cell growth, differentiation, and development. Cell 
Growth Differentiation 13, 95-106.
Winnier G.E., Kume T., Deng K., Rogers R., Bundy J., Raines C., Walter M.A., Hogan B.L. and Conway, 
S. J. (1999). Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular 
development revealed by nonallelic noncomplementation of null alleles. Developmental Biology 
213, 418-431.
Witte F., Dokas J., Neuendorf F., Mundlos S. and Stricker, S. (2009). Comprehensive expression analysis 
of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage 
differentiation. Gene Expression Patterns 9, 215-223.
Xu H., Cheng C., Devidas M., Pei D., Fan Y., Yang W., Neale G., Scheet P., Burchard E.G., Torgerson 
D.G., et al. (2012). ARID5B genetic polymorphisms contribute to racial disparities in the incidence 
and treatment outcome of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology 
30, 751-757.
Xu X., Li C., Garrett-Beal L., Larson D., Wynshaw-Boris A. and Deng, C. X. (2001). Direct removal 
in the mouse of a floxed neo gene from a three-loxP conditional knockout allele by two novel 
approaches. Genesis 30, 1-6.
BIBLIOGRAPHY
159
Yan Z., Cui K., Murray D.M., Ling C., Xue Y., Gerstein A., Parsons R., Zhao K. and Wang, W. (2005). 
PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate 
expression of selective interferon-responsive genes. Genes&Development 19, 1662-1667.
Yang L., Cai C.L., Lin L., Qyang Y., Chung C., Monteiro R.M., Mummery C.L., Fishman G.I., Cogen 
A. and Evans, S. (2006). Isl1Cre reveals a common Bmp pathway in heart and limb development. 
Development 133, 1575-1585.
Zaffran S., Kelly R.G., Meilhac S.M., Buckingham M.E. and Brown, N. A. (2004). Right ventricular 
myocardium derives from the Anterior Heart Field. Circulation Research 95, 261-268.
Zhang J., Chang J.Y., Huang Y., Lin X., Luo Y., Schwartz R.J., Martin J.F. and Wang, F. (2010). 
The FGF-BMP signaling axis regulates outflow tract valve primordium formation by promoting 
cushion neural crest cell differentiation. Circulation Research 107, 1209-1219.
Zhang Y., Chen K., Guo L. and Wu, C. (2002). Characterization of PINCH-2, a new focal adhesion 
protein that regulates the PINCH-1-ILK interaction, cell spreading, and migration. Journal of 
Biological Chemistry 277, 38328-38338.
Zhang Z., Huynh T. and Baldini, A. (2006). Mesodermal expression of Tbx1 is necessary and sufficient 
for pharyngeal arch and cardiac outflow tract development. Development 133, 3587-3595.
Zhou W., Lin L., Majumdar A., Li X., Zhang X., Liu W., Etheridge L., Shi Y., Martin J., Van de Ven 
W., et al. (2007). Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/
CREB family-mediated transcriptional activation of TGFbeta2. Nature Genetics 39, 1225-1234.
Zhu H., Chen T., Zhu M., Fang Q., Kang H., Hong Z. and Zhang, Z. (2008). A novel ARID DNA-
binding protein interacts with SymRK and is expressed during early nodule development in Lotus 
japonicus. Plant Physiology 148, 337-347.
160
161
SUPPLEMENTARY
MATERIAL
162
SUPPLEMENTARY MATERIAL
163
Supplementary figure 1. Tbx2 expression is normal in the IFT at E8.5. In situ 
hybridisation against Tbx2 shows similar expression in wild type and Arid3bgt/gt 
embryos in the heart IFT (arrowheads). Scale bar: 250 mm.
Supplementary figure 2. Immunostaining against pimonidazole (pimo, green), hypoxic marker and Islet1 
(red) at E9.0 (A) and at E9.5 (B). Note the increase of hypoxic regions in Arid3bgt/gt embryos at E9.5. 
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Supplementary figure 3. A-D. In situ hybridisation against Myf5 in 
whole mount embryos. Note the reduction of the signal in the somites in 
Arid3bgt/gt embryos (compare C to D). E. In situ hybridisation on paraffin 
section of Arid3b on wild type embryo at E10.5; note the expression of the 
gene in the miotome (arrow). F-G. In situ hybridisation on paraffin section 
against Pax3 in wild type and Arid3bgt/gt embryos. Note that Pax3 positive 
cells in mutant embryos remain in the somite (arrowhead), while in the wild 
type situation these cells invade the limb. Scale bars: A,B 1 mm; C,D 400 mm; 
E 150 mm. 
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Supplementary figure 4. In situ hybridisation with Arid3b probe 
in whole-mount (A) and on paraffin sections (B,C) in wild type 
and RPB-Jk mutants. Note the ectopic expression of Arid3b in 
the midbrain of the mutant (arrowheads). Scale bars: A 500 mm; 
B,C 100 mm. 
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GENES UPREGULATED IN HEART AND WHOLE E9.0 EMBRYOS
Symbol ID Entrez Gene Name logFC Heart
5430434G16Rik A_52_P1034794 RIKEN cDNA 5430434G16 gene 1,245
5830408C22Rik A_52_P359257 RIKEN cDNA 5830408C22 gene 2,622
A2M A_52_P455370 alpha-2-macroglobulin 3,656
ADM A_51_P265571 adrenomedullin 2,081
ALDOC A_51_P220681 aldolase C, fructose-bisphosphate 2,346
ANKRD37 A_52_P319438 ankyrin repeat domain 37 2,715
ANXA2 A_52_P1196772 annexin A2 1,506
ARHGEF4 A_51_P260504 Rho guanine nucleotide exchange 
factor (GEF) 4
1,428
ARRDC3 A_52_P164136 arrestin domain containing 3 1,401
ATR A_52_P445778 ataxia telangiectasia and Rad3 related 1,090
BHLHE40 A_51_P272553 basic helix-loop-helix family, member 
e40
3,146
BHLHE41 A_51_P451176 basic helix-loop-helix family, member 
e41
2,370
BNIP3 A_51_P155234 BCL2/adenovirus E1B 19kDa 
interacting protein 3
2,408
C17orf58 A_51_P305213 chromosome 17 open reading frame 58 2,423
C3 A_51_P110301 complement component 3 3,318
C4orf29 A_52_P616229 chromosome 4 open reading frame 29 1,916
CCBP2 A_52_P222073 chemokine binding protein 2 1,484
CCL19 A_51_P458258 chemokine (C-C motif) ligand 19 1,544
CCNG2 A_51_P360165 cyclin G2 2,018
Cd55/Daf2 A_52_P199084 CD55 antigen 1,471
CHAC1 A_51_P134812 ChaC, cation transport regulator 
homolog 1 (E. coli)
4,578
CREG2 A_51_P227353 cellular repressor of E1A-stimulated 
genes 2
1,216
CYP2S1 A_51_P180091 cytochrome P450, family 2, subfamily 
S, polypeptide 1
3,217
DBP A_51_P180492 D site of albumin promoter (albumin 
D-box) binding protein
1,674
DDIT3 A_52_P533146 DNA-damage-inducible transcript 3 1,944
DDIT4 A_51_P245796 DNA-damage-inducible transcript 4 3,097
DENND2D A_52_P662796 DENN/MADD domain containing 2D 1,091
EBF4 A_52_P78975 early B-cell factor 4 1,333
EDIL3 A_52_P325527 EGF-like repeats and discoidin I-like 
domains 3
1,219
EGLN3 A_52_P387009 egl nine homolog 3 (C. elegans) 3,119
ENO2 A_52_P748882 enolase 2 (gamma, neuronal) 4,184
ERO1L A_51_P481693 ERO1-like (S. cerevisiae) 1,965
ESM1 A_52_P257625 endothelial cell-specific molecule 1 1,871
ESPN A_51_P451799 espin 2,484
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FAM162A A_52_P563694 family with sequence similarity 162, 
member A
1,102
FN3K A_51_P398525 fructosamine 3 kinase 2,014
HEXB A_51_P453111 hexosaminidase B (beta polypeptide) 1,699
HSPA1A/HSPA1B A_52_P82741 heat shock 70kDa protein 1A 2,729
IER3 A_51_P286488 immediate early response 3 3,466
KBTBD11 A_52_P394448 kelch repeat and BTB (POZ) domain 
containing 11
4,523
KCNE3 A_52_P243425 potassium voltage-gated channel, Isk-
related family, member 3
2,668
KRT19 A_51_P356642 keratin 19 3,015
LINGO3 A_51_P436491 leucine rich repeat and Ig domain 
containing 3
1,796
Lrrc51 A_52_P319137 leucine rich repeat containing 51 1,545
MACROD1 A_52_P559957 MACRO domain containing 1 1,084
MAFF A_52_P608322 v-maf musculoaponeurotic 
fibrosarcoma oncogene homolog F 
(avian)
2,092
MEF2B A_51_P330580 myocyte enhancer factor 2B 2,215
MGARP A_51_P240501 mitochondria-localized glutamic acid-
rich protein
2,390
MT1E A_51_P294979 metallothionein 1E 2,410
MT1H A_51_P246317 metallothionein 1H 2,324
NDRG1 A_51_P405606 N-myc downstream regulated 1 4,424
NDRG2 A_51_P176352 NDRG family member 2 1,852
NEK1 A_52_P818995 NIMA-related kinase 1 1,194
Nppb A_52_P559955 natriuretic peptide type B 1,875
NRN1 A_51_P308844 neuritin 1 3,752
NUPR1 A_51_P519251 nuclear protein, transcriptional 
regulator, 1
3,553
P4HA1 A_52_P593723 prolyl 4-hydroxylase, alpha 
polypeptide I
1,939
PDK1 A_51_P406429 pyruvate dehydrogenase kinase, 
isozyme 1
1,522
PFKFB3 A_52_P138126 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3
2,493
PFKP A_52_P223083 phosphofructokinase, platelet 1,426
PGM1 A_51_P368074 phosphoglucomutase 1 1,191
PHYHD1 A_51_P357606 phytanoyl-CoA dioxygenase domain 
containing 1
1,909
PIK3IP1 A_51_P463428 phosphoinositide-3-kinase interacting 
protein 1
2,126
PLEKHA2 A_51_P280785 pleckstrin homology domain 
containing, family A (phosphoinositide 
binding specific) member 2
1,549
PPIL6 A_51_P224042 peptidylprolyl isomerase (cyclophilin)-
like 6
1,260
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PPP1R3C A_51_P521010 protein phosphatase 1, regulatory 
subunit 3C
1,646
PRELID2 A_51_P480119 PRELI domain containing 2 1,691
PYGL A_51_P452779 phosphorylase, glycogen, liver 1,616
RORA A_51_P477779 RAR-related orphan receptor A 3,246
SESN2 A_52_P154710 sestrin 2 1,327
SLC38A3 A_51_P139030 solute carrier family 38, member 3 2,168
SLC7A3 A_51_P275016 solute carrier family 7 (cationic amino 
acid transporter, y+ system), member 3
4,430
ST3GAL1 A_51_P301804 ST3 beta-galactoside alpha-2,3-
sialyltransferase 1
1,955
STAG3 A_51_P494822 stromal antigen 3 1,244
STC1 A_51_P233334 stanniocalcin 1 2,762
STC2 A_51_P208922 stanniocalcin 2 3,835
TET2 A_51_P478930 tet methylcytosine dioxygenase 2 1,346
TEX40 A_52_P357972 testis expressed 40 1,629
TMEM45A A_51_P288876 transmembrane protein 45A 2,077
TRIB3 A_51_P331570 tribbles homolog 3 (Drosophila) 4,037
VLDLR A_51_P278334 very low density lipoprotein receptor 3,054
Zbtb7b A_51_P473229 zinc finger and BTB domain 
containing 7B
1,142
ZC3H6 A_52_P469956 zinc finger CCCH-type containing 6 2,164
ZMYM6NB A_52_P70216 ZMYM6 neighbor 1,096
GENES DOWNREGULATED IN HEART AND WHOLE E9.0 EMBRYOS
Symbol ID Entrez Gene Name logFC Heart
AMICA1 A_52_P375312 adhesion molecule, interacts with 
CXADR antigen 1
-1,893
ARID3B A_52_P454397 AT rich interactive domain 3B 
(BRIGHT-like)
-4,180
ATM A_52_P369581 ataxia telangiectasia mutated -1,318
Cryge A_51_P289062 crystallin, gamma E -1,844
HEYL A_52_P337259 hairy/enhancer-of-split related with 
YRPW motif-like
-1,405
KLHL31 A_52_P90684 kelch-like family member 31 -1,876
LHX8 A_51_P298615 LIM homeobox 8 -1,475
PPCDC A_52_P409457 phosphopantothenoylcysteine 
decarboxylase
-3,161
VGLL2 A_51_P491648 vestigial like 2 (Drosophila) -2,031
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GENES UPREGULATED IN HEART, HEAD AND TRUNK
Symbol ID Entrez Gene Name logFC Heart
1110035H17Rik A_52_P185054 RIKEN cDNA 1110035H17 gene 1,039
1600014C23Rik A_51_P147064 RIKEN cDNA 1600014C23 gene 2,510
1700001L05Rik A_55_P2404484 RIKEN cDNA 1700001L05 gene 2,168
1700012L04Rik 
(includes others)
A_55_P1982494 predicted gene 4906 2,239
1700016J18Rik A_66_P102628 RIKEN cDNA 1700016J18 gene 1,353
2310047D07Rik A_55_P2182740 RIKEN cDNA 2310047D07 gene 1,524
2410006H16Rik A_66_P111430 RIKEN cDNA 2410006H16 gene 1,577
2500002B13Rik A_55_P2216561 RIKEN cDNA 2500002B13 gene 1,642
2610528A11Rik A_66_P108468 RIKEN cDNA 2610528A11 gene 1,867
2700022O18Rik A_55_P2233462 RIKEN cDNA 2700022O18 gene 1,553
2900055J20Rik A_51_P471273 RIKEN cDNA 2900055J20 gene 4,760
4831440E17Rik A_55_P2361647 RIKEN cDNA 4831440E17 gene 1,702
4930426I24Rik A_55_P2387121 RIKEN cDNA 4930426I24 gene 1,750
4930466F19Rik A_66_P108038 RIKEN cDNA 4930466F19 gene 1,593
4930579K19Rik A_55_P2144701 RIKEN cDNA 4930579K19 gene 1,230
5033406O09Rik A_55_P2324976 RIKEN cDNA 5033406O09 gene 1,171
5430402O13Rik A_55_P2187829 RIKEN cDNA 5430402O13 gene 1,716
5830408C22Rik A_52_P359257 RIKEN cDNA 5830408C22 gene 2,622
6720401G13Rik A_55_P2181934 RIKEN cDNA 6720401G13 gene 1,005
6720407P12Rik A_55_P2316612 RIKEN cDNA 6720407P12 gene 3,630
9330159N05Rik A_55_P2349747 RIKEN cDNA 9330159N05 gene 1,153
9430065F17Rik A_55_P2302848 RIKEN cDNA 9430065F17 gene 1,486
A2M A_55_P2459897 alpha-2-macroglobulin 3,656
A530047J11Rik A_55_P2234704 RIKEN cDNA A530047J11 gene 1,356
A830052D11Rik A_55_P2412319 RIKEN cDNA A830052D11 gene 1,481
ABHD14B A_55_P2059640 abhydrolase domain containing 14B 1,046
Acad12 A_51_P384113 acyl-Coenzyme A dehydrogenase 
family, member 12
1,015
ACVRL1 A_55_P2011380 activin A receptor type II-like 1 1,033
ADAMTS17 A_66_P124114 ADAM metallopeptidase with 
thrombospondin type 1 motif, 17
1,636
ADM A_51_P265571 adrenomedullin 2,081
ADM2 A_55_P2181386 adrenomedullin 2 4,325
ADORA2A A_55_P2109382 adenosine A2a receptor 1,734
AHNAK A_55_P2153621 AHNAK nucleoprotein 1,596
ALDH1L2 A_52_P498193 aldehyde dehydrogenase 1 family, 
member L2
2,313
ALDOC A_55_P2070992 aldolase C, fructose-bisphosphate 2,346
ALOX12 A_51_P520306 arachidonate 12-lipoxygenase 3,421
ALOXE3 A_55_P2023523 arachidonate lipoxygenase 3 1,366
AMY1A (includes 
others)
A_55_P1983418 amylase, alpha 1A (salivary) 2,044
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ANKRD37 A_52_P319438 ankyrin repeat domain 37 2,715
ANKZF1 A_51_P365903 ankyrin repeat and zinc finger 
domain containing 1
1,045
ANXA2 A_55_P2110713 annexin A2 1,506
Apol7d A_55_P2011557 apolipoprotein L 7d 1,936
ARHGEF4 A_51_P260504 Rho guanine nucleotide exchange 
factor (GEF) 4
1,428
ARRDC3 A_52_P164136 arrestin domain containing 3 1,401
ARSG A_55_P2043122 arylsulfatase G 1,038
ASNS A_55_P1959748 asparagine synthetase (glutamine-
hydrolyzing)
1,562
ATF3 A_52_P452689 activating transcription factor 3 1,301
ATR A_55_P2029176 ataxia telangiectasia and Rad3 
related
1,090
B130046B21Rik A_55_P2365710 RIKEN cDNA B130046B21 gene 2,129
BC048594 A_55_P2177498 cDNA sequence BC048594 1,012
BC062258 A_55_P2340101 cDNA sequence BC062258 1,215
BCL6 A_52_P161495 B-cell CLL/lymphoma 6 1,476
BHLHE40 A_51_P272553 basic helix-loop-helix family, 
member e40
3,146
BHLHE41 A_55_P2133001 basic helix-loop-helix family, 
member e41
2,370
BNIP3 A_55_P2091472 BCL2/adenovirus E1B 19kDa 
interacting protein 3
2,408
BNIP3L A_55_P2073699 BCL2/adenovirus E1B 19kDa 
interacting protein 3-like
1,233
BSG A_51_P329441 basigin (Ok blood group) 1,158
C130045F17Rik A_55_P2311208 RIKEN cDNA C130045F17 gene 1,177
C17orf58 A_55_P2102095 chromosome 17 open reading frame 
58
2,423
C20orf173 A_55_P2061934 chromosome 20 open reading frame 
173
1,152
C4orf29 A_55_P2005808 chromosome 4 open reading frame 
29
1,916
C4orf47 A_52_P641195 chromosome 4 open reading frame 
47
1,287
C80012 A_55_P2212733 expressed sequence C80012 1,905
C8G A_55_P2151556 complement component 8, gamma 
polypeptide
1,296
C920006O11Rik A_51_P130447 RIKEN cDNA C920006O11 gene 1,970
C9orf9 A_55_P1979997 chromosome 9 open reading frame 9 1,171
CA12 A_55_P2019312 carbonic anhydrase XII 2,164
CA9 A_55_P2092750 carbonic anhydrase IX 4,447
CCBP2 A_52_P222073 chemokine binding protein 2 1,484
CCDC176 A_55_P1976494 coiled-coil domain containing 176 1,546
CCDC62 A_55_P1999556 coiled-coil domain containing 62 1,191
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CCDC64 A_55_P2152991 coiled-coil domain containing 64 2,004
CCL19 A_55_P2099742 chemokine (C-C motif) ligand 19 1,544
CCNG2 A_55_P2068882 cyclin G2 2,018
CCT6B A_55_P2050273 chaperonin containing TCP1, subunit 
6B (zeta 2)
1,139
CDH13 A_51_P114826 cadherin 13, H-cadherin (heart) 1,103
CDKN1A A_55_P1976204 cyclin-dependent kinase inhibitor 1A 
(p21, Cip1)
1,243
CHAC1 A_51_P134812 ChaC, cation transport regulator 
homolog 1 (E. coli)
4,578
CHADL A_55_P2232325 chondroadherin-like 1,090
CHD5 A_55_P1978371 chromodomain helicase DNA 
binding protein 5
1,668
CLCN3 A_55_P2047842 chloride channel, voltage-sensitive 3 1,297
CNBD2 A_55_P2149144 cyclic nucleotide binding domain 
containing 2
1,019
CNNM1 A_52_P296913 cyclin M1 1,779
CNTD1 A_51_P467960 cyclin N-terminal domain containing 
1
1,119
COL20A1 A_52_P474902 collagen, type XX, alpha 1 1,181
COX4I2 A_55_P2054663 cytochrome c oxidase subunit IV 
isoform 2 (lung)
2,687
CPEB1 A_55_P2074631 cytoplasmic polyadenylation element 
binding protein 1
1,495
CREBRF A_52_P573290 CREB3 regulatory factor 2,605
CRLF1 A_52_P304720 cytokine receptor-like factor 1 1,357
CTSF A_52_P660945 cathepsin F 1,220
CYB5R2 A_55_P2090214 cytochrome b5 reductase 2 2,524
CYP26C1 A_55_P2035407 cytochrome P450, family 26, 
subfamily C, polypeptide 1
1,880
CYP4B1 A_55_P2117959 cytochrome P450, family 4, 
subfamily B, polypeptide 1
1,494
D630032N06Rik A_52_P400637 RIKEN cDNA D630032N06 gene 1,163
DAB1 A_51_P437135 Dab, reelin signal transducer, 
homolog 1 (Drosophila)
1,394
DBP A_55_P2032081 D site of albumin promoter (albumin 
D-box) binding protein
1,674
DDIT3 A_52_P533146 DNA-damage-inducible transcript 3 1,944
DDIT4 A_51_P245796 DNA-damage-inducible transcript 4 3,097
DHRS3 A_55_P2020128 dehydrogenase/reductase (SDR 
family) member 3
1,163
Dnhd1 A_55_P2166703 dynein heavy chain domain 1 1,076
EBF4 A_55_P2011981 early B-cell factor 4 1,333
EDIL3 A_52_P325527 EGF-like repeats and discoidin I-like 
domains 3
1,219
EFHC1 A_51_P440327 EF-hand domain (C-terminal) 
containing 1
1,032
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EGLN1 A_51_P186899 egl nine homolog 1 (C. elegans) 1,146
EGLN3 A_55_P1960916 egl nine homolog 3 (C. elegans) 3,119
EIF4B A_52_P390114 eukaryotic translation initiation 
factor 4B
1,041
ENO2 A_55_P2019457 enolase 2 (gamma, neuronal) 4,184
ENPP5 A_55_P2021704 ectonucleotide pyrophosphatase/
phosphodiesterase 5 (putative)
1,648
EPM2A A_55_P1992034 epilepsy, progressive myoclonus 
type 2A, Lafora disease (laforin)
2,488
ERO1L A_51_P481693 ERO1-like (S. cerevisiae) 1,965
ESM1 A_52_P257625 endothelial cell-specific molecule 1 1,871
ESPN A_55_P1997651 espin 2,484
EZH1 A_55_P2017086 enhancer of zeste homolog 1 
(Drosophila)
1,349
F3 A_65_P08971 coagulation factor III 
(thromboplastin, tissue factor)
1,171
FAM163B A_55_P2168441 family with sequence similarity 163, 
member B
1,306
FAM169A A_52_P488623 family with sequence similarity 169, 
member A
1,271
FAM71F2 A_55_P2125613 family with sequence similarity 71, 
member F2
1,815
FBXL20 A_55_P1976859 F-box and leucine-rich repeat protein 
20
1,190
FERMT3 A_52_P38639 fermitin family member 3 2,268
FGF12 A_52_P193161 fibroblast growth factor 12 1,606
FHAD1 A_55_P1956659 forkhead-associated (FHA) 
phosphopeptide binding domain 1
1,140
FLT1 A_55_P2166282 fms-related tyrosine kinase 1 1,908
FN3K A_55_P2040090 fructosamine 3 kinase 2,014
FNDC1 A_51_P153423 fibronectin type III domain 
containing 1
1,280
FOXO3 A_55_P2150896 forkhead box O3 1,432
FST A_55_P2394308 follistatin 1,361
FUT1 A_55_P1986247 fucosyltransferase 1 (galactoside 
2-alpha-L-fucosyltransferase, H 
blood group)
2,957
FYB A_55_P2006869 FYN binding protein 2,975
GAA A_55_P2024429 glucosidase, alpha; acid 1,121
GAD1 A_52_P144310 glutamate decarboxylase 1 (brain, 
67kDa)
3,430
GIPR A_52_P238468 gastric inhibitory polypeptide 
receptor
3,238
GLS2 A_51_P169087 glutaminase 2 (liver, mitochondrial) 1,728
Gm10621 A_55_P2070262 predicted gene 10621 1,049
Gm10766 A_55_P2044488 predicted gene 10766 1,015
Gm12592 A_66_P103753 predicted gene 12592 2,351
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Gm12758 A_55_P2329298 predicted gene 12758 1,441
Gm12866 A_66_P124728 predicted gene 12866 1,564
Gm14207 A_55_P2155848 predicted gene 14207 1,469
Gm15850 A_55_P2402577 predicted gene 15850 1,908
Gm2011 A_66_P129619 predicted gene 2011 2,162
Gm3367 A_66_P101261 predicted gene 3367 2,849
Gm4791 A_66_P133103 predicted gene 4791 1,578
GPR114 A_55_P2156638 G protein-coupled receptor 114 1,318
GPR146 A_55_P2027392 G protein-coupled receptor 146 1,600
GPT2 A_51_P493886 glutamic pyruvate transaminase 
(alanine aminotransferase) 2
1,248
GYS1 A_55_P2026315 glycogen synthase 1 (muscle) 1,541
HEXA A_51_P282667 hexosaminidase A (alpha 
polypeptide)
1,025
HEXB A_51_P453111 hexosaminidase B (beta polypeptide) 1,699
HIF3A A_55_P2015541 hypoxia inducible factor 3, alpha 
subunit
1,057
HK2 A_51_P204080 hexokinase 2 1,772
HLA-DMB A_51_P278868 major histocompatibility complex, 
class II, DM beta
1,229
HMX2 A_55_P2099620 H6 family homeobox 2 3,443
HMX3 A_51_P413910 H6 family homeobox 3 2,865
HRK A_55_P2083559 harakiri, BCL2 interacting protein 
(contains only BH3 domain)
2,821
HSPA1A/HSPA1B A_55_P2068459 heat shock 70kDa protein 1A 2,729
IDUA A_55_P2097178 iduronidase, alpha-L- 1,319
IER3 A_51_P286488 immediate early response 3 3,466
IGFBP2 A_55_P2056729 insulin-like growth factor binding 
protein 2, 36kDa
1,454
Il4i1/Nup62-il4i1 A_55_P2087622 interleukin 4 induced 1 1,598
Isoc2b A_51_P343356 isochorismatase domain containing 
2b
1,059
ITGA2B A_52_P459564 integrin, alpha 2b (platelet 
glycoprotein IIb of IIb/IIIa complex, 
antigen CD41)
1,858
JAK3 A_51_P355360 Janus kinase 3 1,087
JDP2 A_51_P254646 Jun dimerization protein 2 1,146
JHDM1D A_55_P1962675 jumonji C domain containing histone 
demethylase 1 homolog D (S. 
cerevisiae)
1,705
JPH1 A_55_P2163744 junctophilin 1 1,149
Jpx A_55_P2253169 Jpx transcript, Xist activator (non-
protein coding)
1,197
KBTBD11 A_55_P2075213 kelch repeat and BTB (POZ) domain 
containing 11
4,523
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KCNE3 A_51_P336599 potassium voltage-gated channel, 
Isk-related family, member 3
2,668
KCNJ4 A_51_P166740 potassium inwardly-rectifying 
channel, subfamily J, member 4
1,469
KCNT2 A_55_P1961730 potassium channel, subfamily T, 
member 2
1,040
KCTD16 A_51_P266579 potassium channel tetramerisation 
domain containing 16
3,691
KDM3A A_55_P1982578 lysine (K)-specific demethylase 3A 1,557
KHNYN A_52_P641849 KH and NYN domain containing 1,175
KIT A_66_P128434 v-kit Hardy-Zuckerman 4 feline 
sarcoma viral oncogene homolog
1,306
KLHL24 A_55_P1962284 kelch-like family member 24 1,273
KRT19 A_51_P356642 keratin 19 3,015
Krt42 A_55_P2013840 keratin 42 2,966
LAMA5 A_55_P2064321 laminin, alpha 5 1,242
LAMB3 A_55_P1967196 laminin, beta 3 1,664
LDHD A_55_P2018697 lactate dehydrogenase D 1,633
LINGO3 A_51_P436491 leucine rich repeat and Ig domain 
containing 3
1,796
LOC106740 A_55_P2189571 uncharacterized LOC106740 1,252
LOX A_55_P2032678 lysyl oxidase 2,304
LOXL2 A_52_P480351 lysyl oxidase-like 2 1,563
LRFN2 A_51_P229498 leucine rich repeat and fibronectin 
type III domain containing 2
1,380
LRP2 A_55_P2099677 low density lipoprotein receptor-
related protein 2
1,543
Lrrc51 A_55_P1999760 leucine rich repeat containing 51 1,545
LUC7L2 A_55_P1953369 LUC7-like 2 (S. cerevisiae) 1,749
MACROD1 A_51_P213030 MACRO domain containing 1 1,084
MAFF A_52_P608322 v-maf musculoaponeurotic 
fibrosarcoma oncogene homolog F 
(avian)
2,092
MAML3 A_52_P47126 mastermind-like 3 (Drosophila) 1,201
MAP3K1 A_55_P1961084 mitogen-activated protein kinase 
kinase kinase 1, E3 ubiquitin protein 
ligase
1,029
MEF2B A_55_P1959784 myocyte enhancer factor 2B 2,215
METTL7A A_55_P2172822 methyltransferase like 7A 3,235
MGARP A_55_P2048759 mitochondria-localized glutamic 
acid-rich protein
2,390
MORN1 A_51_P423825 MORN repeat containing 1 1,107
MT1E A_66_P111660 metallothionein 1E 2,410
MT1H A_51_P246317 metallothionein 1H 2,324
Muc2 A_51_P128320 mucin 2 2,948
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NAMPT A_51_P387235 nicotinamide 
phosphoribosyltransferase
1,062
NDRG1 A_51_P405606 N-myc downstream regulated 1 4,424
NDRG2 A_51_P176352 NDRG family member 2 1,852
NDUFA4L2 A_55_P1971244 NADH dehydrogenase (ubiquinone) 
1 alpha subcomplex, 4-like 2
5,046
NEFH A_55_P2099790 neurofilament, heavy polypeptide 1,229
NEIL2 A_55_P2099418 nei endonuclease VIII-like 2 (E. coli) 1,712
NMRK2 A_51_P369762 nicotinamide riboside kinase 2 1,991
NR4A1 A_51_P239654 nuclear receptor subfamily 4, group 
A, member 1
1,079
NRCAM A_55_P2003541 neuronal cell adhesion molecule 1,283
NRN1 A_51_P308844 neuritin 1 3,752
Nrxn3 A_55_P2054643 neurexin III 1,375
NUPR1 A_51_P519251 nuclear protein, transcriptional 
regulator, 1
3,553
NYAP1 A_55_P1999923 neuronal tyrosine-phosphorylated 
phosphoinositide-3-kinase adaptor 1
1,555
Olfr1383 A_55_P1987284 olfactory receptor 1383 1,923
P2RX4 A_55_P2183015 purinergic receptor P2X, ligand-
gated ion channel, 4
1,094
P4HA1 A_55_P2097808 prolyl 4-hydroxylase, alpha 
polypeptide I
1,939
P4HA2 A_52_P663413 prolyl 4-hydroxylase, alpha 
polypeptide II
2,702
PBLD A_51_P165451 phenazine biosynthesis-like protein 
domain containing
1,261
PCSK4 A_55_P2167269 proprotein convertase subtilisin/
kexin type 4
1,357
PDE4B A_52_P423247 phosphodiesterase 4B, cAMP-
specific
1,017
PDGFB A_55_P1974441 platelet-derived growth factor beta 
polypeptide
2,022
PDK1 A_51_P406429 pyruvate dehydrogenase kinase, 
isozyme 1
1,522
PF4 A_51_P441426 platelet factor 4 3,625
PFKFB3 A_52_P362917 6-phosphofructo-2-kinase/fructose-
2,6-biphosphatase 3
2,493
PFKP A_51_P378856 phosphofructokinase, platelet 1,426
PGM1 A_55_P1987483 phosphoglucomutase 1 1,191
PHF15 A_55_P2139753 PHD finger protein 15 1,194
PHYHD1 A_55_P2094896 phytanoyl-CoA dioxygenase domain 
containing 1
1,909
PIK3IP1 A_51_P463428 phosphoinositide-3-kinase 
interacting protein 1
2,126
PIP5K1A A_55_P1999902 phosphatidylinositol-4-phosphate 
5-kinase, type I, alpha
2,055
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PLEKHA2 A_55_P2156274 pleckstrin homology 
domain containing, family A 
(phosphoinositide binding specific) 
member 2
1,549
PLOD2 A_51_P396570 procollagen-lysine, 2-oxoglutarate 
5-dioxygenase 2
1,812
PORCN A_55_P2077666 porcupine homolog (Drosophila) 1,040
PPBP A_51_P428372 pro-platelet basic protein (chemokine 
(C-X-C motif) ligand 7)
4,268
PPIL6 A_51_P224042 peptidylprolyl isomerase 
(cyclophilin)-like 6
1,260
PPP1R16B A_55_P2057040 protein phosphatase 1, regulatory 
subunit 16B
1,477
PPP1R3C A_52_P30451 protein phosphatase 1, regulatory 
subunit 3C
1,646
PPP1R3G A_51_P155873 protein phosphatase 1, regulatory 
subunit 3G
1,084
Ppp4r1l-ps A_52_P91891 protein phosphatase 4, regulatory 
subunit 1-like, pseudogene
1,133
PRELID2 A_51_P480119 PRELI domain containing 2 1,691
PRKAR1B A_55_P2176280 protein kinase, cAMP-dependent, 
regulatory, type I, beta
1,096
PROSER2 A_51_P474169 proline and serine-rich protein 2 1,549
PRSS35 A_55_P2111985 protease, serine, 35 1,715
PTPRZ1 A_55_P2173682 protein tyrosine phosphatase, 
receptor-type, Z polypeptide 1
2,114
Pvr A_52_P628590 poliovirus receptor 1,113
PYCR1 A_51_P503896 pyrroline-5-carboxylate reductase 1 1,459
PYGL A_51_P452779 phosphorylase, glycogen, liver 1,616
RAD9B A_51_P513013 RAD9 homolog B (S. pombe) 1,461
RASD2 A_55_P2107155 RASD family, member 2 1,212
RDM1 A_51_P433127 RAD52 motif 1 1,028
RENBP A_55_P2013357 renin binding protein 1,647
RGS11 A_55_P2000354 regulator of G-protein signaling 11 3,155
RGS9 A_55_P2032232 regulator of G-protein signaling 9 1,046
RNF19A A_51_P277444 ring finger protein 19A, E3 ubiquitin 
protein ligase
1,281
ROBO2 A_52_P597791 roundabout, axon guidance receptor, 
homolog 2 (Drosophila)
1,187
RORA A_55_P2078123 RAR-related orphan receptor A 3,246
RORC A_55_P2051094 RAR-related orphan receptor C 1,450
RPP25 A_51_P104392 ribonuclease P/MRP 25kDa subunit 1,465
RPS6KC1 A_55_P2083664 ribosomal protein S6 kinase, 52kDa, 
polypeptide 1
1,372
RRAS A_52_P635182 related RAS viral (r-ras) oncogene 
homolog
1,186
S100A1 A_55_P1979650 S100 calcium binding protein A1 1,401
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SDC4 A_52_P93467 syndecan 4 1,855
SEMA3B A_55_P1973868 sema domain, immunoglobulin 
domain (Ig), short basic domain, 
secreted, (semaphorin) 3B
1,259
SEMA4G A_51_P331003 sema domain, immunoglobulin 
domain (Ig), transmembrane domain 
(TM) and short cytoplasmic domain, 
(semaphorin) 4G
1,473
SESN2 A_51_P161354 sestrin 2 1,327
SHMT2 A_51_P313761 serine hydroxymethyltransferase 2 
(mitochondrial)
1,008
SLA A_52_P513177 Src-like-adaptor 2,131
SLAMF9 A_51_P246066 SLAM family member 9 1,918
SLC16A6 A_52_P579933 solute carrier family 16, member 6 
(monocarboxylic acid transporter 7)
1,264
SLC16A9 A_51_P493117 solute carrier family 16, member 9 
(monocarboxylic acid transporter 9)
1,516
SLC1A6 A_51_P283016 solute carrier family 1 (high affinity 
aspartate/glutamate transporter), 
member 6
1,017
SLC22A7 A_51_P395856 solute carrier family 22 (organic 
anion transporter), member 7
1,202
Slc26a10 A_55_P2087067 solute carrier family 26, member 10 1,273
SLC2A1 A_51_P464738 solute carrier family 2 (facilitated 
glucose transporter), member 1
1,060
SLC2A3 A_52_P354744 solute carrier family 2 (facilitated 
glucose transporter), member 3
2,224
SLC35D3 A_52_P467488 solute carrier family 35, member D3 1,910
SLC38A3 A_51_P139030 solute carrier family 38, member 3 2,168
SLC39A5 A_51_P206235 solute carrier family 39 (metal ion 
transporter), member 5
1,180
SLC6A9 A_55_P1973838 solute carrier family 6 
(neurotransmitter transporter, 
glycine), member 9
1,079
SLC7A3 A_55_P1988384 solute carrier family 7 (cationic 
amino acid transporter, y+ system), 
member 3
4,430
SLC7A5 A_55_P2017972 solute carrier family 7 (amino acid 
transporter light chain, L system), 
member 5
1,426
SNCB A_51_P448971 synuclein, beta 4,016
SNX21 A_51_P323521 sorting nexin family member 21 1,030
SOX17 A_55_P2157023 SRY (sex determining region Y)-box 
17
1,199
ST3GAL1 A_51_P301804 ST3 beta-galactoside alpha-2,3-
sialyltransferase 1
1,955
STAB1 A_51_P232371 stabilin 1 1,094
STAG3 A_51_P494822 stromal antigen 3 1,244
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STC1 A_51_P233334 stanniocalcin 1 2,762
STC2 A_51_P208922 stanniocalcin 2 3,835
Sts A_51_P377526 steroid sulfatase 1,686
SULT6B1 A_51_P318577 sulfotransferase family, cytosolic, 
6B, member 1
1,496
SYNGR1 A_52_P239320 synaptogyrin 1 1,832
SYT3 A_55_P2048441 synaptotagmin III 1,131
TAC1 A_55_P1954693 tachykinin, precursor 1 1,274
TBL2 A_52_P499206 transducin (beta)-like 2 1,061
TCHH A_52_P468068 trichohyalin 1,481
TEF A_55_P1979893 thyrotrophic embryonic factor 1,164
TEX40 A_51_P182257 testis expressed 40 1,629
Tmem191c A_51_P165082 transmembrane protein 191C 1,271
TMEM217 A_55_P2153411 transmembrane protein 217 1,501
TMEM45A A_51_P288876 transmembrane protein 45A 2,077
TMEM74B A_55_P2002768 transmembrane protein 74B 2,996
TMPRSS13 A_55_P2177998 transmembrane protease, serine 13 1,481
TMTC1 A_55_P1975645 transmembrane and tetratricopeptide 
repeat containing 1
1,518
TNFAIP3 A_55_P2053838 tumor necrosis factor, alpha-induced 
protein 3
1,427
TRAPPC6A A_55_P2106250 trafficking protein particle complex 
6A
1,338
TRIB3 A_55_P2009988 tribbles homolog 3 (Drosophila) 4,037
TRIOBP A_55_P1953353 TRIO and F-actin binding protein 1,858
UAP1L1 A_51_P509669 UDP-N-acteylglucosamine 
pyrophosphorylase 1-like 1
1,459
UPP1 A_51_P302738 uridine phosphorylase 1 1,805
USP35 A_55_P1970454 ubiquitin specific peptidase 35 1,588
VEGFA A_52_P638895 vascular endothelial growth factor A 2,429
VLDLR A_55_P2030524 very low density lipoprotein receptor 3,054
VSIG2 A_55_P2083879 V-set and immunoglobulin domain 
containing 2
1,265
VSIG8 A_55_P2124233 V-set and immunoglobulin domain 
containing 8
1,360
VSTM5 A_51_P220934 V-set and transmembrane domain 
containing 5
1,964
VWF A_55_P2169659 von Willebrand factor 2,267
WDR64 A_51_P184991 WD repeat domain 64 2,399
WIPI1 A_55_P1968808 WD repeat domain, phosphoinositide 
interacting 1
1,025
YBX2 A_55_P1973447 Y box binding protein 2 1,325
ZAN A_55_P2148809 zonadhesin 1,178
ZBTB4 A_55_P2165655 zinc finger and BTB domain 
containing 4
1,076
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Zbtb7b A_51_P473229 zinc finger and BTB domain 
containing 7B
1,142
ZC3H6 A_52_P139819 zinc finger CCCH-type containing 6 2,164
ZCWPW1 A_52_P154026 zinc finger, CW type with PWWP 
domain 1
1,066
ZFR2 A_55_P2053320 zinc finger RNA binding protein 2 1,608
ZMYM6 A_55_P2069525 zinc finger, MYM-type 6 1,011
ZMYM6NB A_55_P2019909 ZMYM6 neighbor 1,096
ZNF383 A_55_P2059936 zinc finger protein 383 1,118
ZNF395 A_55_P2117590 zinc finger protein 395 1,473
GENES DOWNREGULATED IN HEART, HEAD AND TRUNK
Symbol ID Entrez Gene Name logFC Heart
1700121C10Rik A_51_P313397 RIKEN cDNA 1700121C10 gene -1,520
2310026L22Rik A_66_P101427 RIKEN cDNA 2310026L22 gene -1,393
4930524J08Rik A_51_P415247 RIKEN cDNA 4930524J08 gene -1,274
5930422O12Rik A_55_P2115696 RIKEN cDNA 5930422O12 gene -1,509
6030408B16Rik A_66_P136813 RIKEN cDNA 6030408B16 gene -1,602
6530403G13Rik A_55_P2146389 RIKEN cDNA 6530403G13 gene -1,189
A730089K16Rik A_55_P2305010 RIKEN cDNA A730089K16 gene -1,528
ACSBG1 A_52_P496956 acyl-CoA synthetase bubblegum 
family member 1
-1,953
ACYP2 A_55_P2005666 acylphosphatase 2, muscle type -1,788
Adam4/Gm4787 A_66_P101707 a disintegrin and metallopeptidase 
domain 4
-1,687
AMICA1 A_52_P375312 adhesion molecule, interacts with 
CXADR antigen 1
-1,893
AMIGO3 A_51_P442933 adhesion molecule with Ig-like domain 
3
-1,301
AP3B2 A_55_P1982229 adaptor-related protein complex 3, beta 
2 subunit
-1,412
APH1B A_52_P456750 anterior pharynx defective 1 homolog 
B (C. elegans)
-1,350
APOBEC3B A_52_P308875 apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide-like 3B
-1,862
ARID3B A_55_P2123993 AT rich interactive domain 3B 
(BRIGHT-like)
-4,180
ASTN1 A_51_P143951 astrotactin 1 -1,103
ATM A_52_P400509 ataxia telangiectasia mutated -1,318
BRSK2 A_51_P160581 BR serine/threonine kinase 2 -2,034
C11orf1 A_55_P2023290 chromosome 11 open reading frame 1 -1,562
C5orf49 A_51_P234847 chromosome 5 open reading frame 49 -1,544
C9orf64 A_51_P224175 chromosome 9 open reading frame 64 -1,541
CBY1 A_51_P470311 chibby homolog 1 (Drosophila) -1,186
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Ccdc177 A_55_P1990200 coiled-coil domain containing 177 -1,215
CCDC30 A_66_P106421 coiled-coil domain containing 30 -1,547
CCL13 A_51_P286737 chemokine (C-C motif) ligand 13 -2,226
CLDN15 A_51_P306710 claudin 15 -1,042
CPA1 A_52_P161237 carboxypeptidase A1 (pancreatic) -1,051
Cryge A_55_P1975250 crystallin, gamma E -1,844
CTU2 A_55_P2027634 cytosolic thiouridylase subunit 2 
homolog (S. pombe)
-1,521
CYB5B A_55_P1963712 cytochrome b5 type B (outer 
mitochondrial membrane)
-1,055
Cycs A_55_P1968958 cytochrome c, somatic -1,230
D630045M09Rik A_55_P2335648 RIKEN cDNA D630045M09 gene -1,718
DBH A_55_P1974243 dopamine beta-hydroxylase (dopamine 
beta-monooxygenase)
-1,498
DIXDC1 A_52_P434279 DIX domain containing 1 -1,483
DNAH7 A_55_P2184023 dynein, axonemal, heavy chain 7 -1,507
DPYSL4 A_55_P1988413 dihydropyrimidinase-like 4 -1,965
E130201H02Rik A_55_P2066568 Y box protein 1 pseudogene -1,637
EHD2 A_55_P2076906 EH-domain containing 2 -1,111
FAM118B A_55_P2462358 family with sequence similarity 118, 
member B
-1,072
FAM209B A_51_P137184 family with sequence similarity 209, 
member B
-1,159
FBP1 A_51_P474701 fructose-1,6-bisphosphatase 1 -1,260
Fbxl22 A_51_P466685 F-box and leucine-rich repeat protein 
22
-1,928
FDFT1 A_52_P136138 farnesyl-diphosphate 
farnesyltransferase 1
-1,076
Gm10099 A_66_P131406 predicted gene 10099 -1,659
Gm10548 A_66_P105771 ribosomal protein L29 pseudogene -1,357
Gm10664 A_52_P1037027 predicted gene 10664 -1,052
Gm10751 A_55_P2121446 predicted gene 10751 -1,202
Gm13429 A_66_P126459 predicted gene 13429 -1,223
Gm4129 A_55_P2181665 predicted gene 4129 -1,536
Gm5868 A_55_P2034870 predicted gene 5868 -1,710
Gm7271 A_55_P2118234 predicted gene 7271 -1,018
GPD1 A_52_P16419 glycerol-3-phosphate dehydrogenase 1 
(soluble)
-1,267
GPR17 A_51_P170463 G protein-coupled receptor 17 -1,255
GPR84 A_55_P2044932 G protein-coupled receptor 84 -1,832
GPRIN1 A_55_P1967010 G protein regulated inducer of neurite 
outgrowth 1
-1,316
GRK4 A_55_P2155347 G protein-coupled receptor kinase 4 -1,926
GUSB A_52_P160936 glucuronidase, beta -1,106
HDHD3 A_51_P465582 haloacid dehalogenase-like hydrolase 
domain containing 3
-1,031
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HEYL A_52_P337259 hairy/enhancer-of-split related with 
YRPW motif-like
-1,405
HPDL A_51_P317214 4-hydroxyphenylpyruvate 
dioxygenase-like
-1,181
HSD17B7 A_55_P1964598 hydroxysteroid (17-beta) 
dehydrogenase 7
-1,541
HSPH1 A_55_P2003513 heat shock 105kDa/110kDa protein 1 -1,303
INSC A_55_P2038183 inscuteable homolog (Drosophila) -1,855
ITPKA A_51_P273609 inositol-trisphosphate 3-kinase A -1,240
KALRN A_55_P2160623 kalirin, RhoGEF kinase -1,322
KLHL25 A_51_P208121 kelch-like family member 25 -1,064
KRT15 A_55_P2006261 keratin 15 -1,158
KRT36 A_55_P2140036 keratin 36 -1,699
Lipo1/Lipo4 A_55_P2040777 lipase, member O1 -1,342
LRP8 A_55_P2014555 low density lipoprotein receptor-
related protein 8, apolipoprotein e 
receptor
-1,321
LRRC4 A_55_P2176080 leucine rich repeat containing 4 -1,302
LRRC49 A_55_P2054967 leucine rich repeat containing 49 -1,324
LRTM1 A_51_P326685 leucine-rich repeats and 
transmembrane domains 1
-1,401
MRPS11 A_52_P582394 mitochondrial ribosomal protein S11 -1,005
MSRB2 A_51_P464911 methionine sulfoxide reductase B2 -1,400
MT-CO3 A_65_P07196 cytochrome c oxidase III -1,628
MT-CYB A_51_P315595 cytochrome b -1,886
MT-ND1 A_65_P05358 NADH dehydrogenase, subunit 1 
(complex I)
-2,110
MT-ND3 A_55_P2132147 NADH dehydrogenase, subunit 3 
(complex I)
-1,689
MUC4 A_55_P2025687 mucin 4, cell surface associated -2,333
MYB A_55_P2017826 v-myb myeloblastosis viral oncogene 
homolog (avian)
-1,528
NDUFAF2 A_52_P2947 NADH dehydrogenase (ubiquinone) 
complex I, assembly factor 2
-1,291
NETO2 A_52_P381799 neuropilin (NRP) and tolloid (TLL)-
like 2
-1,425
NHLH2 A_55_P2123902 nescient helix loop helix 2 -2,532
NMI A_55_P2034705 N-myc (and STAT) interactor -1,008
NOVA1 A_52_P204629 neuro-oncological ventral antigen 1 -1,354
NSDHL A_66_P137462 NAD(P) dependent steroid 
dehydrogenase-like
-1,089
OSCP1 A_66_P121279 organic solute carrier partner 1 -1,228
P2RY6 A_51_P105124 pyrimidinergic receptor P2Y, G-protein 
coupled, 6
-1,306
PIH1D2 A_55_P2052048 PIH1 domain containing 2 -1,650
SUPPLEMENTARY MATERIAL
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PIK3R3 A_55_P2000158 phosphoinositide-3-kinase, regulatory 
subunit 3 (gamma)
-1,666
PIN1 A_55_P2073268 peptidylprolyl cis/trans isomerase, 
NIMA-interacting 1
-1,018
PITPNA A_51_P466371 phosphatidylinositol transfer protein, 
alpha
-1,059
PKIA A_52_P314129 protein kinase (cAMP-dependent, 
catalytic) inhibitor alpha
-1,044
PPCDC A_52_P409457 phosphopantothenoylcysteine 
decarboxylase
-3,161
PTS A_52_P177021 6-pyruvoyltetrahydropterin synthase -1,130
RAB19 A_51_P414126 RAB19, member RAS oncogene 
family
-1,509
RGS4 A_55_P2026734 regulator of G-protein signaling 4 -1,036
RPS25 A_52_P436318 ribosomal protein S25 -1,098
Rps27a A_55_P2025173 ribosomal protein S27A -1,738
SAA1 A_55_P1994807 serum amyloid A1 -2,150
SF3B4 A_55_P2056293 splicing factor 3b, subunit 4, 49kDa -1,134
SLC25A35 A_52_P436447 solute carrier family 25, member 35 -1,937
SLFN13 A_55_P2135200 schlafen family member 13 -1,419
SNX11 A_55_P2120466 sorting nexin 11 -1,751
SPATA9 A_51_P212980 spermatogenesis associated 9 -1,561
SRRM4 A_52_P14456 serine/arginine repetitive matrix 4 -1,482
TAL2 A_52_P385594 T-cell acute lymphocytic leukemia 2 -1,457
TM4SF1 A_51_P240614 transmembrane 4 L six family member 
1
-1,559
TMED5 A_55_P2105346 transmembrane emp24 protein 
transport domain containing 5
-1,336
TMEM25 A_55_P2126572 transmembrane protein 25 -1,766
TMEM251 A_52_P8903 transmembrane protein 251 -1,029
TMEM56 A_52_P54261 transmembrane protein 56 -1,442
TOMM40L A_55_P2032363 translocase of outer mitochondrial 
membrane 40 homolog (yeast)-like
-1,212
TSSK6 A_55_P2107232 testis-specific serine kinase 6 -1,140
TTPA A_66_P128446 tocopherol (alpha) transfer protein -1,069
TTPAL A_55_P2054435 tocopherol (alpha) transfer protein-like -1,237
UTP6 A_52_P33927 UTP6, small subunit (SSU) 
processome component, homolog 
(yeast)
-1,412
WDR66 A_55_P2082096 WD repeat domain 66 -1,422
WSCD2 A_55_P2086455 WSC domain containing 2 -1,275
SUPPLEMENTARY MATERIAL
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GENES UPREGULATED IN THE HEART BUT NOT IN OTHER STRUCTURES
ATP2B2* A_51_P256384 ATPase, Ca++ transporting, plasma 
membrane 2
1,524
CYP26B1** A_51_P501844 cytochrome P450, family 26, 
subfamily B, polypeptide 1
1,406
ROBO3* A_55_P2144886 roundabout, axon guidance 
receptor, homolog 3 (Drosophila)
1,557
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Cuando te acercas al final de la tesis (y si, además, estás acabando un paper a la vez), el único 
deseo, entre las correcciones, los últimos experimentos, las becas, la búsqueda de postdoc…, es 
acabar todo lo antes posible. Y a uno se le olvida que junto con la tesis también termina el placer de 
compartir tu día a día en el laboratorio (y fuera de él) con gente que has conocido a lo largo de todo 
este tiempo y que realmente ha hecho posible que sea más llevadera, más divertida e incluso más 
productiva. Hay muchas personas que, bien con sus sabios consejos científicos o bien con su no 
menos valioso apoyo afectivo, hicieron que días negros de laboratorio parecieran menos oscuros 
y que días con más suerte mejoraran aún más. Yo me siento muy afortunada del lugar donde he 
podido desarrollar esta tesis, no sólo por su excelentes instalaciones y medios, sino porque me ha 
dado la oportunidad de conocer a personas únicas, de las que aprendí muchísimo –tanto científica 
como personalmente–, y de encontrarme en un ambiente cómodo y amistoso. Y sé que cuando me 
vaya voy a echar de menos muchas cosas; sólo espero que pueda conservar, independientemente 
de dónde esté en un bastante incierto futuro, algunas de las relaciones tan especiales que se han 
forjado aquí. 
A lo largo de los siete años que he estado en el CNIC, he tenido la oportunidad de contar con 
la ayuda y el apoyo de muchos profesionales que lograron obtener lo mejor de mis experimentos. 
Muchas gracias a Ana Belén, que cuidó con tanto amor a mis ratones y que con su trabajo y 
dedicación evitó problemas mayores debidos a mis despistes. Gracias a Antonio y a Elvira, por la 
constante ayuda con los diferentes microscopios y por los consejos de análisis de imagen. Gracias 
también al equipo de Genómica y a Fátima, por los tres microarrays que se han hecho y analizado 
a lo largo de esta tesis, y en especial a Sergio, por la ayuda con las qPCRs. Gracias a Giovanna, 
por haberme enseñado a hacer MEFs y por habernos generado el mutante condicional. También 
gracias a Roisin, para la cual no existe misterio de histología que no pueda resolver.
Quería darle las gracias a Miguel Torres por haberme brindado la oportunidad de llevar a cabo 
mi tesis en el departamento de Desarrollo Cardiovascular, por todo su apoyo y por sus acertados 
consejos sobre el proyecto. También por haber aceptado ser mi tutor y por haber encontrado tiempo 
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